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Enzymes are often sought after for applications in industry and synthetic chemistry due 
to their high reactivity and substrate selectivity, often surpassing their chemical counterparts. 
They are, however, limited by their structural instability and require restrictive environmental 
conditions that are often not compatible with industrial processing. As such, new technologies 
are required to protect enzymes from non-biological conditions. This thesis investigates 
enzyme immobilisation using porous frameworks including metal-organic frameworks 
(MOFs) and hydrogen-bonded organic frameworks (HOFs). The diverse nature of both the 
enzyme and MOF/HOF components offers great potential for creating a broad library of 
biocomposites with novel function. There are however inherent challenges in finding 
appropriate conditions for immobilisation in which the enzyme remains active, and where the 
overall biocomposite is stable. 
Initial studies utilised Zeolitic Imidazolate Framework 8 (ZIF-8), a subclass of MOFs, 
for protein immobilisation. The addition of biomacromolecules, such as proteins, can promote 
the self-assembly of ZIF-8 by a process known as “biomimetic mineralisation”. Systematic 
screening studies established that this process is biomacromolecule dependent, with a subset 
of proteins requiring the addition of organic solvent or increased ligand concentrations to 
promote ZIF-8 nucleation. These reaction conditions were also instrumental in controlling the 
topology, morphology, and particle size of the biocomposites. Investigations into the influence 
of the protein revealed that biomimetic mineralisation is governed by the surface chemistry of 
the biomacromolecules, with a more negative surface charge promoting rapid nucleation, 
resulting from enhanced zinc ion concentration at the surface. Chemical functionalisation can 
be implemented, to alter the electrostatic potential of the protein surface and control the 
biomimetic mineralisation process. 
The biocomposites from different immobilisation strategies for ZIF-8 were assessed for 
biocatalytic activity using two distinct enzymes, a lipase, and a dehalogenase. The activity was 
analysed relative to the free enzyme to interrogate the impact of immobilisation on the function 
and stability of the biocatalyst. Variation in support stability and biocomposite activity were 
observed. Each were dependent on the method of immobilisation with some strategies yielding 
inactive or unstable biocomposites. For lipase, the ZIF-8 framework provided enzymatic 
stability to organic solvent, whilst the framework itself was susceptible to degradation by 





degradation was observed that was deemed responsible for variations in the observed enzyme 
activity. These findings highlight the potential limitations of ZIF-8 for enzyme immobilisation 
and as such, alternative porous supports were targeted. 
Framework chemistry and porosity were further investigated utilising Zeolitic 
Imidazolate Framework-90 (ZIF-90) and a biologically compatible HOF (BioHOF-1) to 
immobilise the lipase and dehalogenase enzymes. Relative to ZIF-8, enhanced activity was 
observed for both enzymes upon immobilisation using these frameworks, with the lipase 
biocomposites demonstrating retention of enantioselectivity, comparable to the free enzyme. 
However, the metal based ZIF-90 material faced similar challenges to ZIF-8, being unstable 
towards phosphate buffer and the dehalogenation reaction conditions. The preliminary results 
for BioHOF-1 were promising, with both enzyme biocomposites maintaining high levels of 
activity, and enzyme stability. BioHOF-1 was capable of protecting the enzymes to denaturing 
conditions including thermal treatment (dehalogenase) and organic solvents (lipase). 
Additionally, both biocomposites could be recycled five times without a significant reduction 
in activity. 
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Chapter 1: Introduction 
1.1 Biocatalysis Overview 
Biocatalysis is a diverse field of research that utilises biological systems to increase the 
rate of complex chemical reactions. Protein catalysts, known as enzymes, are responsible for 
mediating a wide variety of chemical transformations in nature, operating with high specificity 
and catalytic activity.1-2 More specifically, biocatalysis refers to the study of these naturally 
occurring reactions, with the goal of extending their application into new settings beyond the 
cell.3 Early examples of biocatalysis involved the use of whole-cell systems, such as 
fermentation in yeast cells, which utilise the molecular components of the cells for cascading, 
multi-enzyme reaction pathways.4 As such, whole-cell catalysis is a cost-effective technique, 
which minimises the need for the extraction and purification of enzymes and cofactors, 
allowing for both the synthesis and metabolism of complicated molecules.5-6 However, due to 
the intricate nature of whole-cell systems there are inherent challenges in maintaining cell 
viability and control over the reaction selectivity which complicates product extraction and 
waste separation steps.6  
Alternatively, enzymes can be isolated from these systems and applied as crude or 
purified cell extracts, essentially uncoupling the cell growth phase from enzyme catalysis. 
Enzyme purification simplifies the investigation of biological transformations in several ways; 
by reducing the number of enzyme catalysts and unwanted side reactions,  and allowing for the 
step-wise assessment of complicated processes.6 Additionally, utilising pure enzymes enables 
the selective screening of potential substrate compounds which can provide insight into the 
structural and functional properties of each enzyme. Novel substrates can be screened, to 
understand an enzyme’s natural function, potentially expand its application to compounds 
beyond their biological targets.7 With this understanding, the complexity of the biocatalytic 
system can be systematically increased by introducing complementary enzymes that mediate 
controlled, multi-step reactions or those that act on toxic by-products.8-10 For example, enzymes 
that break down hydrogen peroxide (H2O2) can be a useful addition to reactions that generate 
H2O2 as by-product, thus extending the life of the primary enzyme.11-12  
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1.2. Structure-Function Relationship 
One of the advantages of using enzymes over standard chemical catalysts revolves 
around their highly selective nature where they can distinguish between substrates of similar 
functionality and structure.1-2 Enzymes are able to catalyse a broad range of reactions under 
mild conditions. In comparison, chemical catalysts often require harsher reaction conditions to 
afford similar activity and selectivity, including elevated temperature and pressure, making 
enzymes a more environmentally friendly alternative to chemical catalysts.12-13 As such, 
enzyme usage has become more commonplace in industry,14-16 and include applications in the 
production of biofuels,17-18 and pharmaceuticals,19-20 as well as in food technology,21-22 and the 
textile industry.23 
The activity and selectivity of enzymes is closely tied to their complex structure, which 
dictates substrate accessibility and the chemistry of the reactions they can catalyse.1, 24 Protein 
structure can be broken down into four basic levels of classification; primary through to 
quaternary, which describes the biomacromolecule from its amino acid sequence to its three-
dimensional fold, including subunit interactions (Figure 1.1). Enzyme catalysis is dependent 
on the chemistry of the catalytic residues in the active site and is tightly controlled in terms of 
activity and specificity by the spatial arrangement of surrounding amino acid residues.13 
 
Figure 1.1: Schematic of the four protein structural levels in order of increasing complexity. 
The primary structure refers to the amino acid (polypeptide) sequence which can fold through 
hydrogen bonding interactions of the chain backbone to yield secondary structure motifs of α-
helices and β-sheets. Amino acid side chain interactions (hydrophobic, hydrogen bonding, 
ionic and covalent [disulphide]) lead to the overall folded, tertiary structure of the protein. 
Multiple subunits can interact to form the functional, quaternary structure of the protein. 
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Enzymes are categorised by an enzyme commission number (EC) into four different 
levels of classification, dependant on the reactions they catalyse and the substrates they 
utilise.25 The first level classifies enzymes by their general reaction type (Table 1.1), however 
there is significant diversity within each sub-class in terms of reaction mechanism and substrate 
targets. For example, both Candida antarctica lipase B (EC.3.1.1.3) and the LinB dehalogenase 
(E.3.8.1.5) described in Chapters 4, 5, & 6, are classified as hydrolases despite significant 
differences in substrate recognition and active site mechanisms.25 
Table 1.1: Top level Enzyme Commission (EC) number for enzyme classification.25  
Class Reaction 
1. Oxidoreductase Hydrogen, oxygen or electron transfer 
2. Transferase Functional group transfer 
3. Hydrolase Hydrolytic bond cleavage 
4. Lyase Non-hydrolytic cleavage (addition or elimination) 
5. Isomerase Re-arrangement between isomers 
6. Ligase Bond formation between molecules (ATP dependant) 
7. Translocase Movement of ions across membranes 
 
The diversity of reactions that encompasses the lower level EC classifications can be 
attributed to the complexity of the protein folding, and thus the accessibility, binding affinity 
and orientation of substrates within the active site. Pathways that connect the exterior surface 
of the protein to the active site can discriminate between potential substrates based on size, and 
their general interactions with amino acids.26-27 Additionally, residues within the active site 
provide further control through positioning, and alignment of the target molecule towards the 
catalytic constituents. 28-29 The complexity of these interactions allow for enzymes to 
distinguish between structurally similar compounds, reacting in a chemo-, regio- and enantio-
selective manner. Active site residues also play key roles in proton abstraction/donation, 
nucleophilic bond formation, intermediate stabilisation, radical formation and substrate/co-
factor bond activation.29 Sequence homology to known enzymes can be used to predict function 
and substrate range, however minor variations in active site residues can alter the recognition 
of target compounds.3, 30 Binding and activity screening, in combination with structure based 
crystallographic studies, can provide insight into the binding interactions of substrates. With 
an understanding of the mechanism of binding, amino acid residues can be directly targeted for 
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protein engineering, where specific amino acids can be changed to create enzyme mutants with 
novel binding and function.31-32 The industrial application of enzymes can benefit from these 
protein engineering strategies, enabling the development of a diverse range of biocatalysts. 
Through the rational design of enzymes, substrate ranges can be altered to target more 
industrially relevant compounds, and has the potential to enhance activity, selectivity, and 
stability.26  
1.3. Stability 
Despite the potential of enzymes for industrial biocatalysis, the feasibility of their 
application is often impeded by their inherently weak structural interactions (hydrogen 
bonding, hydrophobic interactions, van der Waals and salt bridges).28, 33 To maintain the 
molecular integrity of the enzyme, stringent control of environmental conditions is required, 
often restricting biocatalysis to aqueous media, mild temperatures and narrow pH ranges. 
Enzyme structure is held together by a fine balance of entropic (protein folding and water loss) 
and enthalpic (hydrogen bond formation) contributions that can be easily perturbed by minimal 
energy input (10 kJ.mol-1).28,34 Disruptions to bonding forces by physical, chemical and 
biological denaturing agents (Table 1.2) can lead to protein unfolding that results in either 
enzyme denaturation or inactivation and thus loss of function.33 Polypeptide unfolding 
(denaturation) can be reversed upon removal of the denaturing agent allowing for the protein 
to refold, however excessive loss of structure or the formation of polypeptide aggregates can 
cause an irreversible loss of function (inactivation).35  
Table 1.2: Denaturing agents and the structural interactions they target (adapted from Iyer et. 
al.,2008).33 
Chemical Target 
Acid/Base Charged amino acids 
Organic solvent Hydrophobic interactions, solvation 
Surfactant Hydrophobic and/or charged amino acids 
Physical  
Heat/Cold Hydrogen bonds, hydrophobic bonding, protein solvation 
Radiation Disulphide and peptide bonds 
Force Protein solvation and void space 
Biological  
Protease Peptide bonds 
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1.3.1. Organic Solvent 
The solvent utilised for biocatalysis can have a significant influence on the rate, and 
selectively of the reaction, impacting both substrate solubility and the structure of the enzyme. 
To achieve maximum catalytic activity, the substrate and product compounds need to be 
soluble in the conditions that the enzyme is most active. Since the majority of these reactions 
require aqueous media there is an inherent limitation to the substrate range. Organic solvents 
can be included to increase substrate solubility and reduce competing side reactions, however, 
in their native form enzymes are susceptible to solvent effects and often show significantly 
reduced catalytic activity as the concentration of organic solvent is increased.33, 36-37 Water 
plays a fundamental role in preserving the intermolecular interactions that are essential to both 
protein folding and structural flexibility.38 Organic solvents can disrupt these interactions by 
multiple mechanisms that include the stripping of key water molecules from within the protein 
structure, or direct contact/binding of solvent molecules.37, 39 These processes induce polarity 
changes within the protein that can initiate unfolding and aggregation. It is often desirable to 
lower the water content of the reaction, to increase product formation and supress water 
dependant degradation (e.g. hydrolysis). For example, lipase enzymes can mediate competitive 
hydrolytic and esterification reactions, requiring finely tuned reaction conditions to maximise 
the desired product formation.39 Consequently, the solvent composition can have a significant 
impact on the equilibrium of the enzymatic reaction through substrate solubility constraints 
and solvent induced structural variation of the enzyme. 
1.3.2. Temperature 
The rate of enzymatic catalysis is dependent on protein structural dynamics, and thus 
is influenced by the temperature and duration of the reaction. Increasing the temperature can 
enhance the enzyme’s movement, accelerating the rate of catalysis up to an ‘optimum 
temperature’ that is specific to the enzyme. Enzymes can reversibly transition into 
unfavourable conformations that prelude irreversible structural changes, aggregation and 
permanent loss of activity.35, 40-41 Maintaining temperatures near this apparent optimum can 
reduce the longevity of the catalyst by shifting the equilibrium of the enzyme into the inactive 
conformation, thus increasing the probability of permanent deactivation.35, 40-41 As such, even 
at ambient temperatures, enzymes are generally not stable to extended storage or catalytic 
conditions, and would require frequent replacement.42 
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1.4. Stabilisation Strategies 
The development of new technologies that promote enzyme stability in non-biological 
conditions is required to maximise the productivity and longevity of enzymes for industrial 
catalysis.43 There are micro-organisms, known collectively as extremophiles, that are naturally 
more stable to the temperatures, solvents, substrate/product concentrations and pressures of 
industrial catalysis.44-46 Activity of the enzymes within these organisms is maintained in 
extreme conditions by the unique spatial arrangement of the protein and tight structural 
interactions that are more resistant to modification and conformational change.47-48 
Incorporating similar structural restraints to enzymes from non-extremophiles (mesophiles) has 
the potential to enhance their stability towards the desired reaction conditions.  
In their native form enzymes act as homogeneous catalysts and require separation from 
the reaction mixture using processes that are often challenging, expensive and denaturing to 
the protein structure.49-51 One means to do so, is to attach the protein to an inert support, in a 
technique known as enzyme immobilisation, where enzymes can be anchored to a surface, 
thereby restraining enzyme movement and protecting key residues from alteration. 
Immobilisation transforms enzymes into a heterogeneous form, thus providing an alternate 
method of separation to maximise their reusability.43, 52 As such, immobilisation strategies can 
afford enzyme composites that are more tolerant of harsh environments, whilst increasing their 
overall longevity. Methods of immobilisation that are utilised in both a research and industrial 
setting include enzyme cross-linking, covalent attachment/adsorption, and 
encapsulation/entrapment within biological or synthetic materials (Figure 1.2).43, 53-54  
 
Figure 1.2. Schematic of the four general processes of enzyme immobilisation. (a) Enzyme 
cross-linking (cross-linked enzyme aggregates, CLEA), (b-c) physical adsorption and covalent 
attachment onto a solid support, and (d) encapsulation/entrapment into biological or synthetic 
material. 
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1.5. Immobilisation 
1.5.1. General Considerations 
The primary goal of immobilisation is to stabilise enzymes in their active 
conformations, however, the properties of the support can lead to enzyme biocomposites of 
differing activity and stability.55 Careful consideration of the support material, the 
immobilisation method, and the final application, is therefore necessary when developing 
immobilised enzymes for use in challenging conditions. The chemical and physical properties 
of the support will play a pivotal role in the orientation, conformation and microenvironment 
(local solvent and substrate concentration) of the enzyme, which can influence substrate 
accessibility and binding.55 Immobilisation conditions including solvent choice, temperature, 
pH, and reagents need to be compatible to ensure the enzyme maintains its active structure 
during the immobilisation process and catalysis. As mentioned previously, enzymes require 
some structural movement for activity so there must be a compromise made between enzyme 
flexibility and stabilisation. Too much freedom may insufficiently protect the enzyme, whereas 
high levels of order may prevent the movement required for activity. Hence, an enzyme’s 
activity will likely differ at the solid-liquid interface, in comparison to homogenous catalysis 
in aqueous media, and careful consideration of the enzyme-support interactions is necessary. 
1.5.2.  Cross-linked Enzyme Aggregates (CLEAs) 
One stabilisation method that does not require an external support material is that of 
cross-linked enzymes aggregates (CLEAs). This process involves the addition of precipitating 
agents (salts, solvent, non-ionic polymers) to an enzyme solution, that leads to the formation 
of insoluble, but active conformation enzyme clusters.56-57 The interactions holding the enzyme 
molecules together are reversible, i.e. the enzyme can easily be resolubilised, and thus an 
addition of bi-functional cross-linking reagents, such as glutaraldehyde, is required to maintain 
integrity of the enzyme aggregates.58-59 This process yields a catalyst with a high enzyme 
loading, circumventing the need for expensive support materials. However, difficulties arise 
during formation, where polydisperse materials can form due to poor control over the 
aggregation and cross-linking processes.60-61 This can impact the material in several ways; the 
overall stability of the enzyme material, the ease in which the CLEAs can be separated and 
recycled, as well as the mass transfer of substrates to the internal surfaces of the aggregate.62 
Additionally, CLEAs have been reported to not retain enzyme activity over long periods of 
storage which limits their reusability and reduces their applicability. 
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1.5.3.  Adsorption 
A simple approach for immobilisation is enzyme adsorption onto a support material. 
Enzyme adherence typically occurs through reversible interactions that minimise perturbation 
to the enzyme structure including, van der Waals, ionic, and hydrogen bonding.63 Electrostatic 
enzyme-support interactions are inherently weak, meaning that in aqueous solutions there is a 
high chance for enzyme leaching. This method is therefore best suited for catalysis in organic 
solvents where low enzyme solubility disfavours its separation from the support.54 As the 
enzyme is not a fundamental component of the support structure, if enzyme inactivation were 
to occur, the support can be easily cleared and regenerated via adsorption of fresh catalyst. In 
many cases, this process can be applied directly to the native enzyme without any modification 
steps, however the mode of adsorption will be enzyme dependent and determined by the 
exterior surface chemistry of the protein.43, 54 For example, lipase enzymes tend to have large 
areas of exposed lipophilic regions, and thus can be paired with a hydrophobic material such 
as octyl-agarose or polypropylene. 64-65 These support materials can sometimes lead to ‘hyper-
activation’ of lipases, where the immobilisation process induces conformational changes that 
favour substrate accessibility and enzymatic activity.66-67 In general, lipases possess an active 
site ‘lid’ that restricts access of substrate compounds in aqueous solutions, and requires a 
hydrophobic interface, such as an immobilisation support, to transform the enzyme into an 
active or ‘open’ conformation.65, 68 Whilst this in an interesting phenomena for lipases, 
conformational changes that result in a loss of secondary structure are prominent for many 
enzymes immobilised on hydrophobic supports.69-70 It has been postulated that these structural 
changes expose internal hydrophobic residues of the protein, which may lead to tighter binding 
to the support and/or structure dependent deactivation.71  
An alternative would be to use hydrophilic surfaces (e.g. celite, cellulose), however 
these interactions are often reported to be weaker than hydrophobic supports, due to the 
different conformational changes induced.69, 72 A benefit of hydrophilic support materials is 
that their increased affinity for water can favour the fundamental solvent enzyme interactions 
that assist in maintaining structural integrity in bulk non-aqueous solutions.54-55 Chemical 
modification of the support or the enzyme can be used to increase the affinity of the binding, 
or to stabilise and align the enzyme in the active form.63 This can include the incorporation of 
branched polymers to increase the number of binding interactions,73-74 and sugar moieties to 
mimic solvent interactions.55, 75 Enzyme-support interactions can also be made stronger and 
more permanent via covalent bond formation which is an alternative to physical adsorption. 
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1.5.4. Covalent Attachment 
Covalent attachment generally relies on the availability of reactive residues (lysine; 
NH3, aspartate and glutamate; COOH, cysteine; SH) or other functional groups (sugars) that 
can be covalently bound to the support via a linking reagent. Covalent attachment strengthens 
the enzyme support interactions compared to adsorption, reducing the risk of enzyme leaching 
that is prominent in aqueous solutions.55 Additionally, the presence of multiple reactive sites 
on an enzymes surface can allow for multi-point attachment to the support, to increase its 
rigidity and the strength of interaction. The binding is often non-specific and the abundance of 
reactive residues (lysine, aspartate, glutamate) and can lead to multiple orientations, binding 
affinities and structural flexibility of the enzyme.55, 76 For enzymes where uniform alignment 
is required for active site access, site-directed attachment can sometimes be achieved by 
targeting uncommon surface amino acids such as cysteine. Enzyme engineering techniques to 
include and remove surface exposed cysteines can afford greater control over the orientation 
of the enzyme which can significantly improve enzymatic activity.77-78 For example, 
incorporation of cysteine residues into the sequence of a dehalogenase enzyme (LinB), 
controlled the orientation of the enzyme on a functionalised glass support.79 Greater activity 
was reported for controlled covalent attachment technique (42%), relative to non-specific 
adsorption (0%), highlighting the impact of orientation and spacing of the enzyme on the 
support.79 
1.5.5. Entrapment and Encapsulation 
Attachment to the external surface of a solid support, would exhibit the greatest 
stabilisation at regions closest to the site of attachment. Unfortunately, immobilisation in this 
manner still means that regions of the protein remain exposed to the environment and would 
be susceptible to physical, chemical, and biological denaturing agents. Entrapment methods 
are designed to completely surround the enzyme, providing additional stabilising interactions 
and creating a microenvironment that is compatible with the enzyme in terms of solvation, 
hydrophobicity/hydrophilicity, and pH. Early encapsulation methods typically involved the use 
of polymer matrices, capsules (polymersomes) and inverse micelles, however these materials 
are often affected by slow substrate diffusion caused by low structural order of the material or 
poor membrane permeability.80-82 Materials that are intrinsically porous, can overcome 
substrate diffusion restraints by providing access pathways to the encapsulated enzyme. 
Enzymes can be immobilised into porous materials via two general processes: infiltration and 
in situ encapsulation/entrapment. Infiltration involves the adsorption of enzymes into the pores 
Chapter 1 Introduction  
- 11 - 
 
of pre-synthesised materials, for example mesoporous silicas, and requires careful matching of 
the pore size to the enzyme to maximise loading and minimise leaching.83-84 Alternatively, the 
porous material can be synthesised around the enzyme, (e.g. hydrogels and sol-gels) which can 
prevent enzyme leaching through entrapment,80, 85 however the synthetic conditions (solvents, 
reagents, and timeframe) create additional challenges in preventing enzyme denaturation.86  
1.6. Metal-organic Frameworks  
Metal-organic frameworks are a class of network solids composed of metal nodes and 
organic linkers that self-assemble into an extended crystalline network (Figure 1.3).87-88 These 
materials can be tailored through the modular synthesis and selection of the inorganic and 
organic building blocks which give rise to a diverse range of chemical and physical properties. 
MOFs are widely known for their crystallinity, high internal surface areas, and tuneable 
porosity and chemical functionality. Collectively, these properties have led to the exploration 
of MOFs for application to areas including gas storage/separation,89-91 catalysis,92 and more 
recently biomacromolecule immobilisation.51, 93  
 
Figure 1.3: Metal-organic frameworks (MOFs) form from the self-assembly of metal nodes 
(blue sphere) and organic linkers (black rod) to form an extended, crystalline network. 
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The modular nature of the MOF synthesis means that the framework chemistry itself 
can be tuned to facilitate the immobilisation of enzymes via three general strategies a). Bio-
conjugation (adsorption/covalent attachment), b) Infiltration, and c) Encapsulation (Figure 
1.4). Bio-conjugation via adsorption or covalent attachment methods give rise to similar 
challenges to other porous supports i.e. leaching, conformational changes, and environmental 
exposure. Nevertheless, the vast range of chemically and functionally different frameworks has 
led to the development of an extensive library of biocomposites (Table 1.3).  
 
 
Figure 1.4: Schematic representation of enzyme immobilisation with MOFs; bio-conjugation, 
infiltration and encapsulation. Figure adapted from Doonan et. al.93  
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Table 1.3: Examples of enzyme adsorption and covalent attachment to MOFs. 
Enzyme MOF Method Application Ref. 
GDH ZIF-7, ZIF-67, ZIF-68, ZIF-70, Adsorption Sensing 94 
GOx MIL-100-Fe Adsorption Sensing 95 
Trypsin CYCU-4, UiO66(Zr), ZIF-8 Adsorption Immobilisation 96-98 
Lipase UiO68(Zr), NH2-UiO66(Zr), 
MIL53 (Al), HKUST-1 
Adsorption Catalysis 99-100 
MP-11 [Cu(BPDC)(DABCO)]n Adsorption Catalysis 101 
Trypsin NH2-MIL88B (Cr) Covalent Proteomics 102 
β-glucosidase NH2-MIL53 Covalent Catalysis 103 
GDH ZIF Covalent Sensing 94 
Lipase NH2-UiO66, IrMOF Covalent Catalysis 104 
Abbreviations: GDH: glucose dehydrogenase, GOx: Glucose Oxidase, MP-
11:Microperoxidase, ZIF: zeolitic imidazolate framework, MIL: Materials of Institut 
Lavoisier, UiO: University of Oslo, HKUST: Hong Kong University of Science and 
Technology, (BPDC)(DABCO):4’4 biphenyldicarboxylate, 1,4-diazabicyclo[2.2. 2]octane. 
 
Infiltrating enzymes within the pores of MOFs provides the attributes of simple 
adsorption techniques with the advantages of an increased number of stabilising interactions, 
and greater coverage and control of the enzyme microenvironment (Table 1.4) MOFs, 
however, typically comprise of a microporous structure that is not large enough to post 
synthetically accommodate enzymes and as such, this methodology is limited to MOF materials 
that possess mesopores exceeding the size of the enzyme. The structural diversity of enzyme 
size and shape means that the infiltration method poses the challenges described in Section 
1.5.3, to favour enzyme loading and reduce leaching. 
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Table 1.4: Examples of enzyme infiltration into MOFs. 
Enzyme MOF Method Application Ref. 
Cyt c Tb-mesoMOF Infiltration Catalysis 105 
HRP, GOx PCN-888 Infiltration Catalysis 106 
HRP, Cyt c, MP-11 PCN-332,PCN-333 Infiltration Catalysis 107 






Mb IRMOF-74 Infiltration Storage 111 
Insulin MOF-818 Infiltration Storage 112 
Abbreviations: Cyt c: cytochrome c, HRP: horseradish peroxidase, GOx: glucose oxidase, 
MP-11: microperoxidase, PCN: porous coordination network, Mb: myoglobin,  
 
Alternatively, enzymes can be encapsulated within a microporous MOF material. 
Unlike the previously described methods (adsorption, covalent attachment, infiltration), 
encapsulation involves the MOF formation around the enzyme, via a ‘one pot’ approach, and 
thus requires biocompatible synthetic conditions.51, 93, 113 Employing this strategy, enzymes 
larger than the average pore size of the MOF material can be encased within a microporous 
framework that prevents leaching of the enzyme, whilst retaining free substrate diffusion. The 
method of enzyme encapsulation within MOFs was first proposed in 2014, by Lyu et. al. where 
an enzyme (cytochrome c) was coated with a protective layer of PVP, and encapsulated within 
a MOF; Zeolitic Imidazolate Framework-8; ZIF-8.114 In this work, the encapsulation process 
involved the co-precipitation of the framework in a methanolic solution, generating large 
cavities that are not present in the standard MOF preparation, within which the enzyme was 
contained. Presumably, the PVP coating offered the enzyme a degree of protection from the 
effects of the alcohol. The cytochrome c-ZIF-8 biocomposite demonstrated enhanced activity 
relative to the free enzyme, due to a combined effect of exposure to methanol and the metal 
source (Zn2+) inducing conformational changes that exposed the catalytically active haem 
group.114 Methanol, and many organic solvents can have deleterious effect on enzyme 
structure,33, 36-37 and their addition is not desirable for enzyme co-precipitation/immobilisation. 
A preferred method of immobilisation would involve the use of water based synthetic 
protocols. These were first developed, also using the Zn2+ based Zeolitic Imidazolate 
Framework (ZIFs) materials.  
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1.6. Zeolitic Imidazolate Frameworks (ZIFs) 
The two most commonly studied ZIF frameworks for protein encapsulation are ZIF-8 
and ZIF-90, which form via the self-assembly of Zn2+ ions and imidazolate based linkers; 2-
methyl-imidazole (2-mIM) and imidazole-2-carboxaldehyde respectively (Figure 1.5).115-116 
Both of these frameworks can be synthesised under biocompatible conditions (in water and at 
room temperature) forming highly porous crystalline materials with large internal surface areas 
(Brunauer-Emmet-Teller, BET, surface area ca. 1200 m2.g-1).117-119 These ZIF frameworks 
display negligible cytotoxicity and are stable to elevated temperatures (~400 °C) and a wide 
range of organic solvents, making them an appropriate candidate for enzyme stabilisation.115, 
120-121 Additionally, they possess small crystallographic pore apertures (~3.4 Å) that would 
prevent enzyme leaching, but still enables diffusion of small substrate compounds. 
Furthermore, the ZIF-8 framework exhibits a degree of flexibility through linker rotation, that 
enables the diffusion of substrates larger than the pore aperture of the framework (~5 Å).122-123 
 
Figure 1.5: Representations of the crystal structures of (a) ZIF-8 and (b) ZIF-90 viewed along 
the b axis, showing the continuous network of these frameworks, with Zn2+, C, N and O atoms 
represented by light blue polyhedral and grey, blue and red spheres respectively. 
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The aqueous co-precipitation of a protein within ZIF-90 was first described by Shieh 
et.al. in 2015.124 This method involved the coating of catalase with polyvinyl pyrrolidone 
(PVP), followed by the addition of ZIF-90 precursors (Zn2+ and ICA) to form a catalase-PVP-
ZIF-90 composite. This biocomposite retained full activity after exposure to protease (a peptide 
cleaving enzyme), whilst complete denaturation and loss of activity was observed for the free 
enzyme. Due to the small pore size of the framework, the encapsulation process restricted 
protease access to catalase, whilst allowing for diffusion of the substrate compound (hydrogen 
peroxide). An alternate method was established in the same year by Liang et. al., where ZIF-8 
encapsulation of proteins and DNA was developed using aqueous conditions without additives 
or precipitating agents (Figure 1.6).125 This method was distinguished from co-precipitation, 
by the observation via NMR, that biomolecules (proteins etc.) can concentrate Zn2+ at their 
surface and thus initiate the nucleation of ZIF-8.125 This phenomenon was termed “biomimetic 
mineralisation” due to its similarity to natural self-assembly of exoskeletons around biological 
tissues (biomineralisation).126 In addition to the protection from proteolytic enzymes, the ZIF-
8 biocomposites were tested for their stability to organic solvent, and elevated temperature. 
The ZIF-8 framework demonstrated the protection of horseradish peroxidase (HRP) where 
conditions that inactivate the free enzyme, such as boiling water and boiling 
dimethylformamide (DMF, 150 °C), had minimal impact on the encapsulated enzyme. 
 
Figure 1.6: Schematic of the biomimetic mineralisation strategy. Adapted from Liang et. al.125 
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These studies by Shieh and Liang, highlighted the potential of ZIF materials for enzyme 
protection and instigated extensive research in this field. Over the past five years, efforts have 
been made to advance the field of bioencapsulation by creating novel biocomposites, testing 
the limits of the protective capacity, and understanding and developing the immobilisation 
process. As such, there is an extensive library of enzyme-ZIF literature, focussing on different 
aspects and application of these materials (Table 1.5). 
Whilst there have been a large number of studies on enzyme-ZIF-8 biocomposites, there 
is also considerable diversity of the synthetic protocols utilised for biocomposite synthesis 
(ligand concentrations, additives, formation time). For example, different ZIF-8 synthetic 
procedures have yielded conflicting data for catalase, with both activity and enzyme 
deactivation being reported for the same enzyme and reaction.127-132 A systematic 
characterisation of biocomposite synthesis (and sample handling) is therefore necessary to 
understand the mechanisms of ZIF-8 formation and its impact of enzymatic activity and 
stability. This thesis focusses on the screening and the development of protocols to synthesise 
consistent ZIF-8 biocomposites (henceforth referred to as protein@ZIF-8). This work aims to 
investigate the influence of the protein and MOF precursors on biocomposite formation to 
determine what impact the formation mechanism has on enzymatic activity. Additionally, it 
has been shown that the hydrophobicity of the ZIF-8 framework can impact the activity of 
some enzymes (catalase and urease).129 Comparatively, the ZIF-90 framework, is significantly 
more hydrophilic than ZIF-8, as determined via water vapor adsorption studies, and influences 
enzyme activity differently.133-134 Catalase was one enzyme that was reported to be impacted 
by hydrophobic interactions with ZIF-8 causing a loss in secondary structure of the enzyme (α-
helix and β-sheets). The more hydrophilic ZIF-90 provided more favourable structural 
interactions, which resulted in activity retention. As such, in the work presented hereafter, both 
ZIF-8 and ZIF-90 biocomposites were tested in analogous activity studies. 
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Table 1.5: Examples enzyme encapsulation in ZIF-8 highlighting the novel findings.  
Enzyme Year Comment Ref 
Cyt C, HRP, Lipase 2014 Enhanced activity upon immobilisation 114 
HRP,(PQQ)GDH, Urease 2015 
 
Stable to boiling water, DMF and proteolytic 
agents 
125 
GOx, HRP 2015 Two enzyme cascade reaction 135 
GOx 2015 Polydopamine tethering of ZIF-8 crystals for 
better handling and recycling 
136 
GOx 2016 Combined with a molecular catalyst (hemin) 137 
Lipase 2016 Mechanical grinding synthesis 138 
Urease 2016 Biomimetic mineralisation/ co-precipitation 
comparison 
139 
Catalase 2017 Polyacrylamide coating prior to encapsulation 128 
β-gal and S. cerevisiae. 2017 S. cerevisiae coated with β-gal and ZIF-8 for cell 
survival  
140 
β-gal, GOx, HRP 2018 Two and three enzyme cascade reaction 141 
HRP, Lysozyme 2018 Enzymes@ZIF-8 on gold nanorods 142 
Ace 2018 Recombinantly expressed enzyme tested  143 
Lipase 2018 Thermostable, ultrasound stable 142 
HRP, Urease, GOx 2019 Amino acid assisted ZIF-8 nucleation 145 
Laccase 2019 Enhanced selectivity upon immobilisation 146 
AChE 2019 Co-encapsulation with magnetic nanoparticles  147 
Abbreviations: Cyt C: Cytochrome C, HRP: Horseradish Peroxidase, (PQQ)GDH: 
Pyrroloquinoline glucose dehydrogenase, GOx: Glucose oxidase, β-gal: β-galactosidase, S. 
cerevisiae: Saccharomyces cerevisiae, ACE: Acetyl esterase, AChE: acetylcholinesterase 
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1.7. Hydrogen-bonded Organic Frameworks (HOFs) 
ZIFs are not ideal universal support materials for enzyme immobilisation as the 
synthetic conditions, enzyme-support interactions, and pore size can all contribute to reduced 
catalytic output caused by enzyme denaturation and inhibited substrate diffusion. Additionally, 
ZIFs are not stable to pH <6,121 certain buffers,131, 148-149 and metal chelating agents,150 thus 
limiting their potential application. As such, our group has been continually investigating the 
development of novel porous materials, utilising protein friendly ligands for framework 
formation.  
Recently, a hydrogen-bonded organic framework (HOF) made from tetra-amidinium 
and tetra-carboxylate building units was developed,151-152 and later used for enzyme 
encapsulation.153 Hereafter, this framework is termed BioHOF-1, named for its biocompatible 
synthesis and capacity to encapsulate and stabilise biomolecules. BioHOF-1 self assembles in 
water, taking advantage of non-covalent secondary interactions to yield a continuous 
crystalline solid (Figure 1.7). This framework has a larger pore aperture (~6.4 Å)151-152 than 
the ZIF materials that have been previously investigated, and thus may be advantageous for 
applications that require diffusion of larger substrates. Within the pores of BioHOF-1, there 
are water molecules that assist in maintaining the structural integrity of the framework. Indeed, 
upon activation (desolvation under reduced pressure) this material is known to be non-porous 
to N2 (77 K) due to the removal of these water molecules that caused a loss of long-range order 
(crystallinity). However, in solution phase experiments, fluorescein (7 Å) was shown to 
homogenously diffuse into the framework, confirming solution accessible porosity. Due to the 
retention of water within the pores, BioHOF-1 may favour enzyme stabilisation and activity. 
As described in Section 1.5.3, water may assist in maintaining enzyme structural integrity. 
Additionally, enzymes that require water as a cofactor for reactivity may benefit from 
immobilisation within BioHOF-1. 
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Figure 1.7: (a) Crystallographic representation of the tetra-carboxylate and tetra-amidinium 
ligands. (b-c) Representations of the crystal structures of BioHOF-1 showing the continuous 
network of this framework, with C, N and O atoms represented by grey, blue, red and pink 
spheres, respectively.(a) Solvent (water) molecules have been excluded to show porosity. (b) 
Structurally important water molecules included. 
In the initial enzyme immobilisation study, catalase and alcohol oxidase enzymes were 
immobilised using BioHOF-1, which yielded biocomposites of high crystallinity, enzyme 
loading and framework stability.153 A promising finding of this study was that BioHOF-1 was 
capable forming active biocomposites with enzymes, which, when immobilised within ZIF-8, 
were inactive. Additionally, in initial testing, BioHOF-1 has been proven to stabilise enzymes 
to denaturing conditions such as extreme pH (5-10), proteolytic agents (trypsin), thermal 
treatment (60 °C in water), and an unfolding agent (urea). As such, this thesis also describes 
an investigation into the formation, and resulting activity of novel enzyme@BioHOF-1 
composites, broadening the scope of this burgeoning field of research. 
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1.8. Thesis Coverage 
This thesis consists of five research chapters. Chapter 3 has been published in a peer-
reviewed international journal, whilst Chapters 4, is written in manuscript style and are 
intended to be submitted for peer-review. Chapters 2, 5, and 6 are written as stand-alone thesis 
chapters. Each chapter contains their own introduction and experimental section. The statement 
of authorship can be found at the beginning of the appropriate chapters.  
Chapter 1 introduces the field of biocatalysis, providing context for the immobilisation 
strategies utilised. Here, the challenges associated with enzyme catalysis are described, and the 
technologies currently employed to enhance enzyme stability are presented. Additionally, this 
chapter introduces the porous support materials that are the focus of this thesis, ZIF-8, ZIF-90 
and BioHOF-1. 
Chapter 2 describes the initial screening protocols that were tested to find a general 
immobilisation strategy for ZIF-8. Here it was established that synthetic conditions could be 
controlled to encapsulate a broad range of proteins which contributed to a peer reviewed 
publication.154 This study developed the protocols that were used in later chapters. 
Chapter 3 is a peer reviewed study and provides additional details into the screening 
of successful/unsuccessful proteins, investigating the impact of protein electrostatics on the 
immobilisation protocol.155 Supporting computational studies, analysing the surface charge and 
isoelectric point of the protein, were used to predict this phenomenon and are detailed within 
this chapter alongside experimental studies. Methods to manipulate the biomineralisation 
process by surface functionalisation of the protein were presented. 
Chapter 4 builds on the work of the previous chapters, with an extension to activity 
testing. A lipase enzyme was immobilised via the different protocols described in Chapter 2, 
and was used to test the impact of synthetic conditions on biocomposite activity and stability. 
Chapters 5 and 6 introduced new frameworks (ZIF-90 and BioHOF-1) to test impact 
of new frameworks on the activity/stability of the lipase and a dehalogenase enzyme. In 
Chapter 6, the dehalogenase enzyme was recombinantly expressed and purified prior to 
immobilisation and testing of its activity and thermal stability. 
Chapter 7 provides a summary of the research goals that were achieved in the previous 
chapters and discusses the potential directions in which the research can progress. 
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Chapter 2. Screening Protein@ZIF-8 Biocomposite Synthesis 
2.1.  Introduction 
One of the first, and most broadly utilised frameworks for protein encapsulation in 
metal-organic frameworks (MOFs), is the zinc based zeolitic imidazolate framework-8 (ZIF-
8). This framework can be synthesised under a broad range of synthetic conditions, which can 
be modulated in terms of solvent selection, temperature, and formation time.1-4 There has been 
extensive investigation into the synthetic conditions employed and their effect on the kinetics 
of ZIF-8 formation, with protocols established to yield ZIF-8 composites of varied crystal size, 
morphology and topology.1-4 Typically, ZIF-8 forms crystals with rhombic dodecahedral 
morphology and sodalite (sod) topology, with large pore sizes and but small crystallographic 
pore apertures, 11.4 and 3.4 Å, respectively. Additionally, there are a number of distinct 
topologies (polymorphs) that can arise from aqueous ZIF-8 synthesis, which may impact the 
effectiveness of the framework for enzyme immobilisation, stabilisation and substrate 
diffusion.5-7 One such polymorph is the thermodynamically stable diamondoid (dia) framework 
which, compared to the highly porous sodalite arrangement, is more densely packed and non-
porous to N2.5 If this topology were to arise during enzyme@ZIF-8 immobilisation, the 
resulting biocomposite properties would likely differ from sod ZIF-8 in terms of enzyme spatial 
distribution and capacity for substrate diffusion.8 Additionally, variation in crystal size and 
morphology can confer varied physical properties, including framework flexibility and 
stability.9-11 Hence, when developing enzyme@ZIF-8 biocomposites, a systematic approach to 
the synthesis is paramount, to ensure consistent material formation and characterisation.  
In the study by Liang et. al. in 2015, it was reported that bovine serum albumin (BSA) 
could rapidly induce nucleation of ZIF-8 to yield uniformly sized, rhombic dodecahedral 
crystals of the sodalite topology.12 Liang et. al developed a protocol for ZIF-8 synthesis, 
whereby the driving force for biocomposite formation was the protein/biomacromolecule. The 
method involved the dissolution of a protein such as BSA into an aqueous 2-methyl imidazole 
(2-mIM) solution (160 mM), followed by the addition of an aqueous zinc acetate dihydrate 
(Zn(OAc)2.H2O) solution (40 mM). The mixing of precursors, led to precipitation of the 
biocomposite within seconds, however in the absence of a biomacromolecule, minimal 
precipitate (i.e. ZIF-8) formed over an extended timeframe (24 hours). This process was termed 
‘biomimetic mineralisation’, where the pre-concentration of zinc at the surface of the 
biomacromolecule initiated the ZIF nucleation process.12 This protocol was extended to 
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different proteins and biomacromolecules, however morphological variations were observed 
during characterisation by scanning electron microscopy (SEM) imaging.  
The results of this study became the foundation for the work described in this thesis, as 
the morphology of the protein@ZIF-8 biocomposites appeared to be protein dependent. As 
such, we investigated the process of biomimetic mineralisation in a systematic manner, in order 
to establish new protocols for uniform ZIF formation, and to understand the impact of the 
synthetic conditions on biocomposite formation and thus enzyme activity. The studied 
conditions included variation to the precursor concentrations and solvent selection (for 
synthesis and solvent exchange), as well as the protein surface chemistry (described in Chapter 
3). This chapter describes the initial screening of conditions, that contributed to two peer 
reviewed publications and established the protocols used in the latter chapters of this thesis. 
2.2.  Results and Discussion 
2.2.1. Visual Inspection of Precipitate Formation 
Low ratio 2-mIM:Zn2+(160: 40 mM) 
Initial screening was undertaken using the Zn2+ (40 mM) and 2-mIM (160 mM) 
concentrations reported by Liang et. al using a variety of different proteins to initiate 
nucleation.13 As such, we were interested in investigating the impact that different proteins had 
on forming ZIF-8 in aqueous solutions. During the screening process, it was observed that the 
precipitation, formation rate and final yield of the biocomposite was protein dependent. For 
example, certain enzymes, including lipase from Candida antarctica (CALB) and catalase, 
initiated the instant formation of a precipitate upon mixing the precursors (Figure 2.1). ZIF-8 
nucleation was rapid (within seconds) yielding ~10-15 mg of biocomposite per sample with 
CALB, whereas, after the initial nucleation process for catalase (seconds), formation occurred 
at a slower rate, yielding ~5-10 mg of the ZIF-8 biocomposite. A selection of proteins, that 
included haemoglobin, resembled the protein free control, yielding only low levels of 
precipitate after 16 hours which could not be quantified in terms of yield (Figure 2.1). A 
broader range of proteins were screened and subsequently classed ‘successful’ or 
‘unsuccessful’, resultant from their ability/inability to enhance the rate of ZIF-8 formation 
relative to the no protein sample (Table 2.1, Figure S2.1). It is apparent from the screening 
data, that the biomimetic mineralisation process is heavily influenced by the choice of 
biomacromolecule which, in addition to the morphological differences previously reported, 
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affects the rate of formation and the quantity of biocomposite that is formed. Hence, 
immobilisation at the low 2-mIM:Zn2+ ratio is not applicable to all proteins.  
 
Figure 2.1: Images of the biomimetic mineralisation process using Candida antarctica Lipase 
B (CALB), Haemoglobin (Hb) and Catalase (Cat) after the initial mixing of Zn2+ and 2-mIM 
(t=0) and after 16 hours of formation (t=16). Additional screening using a more comprehensive 
selection of proteins is reported in Figure S2.1. 
Table 2.1: The proteins tested for biomimetic mineralisation, categorised by their ability to 
seed the biomimetic mineralisation of ZIF-8 according to Figure 2.1 and Figure S2.1. 
Successful Unsuccessful 
Bovine Serum Albumin (BSA) Haemoglobin 
Horseradish peroxidase (HRP) Myoglobin 
Catalase Trypsin 




High ratio 2-mIM:Zn2+(1200: 40 mM) 
In aqueous solutions, ZIF-8 can be formed utilising high ligand-to-metal ratios, where 
the basicity1 of the solution promotes ligand deprotonation, nucleation and thus crystal 
formation. As such, higher ligand to metal ratios (8:1, 16:1, 20;1 and 30:1) were examined for 
protein free, haemoglobin, and pepsin ZIF-8 preparations in order to establish a more general 
method of protein encapsulation. Increasing the concentration of 2-mIM does favour 
precipitation in the presence of haemoglobin with the 30:1 molar ratio resulting in the largest 
yield (~20-30 mg) of biocomposite (Figure 2.2). Similar results were obtained in the absence 
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of protein, highlighting that an increased ligand concentration (30:1) is required for significant 
ZIF formation. Pepsin, however, induced rapid nucleation at all ratios (Figure 2.2). 
 
 
Figure 2.2: Images of the ZIF-8 formation 16 hours using different ratios of 2-mIM:Zn2+ for 
(a) no protein control, (b) haemoglobin and (c) pepsin. The Zn2+ concentration was kept 
constant at 20 mM (final concentration) and equal volumes of Zn2+ and 2-mIM were used in 
each preparation. 
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2.2.2. Morphology Investigation 
Low ratio 2-mIM:Zn2+(160: 40 mM) 
To understand the variation in biocomposite formation at low 2-mIM to Zn2+ ratios, the 
influence of the protein was examined by characterising the precipitates that formed after 16 
hours. Two proteins, pepsin (successful) and haemoglobin (unsuccessful) were selected for 
screening purposes. These were not extensively characterised in the initial study,13 and thus 
would extend our understanding of this process to different proteins. Due to the low yields of 
the “unsuccessful” proteins, initial characterisation of the precipitate was limited to SEM 
analysis, where differences in the particle size and morphology could be observed (Figure 2.3). 
Using concentrations of 2-mIM (160 mM) and Zn2+ (40 mM), the haemoglobin preparation 
shared similar morphological features to the protein free control, generating large aggregates 
of material. In comparison, the addition of the pepsin afforded crystals of the characteristic 
rhombic dodecahedral morphology associated with ZIF-8 (Figure 2.3c). Pepsin, much like 
BSA, induced the formation of uniform ZIF-8 crystals, whereas haemoglobin did not 
significantly influence the precipitate formation, acting more as a spectator protein. 
 
 
Figure 2.3: SEM images of the ZIF-8 preparations after16 hours formation using a) no protein 
control, b) haemoglobin, and c) pepsin. The Zn2+ and 2-mIM concentrations were held constant 
at 40 mM and 160 mM (stock concentration, prior to mixing). Inset are images of the precipitate 
after 16-hours. 
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High ratio 2-mIM:Zn2+(1200: 40 mM) 
At higher 2-mIM to Zn2+ ratios (1200:40 mM; 30:1), the particle sizes associated with 
each preparation were different. The no protein and pepsin samples affording homogeneously 
sized crystals after 16-hours of formation (1 µm) (Figure 2.4a, c). Under the same conditions, 
the haemoglobin sample produced significantly larger crystals (~2 µm) (Figure 2.4b), which 
would indicate that the protein is either influencing the initial nucleation, the crystal growth 
phase, or potentially both steps. It is of note that small molecule inhibitors, such as weak bases 
and amino acids have been utilised to modulate the crystal growth of ZIF-8.9, 14-15 This 
phenomenon may translate to larger polypeptides and proteins, and thus may explain the effect 
that haemoglobin has on ZIF-8 formation. 
 
Figure 2.4: SEM images of the ZIF-8 preparations after 16 hours formation using a) no protein, 
b) haemoglobin, and c) pepsin. The Zn2+ and 2-mIM concentrations were held constant at 40 
mM and 1200 mM (stock concentration, prior to mixing). Inset are images of the precipitate 
after 16 hours. 
To understand the differences in crystal formation, the 30:1 haemoglobin and control 
(protein free) samples were analysed via SEM during the early stages of formation (between 
0- and 120- minutes, Figure S2.2-S2.3). The presence of uniform, rhombic dodecahedral 
crystals first appeared after 30 minutes for the protein free control, whilst formation in the 
presence of haemoglobin was slower, yielding equivalent crystals to the no protein control 
sample after 120 minutes. Analysis of the supernatant of the 30:1 haemoglobin@ZIF-8 sample 
indicated that the protein was being immobilised by the higher ratio preparations (Figure S2.4). 
This observation highlights the possibility that ‘unsuccessful’ proteins, such as haemoglobin, 
may slow down the rate at which ZIF-8 forms, by acting like an inhibitor. 15 Thus, at low and 
high 2-mIM:Zn2+ ratios, the protein is likely to impact the final properties of the biocomposite 
that is formed, and as such this should be taken into consideration when comparing 
enzyme@ZIF-8 materials. Hence, all further studies in this thesis utilised 16-hour formation 
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times, to enable direct comparison of the impact of the different proteins/synthetic conditions 
and ensure consistent analysis of each biocomposite 
2.2.3. Topological Investigation 
In addition to the variation in crystal size and morphology, the connectivity and metal- 
ligand geometry can vary to yield different structural topologies. It has been shown that 
increasing the 2-mIM:Zn2+ ratio favours the formation of phase pure sodalite crystals that could 
immobilise the subset of proteins listed in Table 2.1. Increasing the ligand: metal ratio was 
established to encapsulate haemoglobin, with the sodalite topology appearing at the 16:1 ratio 
and above (Figure 2.5). Using haemoglobin and the 4:1, and 8:1 2-mIM:Zn2+ precursor ratios 
generated an unknown phase (later identified as ZIF-C16) and diamondoid topologies 
respectively.8 When examined further, additional topologies, including katsenite, and unknown 
phases 12, 13, and 14 were identified.8 Additionally, the precipitate that forms using the 
‘successful’ proteins at a 4:1 ratio, is not the desired sodalite topology, and instead yields other 
topologies, including an amorphous phase (Figure 2.6). Upon solvent exchange with ethanol, 
these phases can transition to the sodalite topology, as was observed for biocomposites formed 
with HRP and CALB (Figure 2.6). The mechanism of the transition with ethanol is not well 
understood, however, the different phases are now known to impact the release profile of the 
protein.16 For example, amorphous materials are known to release their protein cargo (BSA) 
more rapidly than the densely packed diamondoid topology.16 As such, the characterisation of 
these different topologies may be important for understanding the activity and stability of each 
biocomposite.  
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Figure 2.5: PXRD pattern of haemoglobin ZIF-8 preparations after water washes only using 
increasing 2-mIM:Zn2+ ratios. The 4:1 ratio yielded ZIF-C16, whereas the 8:1 ratio yielded the 




Figure 2.6: PXRD pattern of the 4:1 ratio of proteins CALB and HRP after water washes only 
(water), and sequential water and ethanol washes (EtOH). The initial precipitates of CALB and 
HRP were assigned as ZIF-C15 and Unknown 14 (U14) and could both transition to the sodalite 
topology after an ethanol wash. 
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The phase transition of the BSA biocomposites (160: 40 mM; 4:1, 16 hours) was 
investigated further by solvent exchanging the amorphous precipitates with primary alcohols 
of increasing length (methanol to octanol). Each of the alcohols had the capacity to mediate the 
phase transition from amorphous to sodalite, indicating that the conversion process was not 
limited to the short chain alcohols (Figure 2.7). SEM imaging of the ethanol, butanol and 
octanol washed BSA@ZIF-8 biocomposites highlighted alcohol dependent crystal 
degradation, with the longer chain alcohols (butanol and octanol) causing etching of the crystal 
surfaces (Figure 2.8). This observation is consistent with previous literature, where 
hydrophobic reagents with polar functional groups, were shown to degrade ZIF-8 crystals.17 
Whilst the transition between phases can be mediated by all lengths of the primary alcohols 
tested, the crystals are not stable to the solvent exchange process. 
 
Figure 2.7: PXRD pattern of BSA@ZIF-8 samples after water washes or subsequent 
alcohol washes. The water wash sample consisted of mainly an amorphous phase mixed with 
ZIF-C. After each alcohol wash, the dominant phase was sodalite. 
 
Figure 2.8: SEM images BSA@ZIF-8 with post solvent exchange with different alcohols, a) 
ethanol, b) butanol and c) octanol. 
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2.2.3. Solvent Effects 
The impact of alcohol solvents on ZIF-8 formation and its role in topology transitions 
was investigated further. Protic solvents, such as ethanol and methanol are typically used for 
room temperature syntheses of ZIF-8 at low ligand: metal ratios facilitating rapid nucleation 
and greater control over particle size and crystallinity. As such the low ratio (160: 40 mM) 
protocol was tested with haemoglobin using an alcohol solvent. Changing the solvent system, 
of the low ratio Hb preparation, to a water: methanol composition (3:1, and 1:1) did appear to 
enhance ZIF-8 nucleation, forming a sodalite network without the need for additional (i.e. 
ethanol) washing steps. This rapid nucleation leads to the formation of smaller crystals. Small 
ZIF-8 crystals have been reported be more susceptible to degradation than larger crystals which 
may impact the longevity of the protein@ZIF-8 biocomposite (Figure 2.9).17 It is favourable 
to utilise the water-based system for the initial synthesis of the ZIF-8 biocomposite to minimise 
the exposure time to solvents such as ethanol and methanol that may denature the enzyme 
during encapsulation.  
 
 
Figure 2.9: a) PXRD pattern of the haemoglobin, 4:1 sample, using solvent compositions of; 
100% water, and 3:1 and 1:1 water: methanol ratios. The water-based haemoglobin synthesis 
yielded the ZIF-C.15 b) SEM image of the haemoglobin@ZIF-8 biocomposite formed in 50:50 
water: methanol. 
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2.3.  Conclusions 
In summary, the synthetic protocols for protein@ZIF-8 biocomposites were examined, 
investigating the effects of the protein, the precursor concentrations, washing protocol and 
solvent selection. In this study, significant variability of the encapsulation process was 
observed, and this work provided valuable insight into the encapsulation process, that was 
fundamental to the remainder of the work in this thesis. 
The effectiveness of the biomimetic mineralisation process was not applicable to all 
proteins tested, and a subset of proteins were identified to be incapable of seeding ZIF-8 
nucleation at low 2-mIM:Zn2+ ratios. This led to the investigation and development of synthetic 
conditions that enabled the immobilisation of a broader range of proteins. By increasing the 
concentration of the ligand (2-mIM), ZIF-8 nucleation was favoured, allowing the 
immobilisation of proteins during the ZIF-8 growth phase. Additionally, the ligand 
concentration was important in controlling the topology of the as-synthesised ZIF-8, with dilute 
2-mIM solutions yielding a variety of amorphous or densely packed crystalline phases. 
Conversely, high 2-mIM concentrations favoured the formation of phase pure ZIF-8 
biocomposites, however, the protein was shown to influence the final particle size, ranging 
from 500 nm to 2 µm depending on the protein. This work contributed to a peer reviewed 
publication, that extensively examined the impact of precursor concentrations, and synthetic 
conditions on the formation of protein@ZIF-8 biocomposites. Additionally, these findings 
stimulated further investigation on the effect of the protein chemistry that is presented in 
Chapter 3. 
The aforementioned screening results also established the protocols used in Chapters 
4-6, to ensure a systematic approach to characterisation and activity testing of different 
enzyme@ZIF-8 biocomposites. It was established in these initial screening studies, that the 
choice of protein and synthetic conditions was controlling the formation of ZIF-8. This resulted 
in biocomposites of different topology, morphology and particle size. As such, the activity 
screening studies focussed on a lipase (Chapter 4, 5) and a dehalogenase enzyme (Chapter 6) 
that were both capable of biomimetic mineralisation of ZIF-8 at low 2-mIM concentrations. In 
these studies, enzyme@ZIF-8 biocomposites were also formed at high ratios, to understand the 
impact of synthetic conditions on enzymatic activity. In both cases, careful reporting of the 
synthesis conditions and characterisation of the biocomposites was fundamental to the 
systematic analysis of these variables. 
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2.4.  Experimental 
2.4.1. Materials 
All proteins (excluding lysozyme) were purchased from Merck as lyophilised powders 
and used without purification. Lysozyme was purchased from Astral Scientific. Product codes 
can be found in Chapter 3, Table S3.1. All chemicals were purchased from commercial 
sources and used as received. Ultra-pure Milli-Q (MQ) with resistivity of >18 MΩ cm-1 (Merck 
Millipore purification system) was used for all syntheses, wash protocols and buffer 
preparations.  
2.4.2. ZIF Syntheses 
All ZIF-biocomposites were synthesised in water using 2 mg of protein and varied 
ratios of zinc acetate dihydrate (Zn(OAc)2) and 2-methylimidazole (2-mIM). Zn(OAc)2 (40 
mM 2 mL) was added to a solution of 2-mIM (160 mM/320 mM/640 mM/800 mM/1.2 M, 
2mL) containing protein. The samples were left to form for 16 hours before being washed with 
water (2x) only, or water (2x) and an alcohol solvent (2x). For protocols using methanol as a 
solvent, the methanol concentration was equivalent in both the Zn2+ and 2-mIM solutions. 
2.4.3 Characterisation 
Powder X-ray Diffraction. Powder X-ray diffraction (PXRD) data were collected on 
a Bruker D8 Advanced X-ray powder diffractometer (parallel X-ray, capillary-loaded) using a 
Cu Kα λ=1.5418 Å radiation source, using 0.5 mm glass capillaries and data collected for 
between 2θ of 2° to 52.94° with Phi rotation at 20 rotations per min at 1-second exposure per 
step at 5001 steps. Simulated powder X-ray diffraction patterns were generated from the single 
crystal X-ray data using Mercury 3.9.18 
Scanning Election Microscopy (SEM). SEM images were collected on either the 
Philips XL30 Field Emission Scanning Electron Microscope (FESEM). Samples were dry 
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2.6.  Supporting Information 
 
 
Figure S2.1: Images of the biomimetic mineralisation process after the initial mixing of Zn2+ 
and 2-mIM (t=0) and after 16 hours of formation (t=16).(1) No Protein (NP), (2) Bovine Serum 
Albumin (BSA), (3) Horseradish Peroxidase (HRP), (4) Haemoglobin (Hb), (5) Myoglobin 
(Mb), (6) Catalase (Cat), (7) Lipase (CALB), (8) Urease (Ure), (9) Trypsin (Tryp), (10) 
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Figure S2.2: No protein control. SEM images of the no protein ZIF-8 control formed using the 
30:1 2-mIM: Zn2+ ratio. Samples were taken at each of the corresponding time points which 
were washed with water and ethanol prior to imaging. The Zn2+ concentration was held 
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Figure S2.3:Haemoglobin. SEM images of the haemoglobin ZIF-8 sample formed using the 
30:1 2-mIM: Zn2+ ratio. Samples were taken at each of the corresponding time points which 
were washed with water and ethanol prior to imaging. The Zn2+ concentration was held 
constant at 20 mM (final concentration).
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Figure S2.4: Absorbance spectrum of haemoglobin (red) and the supernatant of the 30:1 
haemoglobin@ZIF-8 biocomposite. The decrease in Soret absorbance of haemoglobin (~400 
nm), indicates that the protein is incorporated into the ZIF-8 material.
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Chapter 3. Protein Surface Functionalisation as a General Strategy for Facilitating 
Biomimetic Mineralisation of ZIF-8 
3.1.  Abstract 
The durability of enzymes in harsh conditions can be enhanced by encapsulation within 
metal–organic frameworks (MOFs) via process called biomimetic mineralisation. Herein we 
show that the surface charge and chemistry of a protein determines its ability to seed MOF 
growth. We demonstrate that chemical modification of amino acids on the protein surface is an 
effective method for systematically controlling biomimetic mineralisation by zeolitic 
imidazolate framework-8 (ZIF-8). Reaction of surface lysine residues with succinic (or acetic) 
anhydride facilitates biomimetic mineralisation by increasing the surface negative charge, 
whereas reaction of surface carboxylate moieties with ethylenediamine affords a more 
positively charged protein and hinders the process. Moreover, computational studies confirm 
that the surface electrostatic potential of a protein is a good indicator of its ability to induce 
biomimetic mineralisation. This study highlights the important role played by protein surface 
chemistry in encapsulation and outlines a general method for facilitating the biomimetic 
mineralisation of proteins. 
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 3.2.  Introduction 
Metal–organic frameworks (MOFs) are a class of porous materials that are constructed 
from metal nodes connected via organic links.1 The chemical mutability of these building units 
offers broad scope for tailoring the properties of MOFs for specific applications such as gas 
separations, drug delivery and catalysis.2-10 A recent development in MOF chemistry is their 
use as matrices for encapsulating biomacromolecules, e.g. proteins and enzymes, via a one-pot 
synthetic approach termed ‘biomimetic mineralisation’.11-16 This strategy has also been 
extended to the synthesis of MOF-based biocomposites composed of viruses,17 and cells,18-19 
and more recently to the co-encapsulation of gene-editing system CRISPR/CAS9.20 A salient 
feature of the MOF coating is that it can protect an encapsulated enzyme from inhospitable 
external environments (e.g. elevated temperatures or proteolytic media) while facilitating size-
selective transport of substrates to the active site via its pore network.21-23 These properties are 
relevant to commercial bio-catalysis, for which strategies to improve enzyme durability are 
sought after.24 
The most studied MOF for biomimetic mineralisation has been zeolitic imidazolate 
framework-8 (ZIF-8),25 a material of sodalite topology comprising tetrahedral Zn2+ ions 
connected via 2-methylimidazole (mIM) bridging units. ZIF-8 is porous (BET surface area ca. 
1200 m2g−1), stable in a wide range of organic solvents and can be synthesised in neat water.26-
27 Standard conditions for the biomimetic mineralisation of ZIF-8 employ a stoichiometric ratio 
metal ions and organic linker (160 mM of mIM and 40 mM of metal salt) in an aqueous solution 
of 2 mg of protein at room temperature.21 While the presence of a biomacromolecule may 
enhance the kinetics, there are cases in which biomimetic mineralisation requires a higher 
excess of organic linker (mIM), or longer times, to engender ZIF formation.28 In order to 
maximise the efficacy and versatility of this promising strategy for the protection of 
biomacromolecules, a general approach is desirable. 
A detailed understanding of the chemistry at the interface of the MOF and the 
biomacromolecule is necessary to develop this burgeoning area. A first step towards this aim 
is to ascertain how the surface chemistry of the protein influences the biomimetic 
mineralisation process. Preliminary data showed that MOF crystallisation was facilitated by 
the capacity of the biomacromolecule to attract and concentrate metal cations and ligands; 
however, empirical data was only provided for a composite made with a single protein, bovine 
serum albumin (BSA).21 Subsequently, we have observed that the kinetics of the biomimetic 
mineralisation process are protein dependent. Under identical reaction conditions the 
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precipitation of the biocomposite varies from seconds to hours and in some cases no composite 
is formed. For example, whilst BSA induces the formation of ZIF-8 within seconds, in our 
hands, a thorough study employing haemoglobin showed that aqueous solutions only yield a 
low quantity of non-ZIF-8 precipitate after several hours and that the precipitate does not 
contain protein. This observation suggests that the surface chemistry of the protein may have 
a significant effect on MOF crystallisation. Moreover, FTIR studies performed on proteins 
encapsulated within ZIF-8 point towards the existence of interactions between Zn2+ cations and 
carbonyl moieties at the protein surface.16 To enhance our understanding of the biomimetic 
mineralisation process we carried out a combined computational and experimental study to 
investigate the role that protein surface chemistry plays in the formation of the MOF-based 
biocomposites. Specifically, we chemically modified the surface amino acid residues of a 
variety of proteins using succinic (or acetic) anhydride or ethylene diamine (Scheme S3.1). 
Analysis of these data indicates that converting the basic residues on the protein surface into 
acidic or non-ionisable moieties is a convenient strategy for facilitating the biomimetic 
mineralisation of proteins under standard conditions. 
3.3.  Results and Discussion 
To determine the main features of the protein chemistry that induce ZIF-8 
encapsulation, we screened a series of structurally distinct proteins under identical biomimetic 
mineralisation conditions (0.5 mg mL−1 of protein dissolved in a solution composed of a 
1 : 4 : 278 molar ratio of Zn2+ : mIM : H2O). These standard conditions were chosen because: 
(1) they have previously been shown to give rise to rapid (within seconds) biomimetic 
mineralisation;21 (2) all proteins investigated are homogeneously dispersed; and (3) a visually 
observable ZIF-8 precipitate is not formed in the absence of a biomacromolecule for several 
hours. Table 3.1 lists the proteins assessed for their capacity to induce the formation of a MOF-
based biocomposite. Analysis of the data indicates that a biomimetically mineralised ZIF-8 
precipitate is formed with proteins that have a low isoelectric point (pI) (see Figure S3.1 and 
S3.2). These proteins contain a greater proportion of acidic residues (aspartate, pKa 3.7, and 
glutamate, pKa 4.3) which will be deprotonated, and thus negatively charged under the basic 
reaction process.29 The proteins that did not induce ZIF-8 formation are those with higher pI 
values (above ca.7) which conversely possess a larger percentage of basic amino acids (lysine, 
pKa 10.5, and arginine, pKa 12.5).29 We posit that basic amino acids will contribute to a 
positively charged protein surface, under the standard reaction conditions, and thus disfavour 
the accumulation of Zn2+ ions that engenders biomimetic mineralisation. 
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Amino acid modifications are commonly applied to increase the binding affinity of 
biomacromolecules for an immobilisation support by controlling the electrostatic 
interactions.24 Thus, we proposed this technique could be applied as a general strategy for 
facilitating biomimetic mineralisation under mild, standard conditions. To explore this 
hypothesis, we chemically modified the basic surface amino acid residues of haemoglobin (Hb) 
and myoglobin (Mb) that would contribute to a positive surface charge. Surface lysine residues 
of Hb and Mb were reacted with succinic or acetic anhydride to convert these exposed basic 
residues into acidic or non-ionisable groups respectively (Figure 3.1 and Scheme S3.1). The 
succinylated forms of Hb and Mb induced immediate precipitate formation upon precursor 
mixing. The precipitate was confirmed to have sodalite topology and rhombic dodecahedral 
crystal morphology characteristic of ZIF-8 by PXRD and SEM, respectively (Figure S3.3–
S3.5). The acetylated variants, which do not provide carboxyl functional groups also facilitated 
precipitation of a crystalline product (Figure S3.1), but PXRD data indicated that the samples 
were not phase pure (Figure S3.4). These results confirm that the biomimetic mineralisation 
process is highly dependent on a protein's surface chemistry, with the ionisable carboxyl groups 
being more effective at facilitating biomimetic mineralisation of the desired ZIF-8 phase. 
Figure S3.6 shows the UV-visible spectra of the supernatants obtained after centrifugation of 
the Hb and Mb biocomposites. The presence of the Soret band at 405 nm, indicates that the 
unmodified proteins remain in solution. To evaluate that the modified forms of these proteins 
were incorporated into the ZIF crystals, we performed UV-vis spectroscopy on dissolved 
samples of the biocomposite. We first washed the composites with SDS to ensure that surface 
bound protein was removed.28 Figure S3.7 shows the UV-vis spectra of the dissolved 
HbAc/Succ@ZIF-8 and MbAc/Succ@ZIF-8 biocomposites. The presence of the Soret band at 
405 nm is evidence that the Hb and Mb proteins are encapsulated within the ZIF-8 crystals. 
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Table 3.1: Reported pI (pH at which the protein is uncharged), experimental zeta potential in 
a mIM solution at pH 11, and binary ZIF-8 growth result for each protein tested in this work. 
The yes/no descriptor for ZIF growth indicates the formation of a biocomposite with sodalite 
topology (determined by PXRD). Uncertainties are twice the standard error in the mean. 
Protein pI Ref Zeta 
Potential 
[mV] 




Pepsin 2.9 30 -30.9 ± 1.4 Yes Amination -7.9 ± 0.6 No 
BSA 5.3 31 -36.4 ± 1.4 Yes Amination -5.8 ± 0.2 No 
Lipase 4-8a 32 -31.7 ± 0.3 Yes    
Catalase 5.4b 33 -30.4 ± 0.6 Yes    
HRP 3.0-9.0c 34 -36.4 ± 1.0 Yes    
Haemoglobin 8.1(α), 7.0(β) 30 -21.0 ± 2.4 No Succinylation -37.0 ± 2.7 Yes 
     Acetylation -35.9 ± 2.6 Yesd 
Myoglobin 7.6 30 -14.7 ± 2.0 No Succinylation -36.6 ± 0.2 Yes 
     Acetylation -36.1 ± 3.6 Yesd 
Trypsin 10.7 30 -9.0 ±1.05 No    
Lysozyme 11, 11.3 30 +6.6 ± 0.2 No    
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Figure 3.1: Schematic representations of the outcomes of biomimetic mineralisation for two 
proteins, namely haemoglobin (Hb) and bovine serum albumin (BSA). Hb does not undergo 
biomimetic mineralisation under standard conditions but can be chemically modified by 
acetylation or succinylation (shown) to increase the surface negative charge and facilitate ZIF-
8 formation and encapsulation. BSA can be biomimetically mineralised but amination 
introduces surface amine groups that are protonated under the conditions used for ZIF-8 
formation and thereby prevent mineralisation. 
Both the pI values and surface modification experiments suggest that the biomimetic 
mineralisation of ZIF-8 depends on electrostatics of the protein surface. Thus, we measured 
the zeta potential of each protein in a 160 mM mIM precursor solution to estimate their charge 
under the reaction conditions. The zeta potential data presented in Table 3.1 indicates that 
precipitation of ZIF-8 crystals is induced when the values are below ca.−30 mV. This trend 
explains why surface modification can switch the biomimetic mineralisation process ‘on’ or 
‘off’. For example, the zeta potentials of both Hb and Mb decrease from −21 and −15 mV 
respectively to values significantly below −30 mV upon succinylation or acetylation. To further 
demonstrate the importance of surface charge, BSA and pepsin were reacted with ethylene 
diamine to yield a more positively charged protein. Amination of the acidic residues was 
confirmed by a positive shift in the zeta potential measurements above this −30 mV threshold. 
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Both modified proteins yielded minimal precipitate, insufficient for PXRD, demonstrating an 
inhibition of the biomimetic mineralisation process (Figure S3.2). 
The experimental data thus far confirm that the surface electrostatic potential of the 
biomacromolecule, which is related to, and for typical surfaces approximately equal to, the zeta 
potential,35 can be used to predict whether ZIF-8 crystallisation will be induced. These findings 
are consistent with previous reports that hypothesised that biomacromolecules concentrate 
positively charged zinc ions at their surface.21 Since the ion concentration varies approximately 
exponentially with the surface potential for purely electrostatic ion–surface interactions 
according to the Boltzmann equation (see Computational methods section), the surface zinc 
ion concentration is expected to double with each 9 mV decrease in the surface potential. This 
would result in an enhancement of the rate of encounters of zinc ions and mIM bridging units 
near the protein surface and thus to more rapid ZIF-8 formation.36 
Both the surface electrostatic potential (zeta potential) and pI of a protein, both of which 
we have shown to be good discriminators of a protein's ability to seed ZIF-8 formation, can be 
determined from theory.37-39 Therefore, whether a protein is likely to undergo biomimetic 
mineralisation can be predicted prior to experimental study. 
From the peptide sequence and acid-base equilibria we calculated the pI for all the 
proteins studied and reproduce the trend in the experimental results shown in Table 3.1 (Figure 
3.2, S3.9). Furthermore, we have used the same method for computing a protein's pI to predict 
the effect of surface modification on propensity for ZIF-8 formation (Figure 3.2, S3.9). 
Figure 3.2 shows the calculated pI for BSA, pepsin, Hb and Mb with and without the 
surface modifications used in the experiments. We assumed that any target residue (lysine for 
acetylation and succinylation, and glutamic acid and aspartic acid for the amination) will 
undergo the modification reaction. As the reaction efficiency may not be 100% and our method 
does not consider whether amino acids are exposed to solvent, the calculated change in the pI 
is expected to be an overestimate; however, we get reasonable agreement to experimental 
values (for example aminated BSA has a pI > 9.5).40 As shown in Figure 3.2 the calculated pI 
values (Figure 3.2a) show the same trend as the experimental zeta potential (Figure 3.2b) and 
clearly predicts the effect of surface modification on ZIF-8 formation for the proteins 
considered. 
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Finally, we have computed the electrostatic potential around each of the proteins 
studied experimentally by solving the Poisson–Boltzmann equation, from which we can 
approximate the protein zeta potential (see Computational methods section and Figure S3.11–
S3.13).37, 41 The calculated surface potential also provides comprehensive 3D information 
about the electrostatic interactions of the protein with the surrounding electrolyte solution. 
Figure 3.3 highlights the differences in the calculated surface potential and zinc ion 
enhancement at pH 11 between a protein that seeds ZIF-8 and one that does not (see also Figure 
S3.13). While not quantitatively reproducing the experimental data, the calculated average 
surface potential follows the same trend as the experimental zeta potential at pH 7 and pH 11 
for the proteins studied (Figure S3.11). Importantly, we show that the predictions made by a 
simple sequence-based model (pI calculations) and a more physical 3D structure-based model 
(surface potential calculations) are equivalent, and that both of these calculations agree with 
our experimental observations. Combined, this supports the idea that computational screening 
can obviate the need for more time-consuming experimental studies. 
 
 
Figure 3.2: Plots of (a) the calculated pI for BSA, pepsin, Hb and Mb, with and without the 
surface modifications used in the experiments; (b) the experimental zeta (ζ) potentials for the 
same biomacromolecules and their modified variants; and (c) the general changes in zeta 
potential for the three types of chemical modifications used. 
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Figure 3.3: (a) Stick representations of protein crystal structures of (left) BSA and (right) 
lysozyme. Hydrogens are omitted for clarity. (b) Surface potential and (c) log10 of the zinc ion 
enhancement at the surface of both proteins. Zinc ion enhancement is defined as the ratio of 
the calculated zinc ion concentration due to the electrostatic potential and the bulk zinc ion 
concentration (0.04 M) at each point near the surface of the protein. Figure S3.13 shows the 
calculated electrostatic surface of all proteins tested in this work. Figures were made using 
OVITO.42 
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3.4.  Conclusions 
In conclusion, we have shown that the electrostatic properties of a protein's surface, as 
described by its pI and zeta potential, are a good predictor of whether a protein will induce ZIF-
8 growth from aqueous solution. Our findings explain why the biomimetic mineralisation of 
ZIF-8 is not observed under standard conditions for a variety of proteins and confirm the role 
of Zn2+ concentration in seeding crystallisation. These results are consistent with studies that 
describe the effect of metal ion concentration gradients on the nucleation and growth of ZIF 
crystals.43 In addition, we have shown that simple chemical modification of surface ionisable 
residues is a convenient strategy for controlling the electrostatic potential of a protein and thus 
the formation of ZIF-8 biocomposites. We posit that chemical surface modification is a general 
strategy that can be applied to facilitate biomimetic mineralisation in a broad range of systems, 
including proteins, viruses and cells. Thus, this work significantly broadens the research scope 
and potential applications of this technique. 
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3.5.  Experimental 
3.5.1. Materials 
All proteins were purchased from Sigma-Aldrich unless otherwise stated (Table S3.1). 
Each of the proteins tested were lyophilised powders and were used without further 
purification. 2-Methylimidazole (mIM) and N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC·HCl) were purchased from Sigma-Aldrich, zinc acetate dihydrate from 
VWR Chemicals, succinic anhydride from BDH, acetic anhydride from Chem Supply, and 
ethylene diamine (EDA) from Merck. The water used was ultra-pure Milli-Q (MQ) with 
resistivity of 18 MΩ cm−1 (Merck Millipore purification system). All other buffers and solvents 
were purchased from commercial sources and used without further purification. 
3.5.2. ZIF synthesis 
Zn(OAc)2 (40 mM, 2 mL) was mixed with a solution of mIM (160 mM, 2 mL) 
containing the protein (2 mg). The reaction mixture was left for 16 hours undisturbed, and 
collected by centrifugation at 4000 rpm. The pellet was washed with water twice, followed by 
ethanol and air dried at ambient temperature and pressure. 
3.5.3. Succinylation and acetylation reactions 
The method for the succinylation and acetylation of proteins was adapted from 
literature procedures.44-46 The protein (20 mg, haemoglobin or myoglobin) was dissolved in 4 
mL of phosphate buffered saline (PBS, 100 mM, pH 8). A 50-fold molar excess of succinic 
anhydride or acetic anhydride was added in small increments over 1 hour. The pH was adjusted 
back to 8 using 2 M NaOH after each addition and the solution was stirred for 1 hour after the 
final addition. The protein solution was washed by ultra-filtration once with PBS (100 mM, pH 
7.4) and twice with MQ water to remove excess salts (Vivacell 100, Sartorius Stedim, 10 kDa 
at 4000 rpm/1699 g). The protein solution was concentrated to 4 mg mL−1 in MQ water. 
3.5.4. Amination reactions 
The method for the chemical amination of proteins was adapted from a literature 
procedure.47 A 2 mL solution of EDA (0.268 mL, 4.01 mmol) dissolved in MQ water was 
prepared and the pH was adjusted to 4.5 using 6 M HCl. The protein (20 mg, BSA or pepsin) 
was dissolved in the EDA solution followed by EDC·HCl (7.2 mg, 0.038 mmol). The solution 
was stirred on ice for 120 minutes before being washed and concentrated as described above. 
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3.5.5. Characterisation 
Powder X-ray diffraction (PXRD). PXRD data were collected on a Bruker D8-
Advanced X-ray powder diffractometer (parallel X-ray, capillary-loaded) using a Cu Kα (λ= 
1.5418 Å) radiation source. Samples were mounted in 0.5 mm glass capillaries and data 
collected for between 2θ of 2° to 52.94° with Phi rotation at 20 rotations per min at 1-second 
exposure per step at 5001 steps. The data were then converted into xye format and background-
subtracted using WinPlotr 2000 software.48 Simulated powder X-ray diffraction patterns were 
generated from the single crystal X-ray data using Mercury 3.9.49 
Scanning electron microscopy (SEM). SEM images were collected using a Philips 
XL30 field emission scanning electron microscope (FESEM). Samples were dry loaded onto 
an adhesive carbon tab and sputter coated with 5 nm platinum thin film. 
UV/Visible (UV/Vis). Spectra were recorded at 30 °C on an Agilent Cary 60 UV/Vis 
spectrophotometer. Samples were diluted to 4 mL prior to each measurement. 
Zeta potential measurements. Measurements were recorded on a Malvern Zetasizer 
nano using a disposable folded cell capillary (DTS1070). Protein samples were dissolved in a 
HmIM solution (160 mM, pH 11) or MQ water (≈pH 7) with measurements recorded with the 
following parameters: Dispersant RI: 1.33, viscosity (Cp): 0.887, Dispersant dielectric constant 
78.5, f(Ka): 1.5 (Smoluchowski approximation). 
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3.5.6. Computation methods 
Calculation of the pI from protein sequence. For each protein, the sequence of natural 
amino acids was extracted from the FASTA file associated with each PDB entry (Table S3.1). 
Using the Biopython module50 and the Henderson–Hasselbach equation, the average charge, 
  (1) 
of each ionisable residue as a function of pH was calculated. The total protein charge was 
calculated as the sum of the average charges of all ionisable residues and the pH varied until 
the total protein charge was 0 ± 0.0001e to determine the sequence pI. The pKa of all residue 
types were kept constant and defined within Biopython. 
Surface modification of proteins. The pI of surface-modified proteins was calculated 
using Biopython and assuming 100% efficiency of modification reactions on all target residues. 
For the amination reaction, any aspartate or glutamate residues were treated as lysine residues 
with respect to their charge and pKa. For the acetylation and succinylation reactions, any lysine 
residues were either ignored in the calculation of the protein charge (acetylation) or treated as 
glutamate residues with respect to their charge and pKa (succinylation). See Scheme S3.1 for 
the reaction schemes. 
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Calculation of average surface potentials. Crystal structures were obtained from the 
Protein Data Bank51 for each protein (PDB accession codes given in Table S3.1). PROPKA 
3.0,52-53 was used to assign charge states to each ionisable residue in the PDB file and the 
PDB2PQR software54-55 was used to prepare the protein structures for analysis. See ESI for 
details. 
Using the SURFPOT module,37 within the DELPHI software,41 the linearised Poisson–
Boltzmann equation,56 
∇ [ε(r)∇ψ(r)] −ε0εrκ(r)2ψ(r) = −ρ(r),  (2) 
was solved to calculate the electrostatic potential, ψ(r), at position r. In the expression, ρ(r) is 
the (fixed) charge density of the solute (protein), ε(r) is the spatially varying dielectric 
permittivity, which is different in the protein and in the solution, and κ(r) is the Debye 
screening parameter given by 
  (3) 
outside of the protein and is zero inside of the protein. In expression (3), e is the elementary 
charge, kB is the Boltzmann constant, T is temperature, ε0 is the vacuum permittivity, εr is the 
relative permittivity of water (80), and c0i and zi are the bulk concentration and valency of ions 
of type i, respectively. For all our calculations the Debye length (κ−1) was 8.86 Å. The 
efficiency of the linearised Poisson–Boltzmann equation makes it more amenable to high-
throughput computational screening than solving the full nonlinear equation and comparison 
of the calculated average surface potentials with experimental zeta potentials at pH 7 and pH 
11 (see Figure. S3.11) suggest that the linearised equation is sufficiently accurate for our 
purposes. 
The zeta potential for each protein was estimated to be the average electrostatic 
potential on a surface at 4 Å from the van der Waals surface of the protein. The zeta potential 
of a particle undergoing electrophoresis is defined by the electrostatic potential at the shear 
plane, which is not readily determined for heterogeneous and rough surfaces such as proteins. 
The chosen surface at which the zeta potential was calculated is expected to be a reasonable 
approximation for the shear plane and is similar to that used previously in the literature to 
estimate the zeta potential of proteins.37 An interior protein dielectric coefficient of 4 was used 
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and it was confirmed that the average surface potential was not sensitive to this parameter 
(results not shown), which agrees well with literature.37 We used a grid spacing of 0.5 Å, a 
probe radius (to define the protein surface) of 1.4 Å, which is equivalent to the radius of a water 
molecule, dipolar boundary conditions on the edge of the box, and a box size such that the 
longest dimension of the solute was 60% of the box size. 
Ion concentrations and enhancements. The concentration of ions of type i at 
position r was calculated from the electrostatic potential (ψ(r)) using the Boltzmann equation, 
  (4) 
To match the experimental conditions, the bulk concentrations of the cations (zinc) and 
anions (acetate) in solution were taken to be c0+= 0.04 M and c0−= 0.08 M, respectively, and 
were assumed to be independent of pH. The cation and anion valencies were z+ = +2 and z− = 
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3.9.  Supporting Information 
3.9.1. Materials  
Table S3.1. Details of the proteins, their sources, product codes and the Protein Data Bank 
(PDB) codes for the proteins investigated in this research. 
Protein Source Product Code 
PDB    
File Used 
Pepsin Porcine gastric mucosa P6887 4pep1 
Bovine serum albumin 
(BSA) 
Bovine A9418 4f5s2 
Candida antarctica Lipase 
B (CALB) 
Aspergillus oryzae 62288 1tca3 
Catalase Bovine Liver C9322 3re84 
Peroxidase from 
horseradish (HRP) 
Horseradish 77332 1w4w5 
Myoglobin Equine skeletal muscle M0630 2frf6 
Haemoglobin Human H7379 2dn27 
Trypsin Porcine pancreas T4799 1s818 
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3.9.2. Protein surface modification reactions 
 
Scheme S3.1: Surface modification reactions. Succinylation and acetylation reactions lower 
the pI of a protein by modification of exposed amine groups. Amination reactions cap carboxyl 
groups with a free amine, thus increasing the pI. 
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3.9.3. Time course biomimetic mineralisation studies 
 
Figure S3.1: Sequential photographs of haemoglobin (Hb), succinylated haemoglobin 
(HbSucc), acetylated haemoglobin (HbAc), myoglobin (Mb), succinylated myoglobin 
(MbSucc), and acetylated myoglobin (MbAc) samples (2 mg protein) immediately after mixing 
of the mIM (160 mM) and zinc solutions (40 mM) (t=0) until immediately prior to 
centrifugation and washing (t=16 hours). The unmodified haemoglobin and myoglobin 
samples remain clear upon addition of the zinc solution, both yielding minimal product after 
16 hours. The succinylated and acetylated forms of both proteins cause immediate precipitation 
of ZIF.  
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Figure S3.2: Sequential photographs of unmodified and aminated bovine serum albumin 
(BSA) and pepsin (2 mg protein) immediately after mixing of the mIM (160 mM) and zinc 
solutions (40 mM) (t=0) until immediately prior to centrifugation and washing (t=16 hours). 
The unmodified BSA and pepsin samples gave immediate biomineralization upon addition of 
the zinc solution. The aminated BSA and pepsin samples show a dramatic reduction in 
precipitation yielding only minimal product after 16 hours. 
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3.9.4. Powder X-ray diffraction (PXRD) data 
 
Figure S3.3: Powder X-ray diffraction patterns of biomimetically mineralised ZIF samples of 
unmodified proteins made under standard conditions (4:1 mIM:Zn2+). Data collected on dried 
samples after washes with water and ethanol. Unmodified haemoglobin, myoglobin, lysozyme, 
and trypsin did not yield sufficient product for PXRD analysis. The simulated pattern relates 
to ZIF-8. 
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Figure S3.4: Powder X-ray diffraction patterns of biomimetically mineralised ZIF samples of 
HbSucc and MbSucc (top) and HbAc and MbAc (bottom ) made under standard conditions 
(4:1 mIM:Zn2+). Data collected on dried samples after washes with water and ethanol. 
Aminated BSA and pepsin, did not yield sufficient product for PXRD analysis. The simulated 
pattern relates to ZIF-8. 
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3.9.5. Scanning electron microscopy 
 
Figure S3.5: HbSucc@ZIF-8 (left) and MbSucc@ZIF-8 (right) after 16 hours from the 
beginning of the biomimetic mineralization reaction; the rhombic dodecahedral morphology 
can be observed. 
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Figure S3.6: UV-visible spectra of the supernatant removed after centrifugation of the 
biocomposite samples where the protein was myoglobin (Mb), succinylated myoglobin 
(MbSucc), and acetylated myoglobin (MbAc) (left) and haemoglobin (Hb), succinylated 
haemoglobin (HbSucc), and acetylated haemoglobin (HbAc) (right). Unmodified haemoglobin 
and myoglobin formed minimal product and therefore show a large Soret absorbance in the 
removed solution, indicating that the protein has not been immobilised. In both the succinylated 
and acetylated variants, the absorbance has decreased thus indicating that the protein has been 
removed from solution and incorporated into ZIF-8 as it formed. 
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Figure S3.7: UV-visible spectra of the washings of succinylated haemoglobin ZIF-8 samples. 
The supernatant (red) was obtained after centrifugation of the product and shows no evidence 
of protein remaining in solution. SDS washes 1 (blue) and 2 (pink) show the appearance of the 
haemoglobin absorbance peak, indicating that some protein was surface bound had been 
washed off. After the SDS washes to remove surface bound protein showed nofurther protein, 
the ZIF-8 sample was dissolved in citric acid buffer (pH 6) containing EDTA (20 mM) and the 
absorbance was measured to show presence of encapsulated protein. 
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3.9.7. Additional computational methods 
Calculation of the average hydropathic index. The hydropathic index is a measure 
of an amino acid sequences hydropathicity. Negative values imply an overall hydrophilic 
protein, whereas positive values imply an overall hydrophobic protein. The hydropathic index 
for a protein sequence was calculated using the Kyte and Doolittle scale of residue 
hydropathicity,10 which quantifies the hydropathicity of each residue, and the Biopython 
module.11-12 A single value is reported, which is the sum of the hydropathic indices of all 
residues divided by the length of the sequence.  
Preparation of PDB files and calculation of protein charge state. Crystal structures 
were obtained from the Protein Data Bank13 for each protein (PDB accession codes given in 
Table S3.1). Where available a protein structure associated with the same organism as the 
experimental source was obtained. Each PDB file comes with one or more peptide chain, where 
each chain represents a separate sequence of amino acids in the crystal structure. For BSA, 
only the first polypeptide chain in the PDB file was used because this protein is expected to 
exist as a monomer in solution. In all other cases all chains in the PDB file were used. 
Heteroatoms (non-natural amino acid residues or ligands), bound ions or water molecules in 
the protein structures were removed.  
PROPKA 3.0,14-15 was used to estimate the pKa of each ionisable residue in each 
protein structure using a highly efficient, empirical method. PROPKA uses effective potentials 
to calculate the total environmental perturbation to the free energy of protonation due to 
moving the ionisable residue from water into the 3D environment of the protein. The resultant 
free energy was used to determine the shift in the known pKa of each residue due to the protein 
environment. We have confirmed that similar results are obtained for the calculated pKa’s 
using the more sophisticated DELPHIPKA16 to assign atom charges and protonation states 
(results not shown). DELPHIPKA uses a variable dielectric coefficient within the protein and 
the free energy difference between the protonated and deprotonated state of each ionisable 
residue within the 3D structure (using a Poisson–Boltzmann based approach to calculate the 
free energy difference) to obtain the pKa for each residue. The calculated pKa of each ionisable 
residue, given by PROPKA, was then used to calculate the 3D model pI of each protein using 
the Henderson–Hasselbach equation.  
Before analysing each crystal structure, the PDB2PQR software17-18 was used to add 
missing heavy atoms, to make sure there were no overlapping atoms in the structure, to 
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protonate the structure based on the pKa’s calculated by PROPKA and the given pH (where a 
residue is protonated if its pKa is greater than the given pH) and to assign charges and radii 
from the AMBER19 force field to each atom. We note that the AMBER force field included 
with PDB2PQR does not contain charge parameters for residues in certain protonation states 
derived by PROPKA (for example, a neutral N terminus state is not supported by the force 
field provided by PDB2PQR) and therefore some residues will always exist in their pH 7 state. 
8. Additional computational results 8.1.  
3.9.8. Additional computational results 
Protein Metrics. In Figure S3.8 we show the calculated average hydropathic index of 
the sequence of each protein. The results indicate that the proteins that seed ZIF-8 growth have 
hydropathicities that overlap completely with proteins that do not seed ZIF-8 growth. This 
finding further supports the dominant nature of electrostatic interactions in determining ZIF-8 
formation, which allows for the use of such simplified screening methods. 
 
Figure S3.8: Categorical scatterplot of the average hydropathicity of the peptide sequences for 
all proteins. Closed circles are proteins that form ZIF-8 and open circles are proteins that do 
not form ZIF-8. 
Comparison of pI from sequence models, 3D models and experiments. Figure S3.9 
shows categorical scatter plots of the calculated pIs from the 3D structure (obtained from 
PROPKA 3.0) and peptide sequence (obtained from Biopython) of each protein, which shows 
that both calculation methods predict ZIF-8 growth reasonably accurately. Parity plots of the 
pIs obtained from both calculation methods as well as a comparison between the pIs calculated 
from the 3D protein structure and the reported pIs (Table 3.1) are also shown. Importantly, 
reasonable agreement between the two calculation methods was obtained, indicating that the 
much simpler sequencebased model can be used without adversely affecting prediction 
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accuracy. We note that some experimental pIs are reported as a range of values, and so error 
bars are included in Figure S3.9d, for which the uncertainty encompasses the reported range 
and the pI is the mean of the reported range. 
 
 
Figure S3.9: Categorical scatter plots of the calculated pI (a) from the 3D model and (b) 
sequence model of all proteins. Parity plots comparing the calculated pI from the 3D model 
and (c) the sequence model and (d) the reported pI values (the y = x line is shown). Error bars 
represent ranges of pI values reported from experiments. Closed circles are proteins that form 
ZIF-8 and open circles are proteins that do not form ZIF-8. 
Experimental zinc ion enhancement. Figure S3.10 shows a categorical scatter plot 
of the enhancement of zinc ions calculated from the experimental zeta potentials in Table 3.1 
using Equation 4. Experimental zeta potentials give reasonable approximations of the surface 
electrostatic potential of each protein in solution and, therefore, a proteins ability to enhance 
zinc ion concentrations near the surface and, hence, seed ZIF-8 growth. Based on Figure S3.10, 
a surface zinc ion enhancement of > 10, which is a zinc ion concentration of 0.4 M, leads to 
ZIF-8 formation under experimental conditions. 
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Figure S3.10: Categorical scatterplots of the zinc ion enhancements calculated from the 
experimental zeta potentials at pH 11 for all proteins. Closed circles are proteins that form ZIF-
8 and open circles are proteins that do not form ZIF-8. 
Zinc ion enhancement from 3D model. The calculated average surface potentials 
from the 3D model of each protein show reasonable agreement with the experimental zeta 
potentials (Figure S3.11). The main discrepancies are the overestimation of the average surface 
potential compared with experimental zeta potentials for very highly charged proteins, such as 
BSA, catalase and pepsin. This result is not unexpected, given the use of the linearised Poisson–
Boltzmann equation, which breaks down in regimes of high zeta potential ((|𝜁| >  B  ≈
12 mV). The underestimation of the average surface potential compared with experimental zeta 
potentials for lipase and HRP is likely a result of experimental impurities. Both proteins are 
expected to be glycosylated,20-21 which is known to affect zeta potential measurements,22 
whereas the calculations used non-glycosylated structures. Additionally, HRP could be a 
mixture of different iso-enzymes with vastly different electrostatic properties.23 We note that 
both proteins have reported pIs that span a broad range of values (Table 3.1), indicating a broad 
range of electrostatic properties for different samples. Our calculation methodology used static 
3D structures of each protein obtained from X-ray crystallography, which are unlikely to be 
representative of the protein structure in solution at a pH of 11. At high pHs, the presence of 
high-charge regions would lead to repulsion and a degree of unfolding, which such a simple 
model could not take into account. We also note that it has been shown previously that the 
interior of a protein has a highly variable dielectric coefficient and assuming a constant 
dielectric coefficient, as we have, can give rise to errors near the surface of proteins.24 
Furthermore, by taking the average surface potential to be equal to the experimental zeta 
potential for a heterogenous protein surface we assumed that the electric double layer 
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surrounding the protein is thin compared with the size of the protein and that the linearised 
Poisson–Boltzmann equation applies, which may not always be the case for the systems studied 
(discussed above).25 The semi-quantitative agreement with experiment in most cases is very 
encouraging, considering the approximations in the calculations. 
 
Figure S3.11: Parity plots comparing the calculated surface potential from our 3D model and 
experimental zeta potentials at (a) pH 7 and (b) pH 11 for all proteins (the y = x line is shown). 
Closed circles are proteins that form ZIF-8 and open circles are proteins that do not form ZIF-
8. Figure S3.12 shows a categorical scatter plot of the calculated average surface potentials at 
pH 9 and pH 11 for all proteins. These results support the experimental findings and show a 
reasonable ability to predict a protein’s propensity to seed ZIF-8 formation. Results at pH 9 
and pH 11 are shown as the initial solution (before zinc ions are added) is at approximately pH 
11, but upon zinc ion addition, the pH quickly decreases to around 9, likely because of ZIF 
nucleation.26 Finally, Figure S3.13 shows the variation in the surface potential around all 
proteins at pH 11 calculated from our 3D model. 
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Figure S3.12: Categorical scatterplots of the calculated surface potential from the 3D model 
(a) at pH 9 and (b) pH 11 for all proteins. Closed circles are proteins that form ZIF-8 and open 
circles are proteins that do not form ZIF-8. The shaded region highlights the approximate 





Figure S3.13: Surface potential surrounding all proteins calculated from our 3D model at pH 
11. Lipase and HRP are outliers based on our analysis. 
  
Chapter 3   
- 94 - 
 
Supporting Information 3.9. References 
1. Sielecki, A. R.; Fedorov, A. A.; Boodhoo, A.; Andreeva, N. S.; James, M. N. G., 
Molecular and crystal structures of monoclinic porcine pepsin refined at 1.8Å resolution. J. 
Mol. Biol. 1990, 214 (1), 143-170. 
2. Bujacz, A., Structures of bovine, equine and leporine serum albumin. Acta Crystallogr. 
Sect. D. Biol. Crystallogr. 2012, 68 (10), 1278-1289. 
3. Uppenberg, J.; Hansen, M. T.; Patkar, S.; Jones, T. A., The sequence, crystal structure 
determination and refinement of two crystal forms of lipase B from Candida antarctica. 
Structure 1994, 2 (4), 293-308. 
4. Purwar, N.; McGarry, J. M.; Kostera, J.; Pacheco, A. A.; Schmidt, M., Interaction of 
nitric oxide with catalase: structural and kinetic analysis. Biochemistry 2011, 50 (21), 4491-
4503. 
5. Carlsson, G. H.; Nicholls, P.; Svistunenko, D.; Berglund, G. I.; Hajdu, J., Complexes 
of horseradish peroxidase with formate, acetate, and carbon monoxide. Biochemistry 2005, 44 
(2), 635-642. 
6. Copeland, D. M.; Soares, A. S.; West, A. H.; Richter-Addo, G. B., Crystal structures of 
the nitrite and nitric oxide complexes of horse heart myoglobin. J. Inorg. Biochem. 2006, 100 
(8), 1413-1425. 
7. Park, S.-Y.; Yokoyama, T.; Shibayama, N.; Shiro, Y.; Tame, J. R. H., 1.25 Å 
Resolution crystal structures of human haemoglobin in the oxy, deoxy and carbonmonoxy 
forms. J. Mol. Biol. 2006, 360 (3), 690-701. 
8. Transue, T. R.; Krahn, J. M.; Gabel, S. A.; DeRose, E. F.; London, R. E., X-ray and 
NMR characterization of covalent complexes of trypsin, borate, and alcohols. Biochemistry 
2004, 43 (10), 2829-2839. 
9. Wang, J.; Dauter, M.; Alkire, R.; Joachimiak, A.; Dauter, Z., Triclinic lysozyme at 0.65 
A resolution. Acta Crystallogr. Sect. D. Biol. Crystallogr. 2007, 63 (12), 1254-1268. 
10. Kyte, J.; Doolittle, R. F., A simple method for displaying the hydropathic character of 
a protein. J. Mol. Biol. 1982, 157 (1), 105-132. 
11. Hamelryck, T.; Manderick, B., PDB file parser and structure class implemented in 
Python. Bioinformatics 2003, 19 (17), 2308-2310. 
12. Cock, P. J. A.; Antao, T.; Chang, J. T.; Chapman, B. A.; Cox, C. J.; Dalke, A.; 
Friedberg, I.; Hamelryck, T.; Kauff, F.; Wilczynski, B.; de Hoon, M. J. L., Biopython: freely 
Chapter 3   
- 95 - 
 
available Python tools for computational molecular biology and bioinformatics. Bioinformatics 
2009, 25 (11), 1422-1423. 
13. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; 
Shindyalov, I. N.; Bourne, P. E., The Protein Data Bank. Nucleic Acids Res. 2000, 28 (1), 235-
242. 
14. Søndergaard, C. R.; Olsson, M. H. M.; Rostkowski, M.; Jensen, J. H., Improved 
treatment of ligands and coupling effects in empirical calculation and rationalization of pKa 
values. J. Chem. Theory. Comput. 2011, 7 (7), 2284-2295. 
15. Olsson, M. H. M.; Søndergaard, C. R.; Rostkowski, M.; Jensen, J. H., PROPKA3: 
Consistent treatment of internal and surface residues in empirical pKa predictions. J. Chem. 
Theory. Comput. 2011, 7 (2), 525-537. 
16. Wang, L.; Li, L.; Alexov, E., pKa predictions for proteins, RNAs, and DNAs with the 
Gaussian dielectric function using DelPhi pKa. Proteins 2015, 83 (12), 2186-2197. 
17. Dolinsky, T. J.; Nielsen, J. E.; McCammon, J. A.; Baker, N. A., PDB2PQR: an 
automated pipeline for the setup of Poisson–Boltzmann electrostatics calculations. Nucleic 
Acids Res. 2004, 32, W665-W667. 
18. Dolinsky, T. J.; Czodrowski, P.; Li, H.; Nielsen, J. E.; Jensen, J. H.; Klebe, G.; Baker, 
N. A., PDB2PQR: expanding and upgrading automated preparation of biomolecular structures 
for molecular simulations. Nucleic Acids Res. 2007, 35, W522-W525. 
19. Wang, J.; Cieplak, P.; Kollman, P. A., How well does a restrained electrostatic potential 
(RESP) model perform in calculating conformational energies of organic and biological 
molecules? J. Comput. Chem. 2000, 21 (12), 1049-1074. 
20. Spadiut, O.; Rossetti, L.; Dietzsch, C.; Herwig, C., Purification of a recombinant plant 
peroxidase produced in Pichia pastoris by a simple 2-step strategy. Protein Expr. Purif. 2012, 
86 (2), 89-97. 
21. Høegh, I.; Patkar, S.; Halkier, T.; Hansen, M. T., Two lipases from Candida antarctica: 
cloning and expression in aspergillus oryzae. Can. J. Bot. 1995, 73 (S1), 869-875. 
22. Kreuß, M.; Strixner, T.; Kulozik, U., The effect of glycosylation on the interfacial 
properties of bovine caseinomacropeptide. Food Hydrocol. 2009, (7), 1818-1826. 
23. Hoyle, M. C., High resolution of peroxidase-indoleacetic acid oxidase isoenzymes from 
horseradish by isoelectric focusing. Plant. Physiol. 1977, 60 (5), 787-793. 
24. Li, L.; Li, C.; Zhang, Z.; Alexov, E., On the dielectric “constant” of proteins: smooth 
dielectric function for macromolecular modeling and its implementation in DelPhi. J. Chem. 
Theory Comput. 2013, 9 (4), 2126-2136. 
Chapter 3   
- 96 - 
 
25. Fogolari, F.; Zuccato, P.; Esposito, G.; Viglino, P., Biomolecular electrostatics with the 
linearized Poisson-Boltzmann equation. Biophys. J. 1999, 76 (1 Pt 1), 1-16. 
26. Jian, M.; Liu, B.; Liu, R.; Qu, J.; Wang, H.; Zhang, X., Water-based synthesis of zeolitic 
imidazolate framework-8 with high morphology level at room temperature. RSC. Adv. 2015, 5 
(60), 48433-48441.
Chapter 4   





Influence of Fabrication Conditions and Formation 
Kinetics on the Activity of Candida antarctica Lipase B 
ZIF-8 Biocomposites 
This work is to be submitted for publication. 
  
Chapter 4   
- 98 - 
 
 
Chapter 4   




Chapter 4   
- 100 - 
 
Chapter 4. Influence of Fabrication Conditions and Formation Kinetics on the Activity 
of Candida antarctica Lipase B ZIF-8 Biocomposites 
4.1.  Abstract 
The biomimetic mineralisation of ZIF-8 has been widely reported as a strategy for 
enzyme immobilisation, enabling the heterogenisation and protection of biomacromolecules. 
Here, we report the preparation of different Candida antarctica lipase B biocomposites 
(CALB@ZIF-8) of different particle size by altering the concentrations of Zn2+ and 2-
methylimidazole (2-mIM). The influence of synthetic conditions on the catalytic activity of 
CALB was measured by hydrolysis and transesterification assays. We demonstrated that for 
both reactions, activity was retained for the biocomposites formed at low 2-mIM:Zn2+ but 
almost entirely lost when the ligand concentration was increased. Additionally, phosphate 
buffer could regenerate the activity of larger particles by degrading the crystal surfaces and 
releasing encapsulated CALB into solution. The transesterification reactions were undertaken 
in 100% hexane, giving rise to enhanced CALB activity relative to the free enzyme. These 
observations highlight the fundamental importance of synthetic protocols and solvent selection 
for developing enzyme MOF biocomposites with improved activity in challenging conditions. 
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4.2.  Introduction 
Enzymes are protein catalysts that function under mild biological conditions, 
providing an alternate, low energy pathway for complex chemical reactions.1 In general, 
enzyme reactions are rapid and highly selective under ambient conditions and as such 
they are sought after for application to industrial processes.2-3 However, their catalytic 
output is often restricted by the necessity of aqueous conditions which limits the 
substrate range and concentration that is tolerated by the enzyme.4-5 Thus, challenges 
include improving the tolerance of enzymes to high substrate concentration and 
challenging conditions, such as organic solvents and elevated temperatures.6 
Immobilisation of enzymes directly onto, or within a solid support, is one 
strategy that has been explored to protect enzymes from harsh conditions whilst 
additionally facilitating reusability.7-8 Metal-organic frameworks (MOFs) are a class of 
extended solids that have recently shown promise for enzyme immobilisation.8-13 
Enzyme-MOF composites can be synthesised via infiltrating biomacromolecules into 
the framework pores,14 surface adsorption,15 covalent attachment,16 and ‘one-pot’ 
encapsulation of enzymes within MOF crystals.17 Zeolitic imidazolate-8 (ZIF-8), a 
porous framework composed of tetrahedral Zn2+ ions linked via 2-methylimidazole (2-
mIM), is commonly utilised for its porosity and thermal stability.18-19 Recently it has 
been shown that enzymes can induce the growth of ZIF-8 crystals from its precursors 
(Zn2+ and 2-mIM) in aqueous conditions.20 This process termed ‘biomimetic 
mineralisation’ yields enzyme@MOF biocomposites where the biomacromolecule is 
encapsulated within the ZIF-8 crystals. The formation of enzyme@ZIF-8 biocomposites 
of uniform size (ca. 1 µm), topology (sodalite; sod), and morphology (rhombic 
dodecahedral; RD) can be achieved using either high precursor concentrations or a high 
2-mIM: Zn2+ ratio.21 Conversely, dilute or low ratio precursors give rise to a variety of 
network topologies and morphologies including an amorphous phase that requires 
ethanol washing to generate, crystalline, phase pure sodalite frameworks.22 Presumably, 
modulating the biocomposite synthesis conditions and precursor concentration/ ratio, 
gives rise to the different nucleation and growth rates, that determine the wide variety 
of observed ZIF phases. Understanding the synthetic conditions required to predicably 
yield a ZIF-based biocomposite of a specific topology/morphology is essential as each 
ZIF phase possesses distinct physical properties that have a direct input on catalysis. For 
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example, ZIF-8 (sodalite; sod) is porous whereas its denser counterpart ZIF-8 
(diamondoid; dia) is non-porous.23  
It can be anticipated that the crystal properties will influence the catalytic output 
of the biocomposite as the particle size will affect composite stability, enzyme spatial 
distribution, and mass transfer (diffusion) of substrates and products. In addition, reports 
have shown that phosphate containing solutions cause rapid degradation of ZIF particles 
due to the high affinity of Zn2+ for the phosphate anions.24-26 The rate of this degradation 
is known to be size dependent and may account for conflicting reports of biocomposite 
activity reported in the literature. For example, we have previously shown that catalase 
immobilisation within ZIF-8 generates an inactive biocomposite due to the frameworks 
hydrophobicity.27 However, there are literature reports that catalase@ZIF-8 
biocomposites are active when stored and tested in phosphate buffered saline (PBS).28-
30 Accordingly, we were motivated to understand the underlying chemistry of how 
biocomposite activity is related to crystal size and handling conditions. 
 In this present work, we synthesised ZIF-based biocomposites of Candida antarctica 
lipase B (CALB) using different metal : ligand ratios (yielding particle sizes of 500 nm to 1 
µm) and assessed how activity was influenced by handling conditions (phosphate buffer) 
and crystal size. Though lipases have been immobilised onto various MOF supports, to 
date the effect of synthetic conditions, particle size, topology, and solvents have not 
been systematically investigated.17, 31-33 We found that phosphate buffer mediated 
degradation facilitated hydrolytic activity after prolonged exposure regardless of the 
crystal preparation conditions (Figure 4.1). However, an additional and noteworthy result 
is that the activity of CALB@ZIF-8 biocomposites was dependent on crystal size, which is 
determined by the precursor concentrations used to synthesise ZIF-8. These findings 
highlight that both preparation and handling conditions can affect the biocatalytic activity of 
ZIF-based biocomposites  
 
  
Chapter 4   
- 103 - 
 
 
Figure 4.1: Schematic representation of the relationship between particle size, solvent stability 
and enzymatic activity of CALB@ZIF -8 biocomposites. Small (500 nm) particles can be 
synthesised using a low 2-mIM: Zn2+ ratio, which generate active () CALB@ZIF-8 
biocomposites whilst larger (1 µm) crystals are formed using a higher 2-mIM: Zn2+ ratio and 
are inactive (). Standard activity was measured via two reactions: hydrolysis in aqueous tris 
buffered media and transesterification in hexane. An additional hydrolysis reaction in 
phosphate buffer caused size dependant crystal degradation that led to the restoration of activity 
of the larger biocomposites (Figure 4.6, S4.12). 
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4.3.  Results and Discussion 
4.3.1. CALB@ZIF-8 Synthesis 
Lipase B from Candida antarctica (CALB) was chosen as the enzyme for this study 
for its low isoelectric point that can mediate ZIF-8 biomimetic mineralisation at low 2-mIM 
concentrations, and for its proven stability to a broad pH range.34-35 CALB@ZIF-8 
biocomposites were synthesised using a range of Zn2+ and 2-mIM ratios with the ligand 
concentration ranging from 80-640 mM in the final solution. Specifically, a zinc acetate 
dihydrate solution (2 mL) was mixed with a solution of 2-mIM (2 mL) containing CALB (2 
mg powder) such that the final Zn2+: 2-mIM concentrations were 20:80, 20:160, 20:400, and 
40:640 mM. This procedure gave rise to biocomposites with particle size distributions of 0.57 
± 0.02 µm, 0.71 ± 0.02 µm, 1.06 ± 0.03 µm, and 1.13 ± 0.03 µm, respectively (Figure 4.2). At 
low ratios, the rate of precipitate formation is accelerated in the presence of CALB, however 
this effect was reduced as the 2-mIM concentration increased (Figure S4.1). This suggests that 
the formation of the crystalline biocomposites is influenced by the enzyme at low ratios but is 
dominated by the 2-mIM concentration at high ratios. As such, we chose precursor ratios that 
would generate ZIF-8 biocomposites via competing nucleation mechanisms. For example, at 
low Zn2+: 2-mIM ratios (20:80, 20:160 mM), crystal formation is induced by the presence of 
the biomacromolecule, whereas higher ratio preparations (20:400, 40:640 mM) can form from 
the precursors alone (Figure S4.1). This is consistent with previous observations where excess 
ligand (Zn2+: 2-mIM ratios, 40:1200 and 40:1600 mM) precipitate crystals, albeit of reduced 
particle size, with a loss of edge definition. In this case the basic solution, that results from 
excess 2-mIM, controls crystal formation.21 
Low 2-MIM: Zn2+ ratios can produce a number of different phases which when washed 
with ethanol yield a phase change to pure, sodalite (sod) topology. However, high ratios form 
sodalite samples without requiring an ethanol wash.21-22 Consistent with previously reported 
data, the water washed samples of 20:80 and 20:160 generated ZIF-C,22, 36 and diamondoid 
(dia) topologies, respectively, whilst the higher ratio samples (20:400, 40:640) favoured the 
sodalite topology (Figure 4.3a). For consistency, each sample was also washed with ethanol 
to ensure that only sodalite ZIF-8 was present (confirmed by PXRD) (Figure 4.3b). This 
yielded two sets of samples for activity studies (water vs ethanol washed).  
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We also ensured that the free enzyme maintained full activity after exposure to the most 
concentrated 2-mIM (~pH 11) solution to confirm that initial enzyme exposure to the 
precursors did not modify its activity (Figure S4.2). Given that deactivation was not observed, 
enzyme activity upon immobilisation could be analysed relative to each CALB@ZIF-8 
biocomposite synthetic protocol. 
 
Figure 4.2: SEM images of each CALB@ ZIF-8 preparation (Zn2+:2-mIM concentrations, 
mM) with corresponding particle size distributions. Mean particle sizes were calculated to be 
a) 571 ± 18 nm, b) 709 ± 15 nm, c) 1.06 ± 0.03 µm, d) 1.13 ± 0.03 µm. 
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Figure 4.3: Powder X-ray Diffraction (PXRD) patterns of each CALB@ZIF-8 biocomposite 
after two water washes (a) and two additional ethanol washes (b). Samples were air dried at 
room temperature overnight, and gently ground prior to analysis. 
4.3.3. Spatial Distribution Analysis with ZIF-8 Biocomposites 
We investigated the spatial localisation of CALB within the ZIF-8 crystals by 
performing Confocal Laser Scanning Microscopy (CLSM) on biocomposites synthesised from 
fluorescein isothiocyanate tagged CALB (FITC-CALB) (Figure 4.4, S4.3). Close inspection 
of the CLSM images indicated co-localisation of the enzyme with the crystals; however, the 
precise spatial distribution could not be determined due to small particle size and crystal 
aggregation (Figure 4.4). Analysis of the supernatants via UV-Vis spectroscopy and SDS-
PAGE detected no protein, indicating complete protein immobilisation for all biocomposites 
(Figure S4.4). 
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Figure 4.4: Confocal Laser Scanning Microscopy (CLSM) images of ethanol washed FITC-
CALB@ZIF-8 biocomposites, showing the fluorescence, bright field and overlay images. All 
samples were dispersed in ethanol and dried on a glass slide prior to analysis. Attempts were 
then made to treat the different biomineralised ZIF-8 samples to remove surface bound enzyme 
however, due to the small sample sizes, 100% removal of surface enzyme could not be 
confirmed (Figure S4.22-S4.24). 
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4.3.4. CALB@ZIF-8 Activity Testing (Hydrolysis) 
The hydrolysis activity of each CALB@ZIF-8 biocomposite was determined for water 
and ethanol washed samples, by measuring the rate of p-nitrophenyl butyrate (p-NPB) 
hydrolysis in tris buffer, 50 mM, pH 7.4 containing 0.1% Triton X-100 (Figure 4.5, Table 4.1, 
Figure S4.5). The water washed 20:80 CALB@ZIF-8 sample, i.e. the biocomposite with the 
smallest particle size and ZIF-C topology, showed an enhanced rate of p-NPB hydrolysis 
compared to the BSA@ZIF-8 controls (BSA = Bovine serum Albumin, Figure S4.6). Slightly 
lower activity was observed for the 20:160 biocomposite, however materials prepared using 2-
mIM: Zn2+ ratios of 20:400 and 40:640 showed significantly reduced p-nitrophenol production. 
The post ethanol washed 20:80 (i.e. ZIF-C to sod) sample showed a 50% reduction in activity 
whilst the 20:160 (dia to sod) sample maintained full activity (Figure S4.5). In comparison, 
the 20:400 and 40:640 ethanol washed samples (sod) were inactive.  
 
Figure 4.5: General reaction scheme showing the reactions catalysed by CALB. a) The 
hydrolysis of p-nitrophenyl esters I (R’=4, p-nitrophenyl butyrate; p-NPB) to generate p-
nitrophenol II and a carboxylic acid III (butyric acid). b) The transesterification of vinyl acetate 
IV with an alcohol V (R”=6, hexanol) to generate an ester VI (hexyl acetate) and vinyl alcohol 
VII. Vinyl alcohol rapidly tautomerises to acetaldehyde VIII, inhibiting the reverse reaction. 
In the presence of water, the ester product VI can be hydrolysed to form acetic acid IX and the 
initial alcohol V. 
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Given that CALB was stable to the highest 2-mIM concentration, (Figure S4.2) we 
hypothesized that the variation in activity may arise from structural differences between the 
biocomposites. Accordingly, we analysed the porosity of the CALB@ZIF-8 samples by 
performing 77 K N2 adsorption isotherms (Figure S4.7). Brunauer-Emmett-Teller (BET) 
analysis yielded surface areas of 1026 ± 4, 248 ± 2, 1570 ± 11 1956 ± 20 m²/g, for the 20:80, 
20:160, 20:400, and 40:640 samples respectively (Figure S4.7a). The 20:80 and 20:160 
samples were not stable to activation conditions used for the 20:400 and 40:640 samples and 
required the use of milder activation conditions that allowed for BET surface area and pore 
size analysis of the 20:80 sample. Furthermore, pore size distribution analysis, (Figure S4.7b), 
calculated via DFT N2 model (DFT = density functional theory), revealed the presence of larger 
pores (10.9, 17.3 Å) in the samples formed at lower Zn2+:2-mIM ratios (20:80) compared to 
the 20:400 and 40:640 samples (10.9,13.6 Å). These data indicate that the biocomposites of 
smaller crystal size, which retain activity, possess a more hierarchical pore structure which also 
reflects the qualitative difference in biocomposite formation kinetics. In summary, the different 
pore structure of the CALB@ZIF-8 biocomposites may influence the activity of the 
biocomposites as larger pore size would favour the diffusion of substrate molecules.37 
Furthermore, the more heterogeneous pore structure could facilitate trapping partially 
embedded enzymes that are not hindered by mass transfer to the same extent as fully embedded 
enzymes.38 
Table 4.1: a) Rate of hydrolysis measured as of p-nitrophenol production of each ZIF-8 
biocomposite in tris and phosphate buffer after 0 minutes of incubation. b) Percentage 
conversion of hexanol into hexyl acetate after 24 hours in hexane. 
 
To assess the contribution of surface bound enzyme to the biocomposite activity CALB 
was adsorbed onto the surface of protein free samples of ZIF-8, 1 µm synthesised using a 





Size (µm) Tris Phosphate Hexane 








Ethanol          
Washed 
20:80 0.57 ± 0.02 3.7 ± 0.1 2.5 ± 0.1 4.7 ± 0.1 2.5 ± 0.1 97 
20:160 0.71 ± 0.02 3.6 ± 0.1 3.6 ± 0.4 3.8 ± 0.3 4.6 ± 0.1 97 
20:400 1.06 ± 0.03 0.5 ± 0.0 0.3 ± 0.1 0.5 ± 0.0 0.6 ± 0.0 5 
40:640 1.13 ± 0.03 0.2 ± 0.1 0.0 ± 0.2 0.7± 0.0 0.6 ± 0.1 2 
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Zn2+:2-mIM ratio of 40:640 (Supporting information Section 4.9.6, Figure S4.9-S4.10). For 
these materials the rate of hydrolysis of p-NPB did not increase significantly relative to the 
biomimetically mineralised sample (Figure S4.10a). To assess the potential effects of surface 
enzyme crowding on activity, we decreased the mass of support used to increase coverage on 
the ZIF surface. Thus, potentially increasing favourable enzyme-enzyme interactions that could 
reduce the inhibitory effect of the ZIF-enzyme surface interactions on enzyme activity. 
However, the increased enzyme surface coverage did not alter the rate, reinforcing the idea that 
large ZIF-8 particles are unsuitable for CALB immobilisation (Table S4.1, Figure S4.10). 
Analysis of the supernatant of the surface only samples, indicated that near 100% adsorption 
of CALB (and FITC-CALB) was possible, but this reduced when the mass of support was 
decreased. It has been reported for non-MOF immobilisation that the support particle size can 
effect activity due to variations in the degree of enzyme-enzyme interaction, enzyme-support 
interaction, and enzyme position and orientation on the support.39-41 We therefore postulate, 
that there is a feature of the larger, more stable and highly crystalline ZIF-8 that is disfavours 
CALB activity. Encapsulating the enzyme within or adsorbing the enzyme to the surface of the 
crystals (40:640 sample) gave rise to inactive biocomposites, indicating that the enzyme-ZIF 
surface interactions are deactivating the enzyme. 
Next, we sought to understand the effect of different buffers on biocomposite activity. 
Each biocomposite, both water and ethanol washed samples, were assayed in 50 mM phosphate 
buffer, pH 7.4 containing 0.1% Triton X-100. All ZIF-8 bio composites were marginally more 
active than in the tris assay, however the trend in the small versus large samples remained 
unchanged (Table 4.1, Figure 4.6, Figure S4.11). Incubating the sample in phosphate buffer 
for 15- or 30- minutes prior to substrate addition resulted in an increase in enzymatic activity 
that was not observed for the tris samples (Figure 4.6, S4.12). The larger crystal samples 
increased in activity to a rate that is comparable to the smaller, ethanol washed samples, 3.0 ± 
0.0 and 4.6 ± 0.0 µM.min-1 respectively. After incubation in buffer, each composite was 
pelletised via centrifugation and filtered through a 0.2 µm filter to remove particles larger than 
the membrane and the flow through was assayed for the same reaction. The filtrate of all the 
active samples retained activity in the filtrate suggesting that either enzyme had leached off of 
the surface of the crystals, and/or CALB@ZIF-8 particles smaller than the membrane were 
contributing to the activity (Figure 4.2, 4.6, S4.12).  
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Figure 4.6: Average rates of p-NPB production using the water washed samples after exposure 
to tris or phosphate buffer for 0, 15, or 30 minutes (solid colours). Equivalent samples were 
filtered prior to commencement of the assay to account for small particle size and leached 
enzyme (dashed). The effectiveness of centrifugation was affected by particle size and buffer 
related aggregation, which may account for variation of filtered versus non-filtered assays 
between samples. The equivalent ethanol samples are shown in Figure S4.12. 
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4.3.5. CALB@ZIF-8 Stability Testing 
The stability of each biocomposites to the buffered solutions was further examined by 
exposing the crystals to tris and phosphate buffers (50 mM, pH 7.4) (Figure S4.13-S4.16). 
When exposed to tris buffer, the larger crystals of 20:400 and 40:640 remained well dispersed 
in solution and could not be easily pelletised by centrifugation, requiring the addition of ethanol 
to enable collection of the crystals. The smaller samples could easily be obtained from the 
buffer solution by centrifugation, however for consistency, ethanol was used for collection of 
all crystals. Scanning Electron Microscopy (SEM) images showed no noticeable etching to the 
crystal surface, however an increase in surface charging, aggregation and a reduction in the 
definition of the crystal edge was observed, attributed to an observable tris coating on the 
crystal surfaces (Figure S4.13). Tris has a reduced solubility in ethanol compared to water, and 
thus favours aggregation and pelletisation upon addition of ethanol. In contrast, phosphate 
buffer led to size dependent degradation of the crystals after 30 minutes of exposure as shown 
by SEM (Figure S4.14) and PXRD (Figure S4.15). The smaller crystals (20:80 and 20:160) 
transitioned to an amorphous material, whereas the larger crystals retained long range order 
however demonstrated surface conversion to zinc phosphate by SEM. Energy Dispersive X-
ray (EDX) analysis showed high levels of phosphorous in the remaining material due to zinc 
phosphate formation. (Figure S4.16).24  
 Next, 100 µm protein free crystals were synthesised,42 and exposed to the same buffers 
to obtain more insight into the changes occurring at the crystal surfaces. Similar to the 
CALB@ZIF-8 samples, tris appeared to coat the surface the surface of the 100 µm sized 
crystals, whereas phosphate buffer caused etching of the crystal surface and led to the formation 
of zinc phosphate (Figure 4.7, S4.17). The PXRD pattern of the bulk material demonstrated 
retention of long-range order, but no crystalline zinc phosphate was observed (Figure S4.18). 
These combined results may help explain the variations in activity that are reported for some 
enzyme@ZIF-8 composites in the literature where differences in synthetic procedures, particle 
size, and treatment/storage in buffer can impact the observed activities. These results also 
suggest that tris is a suitable buffer to increase the solubility and dispersion of hydrophobic 
ZIF-8 crystals, however the change in surface chemistry may lead to issues regarding 
collection, handling and re-usability.  
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Figure 4.7: SEM images of >100 µm protein free crystals, (a) as-synthesised and after 
exposure to (b) tris buffer (50 mM, pH 7.4), (c) phosphate buffer (50 mM, pH 7.4) and (d) 
100% hexane.  
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4.3.5. CALB@ZIF-8 Activity Testing (Transesterification) 
 Given that ZIF-8 crystals were stable to hexane (Figure 4.7), we were interested in 
assessing the activity of CALB@ZIF-8 for transesterification reactions in organic solvent. This 
would be advantageous in this research, as it could broaden the scope of solvents and reactions 
for ZIF-8 biocatalysis and provide an effective means to stabilise CALB in non-biological 
conditions. For example, lyophilised CALB cannot be solubilised in 100% organic solvent, and 
requires immobilisation to maintain activity in non-aqueous conditions.41 The catalytic 
performance of CALB@ZIF-8 biocomposites for the transesterification of hexanol with vinyl 
acetate (forming hexyl acetate and vinyl alcohol) were examined using hexane as the organic 
solvent (Figure 4.5b). This reaction has been reported previously for pure ZIF-8, however the 
conditions for catalysis required elevated temperature and high reactant concentrations (alcohol 
solvent), which led to etching of the crystal surface and release of catalytically active Zn2+.42 
Immobilised CALB can catalyse the transesterification at room temperature, utilising lower 
substrate concentrations and different solvent systems, which can negate crystal etching and 
increase the longevity of the catalyst.43-44 
 Initial screening conditions utilised a 50:50 water/hexane solvent system to develop 
baseline level of activity of the free enzyme for comparison to the immobilised variants. The 
catalytic activity of the free enzyme was tested using a 5:1 molar ratio of vinyl acetate: n-
hexanol with aliquots taken from the hexane layer for analysis (Figure S4.19). As expected, 
the free enzyme showed rapid transesterification in the early stages of the reaction (for both 
5:1 and 10:1 substrate ratios), measuring a conversion of approximately 53% at the 1-hour 
timepoint. In later aliquots, the concentration of hexyl acetate decreased, due to CALB 
mediated hydrolysis (Figure S4.19). 
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The catalytic activity of the water washed 20:80 and 40:640 CALB@ZIF-8 samples 
were tested in 50% hexane under the same conditions described for the free enzyme. First, we 
measured the activity of BSA@ZIF-8 control samples which showed minimal activity (<1%), 
indicating that at mild reaction conditions the reaction is not catalysed by framework or by 
leached Zn2+. For the CALB@ZIF-8 biocomposites, the 20:80 sample(small crystals) showed 
the fastest hexyl acetate production of the ZIF biocomposites (Figure 4.8), yielding 65% 
conversion after 8 hours. However, the activity of the 40:640 sample (large crystals) was 
negligible and only slightly above that of the BSA@ZIF-8 controls (Figure 4.8). Washing the 
20:80 sample with ethanol to transition to the sodalite topology led to a reduction in both the 
initial rate, and the overall maximum conversion of 43% (Figure 4.9a).  
 
Figure 4.8: Transesterification of vinyl acetate and hexanol in 50:50 water: hexane 
using the 20:80 CALB@ZIF-8 sample. Maximum measured conversion (65 %) 
occurred after 8 hours, which reduced to 60% after 24 hours, likely due to competitive 
transesterification and hydrolysis that occurred during these timepoints. Product 
conversion is calculated from the concentration of hexyl acetate detected, relative to the 
limiting reagent (hexanol). No production was observed for the 40:640 when compared 
to a 20:80 BSA@ZIF-8 sample under identical conditions. Concentrations refer to the 
hexane layer of the biphasic system (See Figure S4.21 for GC-FID retention times). 
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To minimise the observed hydrolysis in the biphasic system, 100% hexane was used as 
the solvent. Under these conditions no transesterification activity was observed for the free 
enzyme. Additionally, the initial rate of the 20:80 (ethanol washed) sample remained 
unchanged (relative to the biphasic system), however, generated hexyl acetate to a yield of 97% 
after 24 hours (Figure 4.9a). The ethanol washed 20:160 sample reached maximum 
conversions of 50% and 100% for biphasic and hexane solvents respectively, (Figure 4.9b) 
whilst the 20:400 and 40:640 remained inactive in both cases (Figure 4.9c-d). The 20:80 was 
reused five times, with no loss of activity (Figure 4.10), indicating that high retention of active 
enzyme on the support was possible after multiple reaction cycles and washes in hexane. 
 
Figure 4.9: Transesterification plots of each biocomposites in 50:50 hexane: water (Δ) and 
100% hexane (■). All samples were treated with an ethanol wash for sodalite topology 
comparison, which led to a reduction in rate for the 20:80 CALB@ZIF-8 sample, relative to 
the water washed sample in the biphasic systems (Figure 4.8). All concentrations are expressed 
using the total volume of the biphasic or 100% hexane system. 
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Figure 4.10: Activity of the 20:80 CALB@ZIF-8 sample in 100% (normalised to the first 
cycle). After each cycle, the hexane was removed, and the sample was washed three times with 
fresh hexane to remove reactant/ product from the previous reaction. Activity was maintained 
after each 24-hour cycle and with the first cycle equalling 97% conversion. 
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4.4.  Conclusion 
Herein, we showed that the rate of CALB@ZIF-8 catalysis was strongly influenced by 
the crystal size of the biocomposite. Gas adsorption experiments suggest this may be due to 
hierarchical porosity in the smaller sized samples resulting from different formation kinetics. 
Specifically, the rate of CALB@ZIF-8 catalysis for model hydrolysis and transesterification 
reactions was highly dependent on the synthetic conditions of the biocomposite. At low 2-
mIM:Zn2+ ratios (20:80 mM, and 20:160 mM), sub-micron particles were generated which 
demonstrated higher activity for both reactions compared to larger crystals that were formed at 
increasing ratios (20:400, 40:640 mM). Further, we observed that phosphate buffer could be 
used to regenerate activity for the larger samples, by degrading the exterior surfaces of the 
crystals, thus changing the microenvironment surrounding the enzyme and allowing for greater 
exposure to the reactants and potential enzyme release. In addition to the framework 
hydrophobicity, 27 the kinetics of formation can influence the structure and activity of ZIF-
based biocomposites. We are currently investigating the generality of this concept by 
examining the properties of a number enzyme@ZIF-8 biocomposites.  
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4.5.  Experimental 
4.5.1. Materials 
Lipase B from Candida antarctica (CALB) recombinant from Aspergillus oryzae 
(Product Code 62288) was purchased from Merck as a lyophilised powder and used without 
purification. All chemicals were purchased from commercial sources and used as received. 
Ultra-pure Milli-Q (MQ) with resistivity of >18 MΩ cm-1 (Merck Millipore purification 
system) was used for all syntheses, wash protocols and buffer preparations.  
4.5.2.  Fluorescein Tagged CALB 
CALB was tagged using fluorescein isothiocyanate (FITC) as per previously reported 
protocols. CALB (15 mg) was dissolved in carbonate-bicarbonate buffer (0.1 M, pH 9.2, 2 
mL). FITC in acetone (20 µL, 10 mg. mL-1, 0.2 mg) was added and the protein solution was 
gently stirred at room temperature for 2 hours in darkness. The tagged enzyme was recovered 
using Illustra NAP-25 column (GE Healthcare Life Sciences, NSW, Australia) and 
concentrated and exchanged into ultra-pure water using a 10 KDa membrane and centrifugation 
(3400 rpm 3 x 15 minutes 4°C). The FITC-CALB was stored in darkness at 4°C prior to use. 
4.5.3.  ZIF-8 Syntheses 
All ZIF-8 biocomposites were synthesised in water using 2 mg of CALB (lyophilised 
powder or FITC-CALB solution) using varied ratios of zinc acetate dihydrate (Zn(OAc)2) and 
2-methylimidazole (2-mIM). Zn(OAc)2 (40 mM/80 mM, 2 mL) was added to a solution of 2-
mIM (160 mM/320 mM/800 mM/1.2M, 2mL) containing CALB. The samples were left to 
form for 16 hours before being washed with water (2x) only, or water (2x) and ethanol (2x). 
Surface Adsorption of CALB (CALB-on-ZIF-8). CALB (2 mg lyophilised powder) in 
water (0.5 mL) was combined with ZIF-8 in water (1 mL) that had been synthesised without 
protein using the 40 mM:640 mM Zn2+:2-mIM (final concentration) protocol. The CALB on 
ZIF-8 sample was gently shaken for 4 hours and washed with water (2x) to remove loosely 
bound enzyme. 
4.5.4.  Activity Testing 
Hydrolysis. The hydrolysis of p-nitrophenyl butyrate (p-NPB) assay was adapted from 
the protocol available online from Sigma.45 Each ZIF biocomposite sample made to a final 
volume of 1 mL in water. The ZIF sample (50 µL) was added to a tris buffer solution (50 mM, 
4.9 mL) pH 7.4 containing Triton X-100 (0.1%) and p-NPB (50 µl, 25 mM). Triton X-100 is 
used to solubilise and activate the enzyme and is known to be ineffective at removing surface 
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bound enzyme.21 An equivalent stock concentration of CALB or BSA (2 mg mL-1) was used 
for free enzyme and control reactions respectively. At each time point 100 µL of the reaction 
mixture was collected and centrifuged before measuring the absorbance between 380-600 nm. 
The absorbance of A405-A500 was used for activity determination to account for scattering due 
to remaining particulate matter. The rate of activity was measured using the molar extinction 
coefficient of p-nitrophenol at 405 nm of 18,500 M-1 cm-1. phosphate buffer (50 mM, pH 7.4) 
was also tested using the same protocol. Standard error at each time point was calculated from 
a minimum of two repeats. 
Transesterification. Hexanol (2 mM) and vinyl acetate (10 mM) in hexane (2 mL) was 
combined with an aqueous suspension of the CALB (test) or BSA (control) ZIF-8 biocomposite 
(2 mL) or an air-dried sample in hexane (2 mL) in a 5 mL glass vial. The reaction mix was 
shaken at 30°C, and aliquots were taken from the hexane and aqueous layer at 1-hour intervals. 
Lyophilised CALB (2 mg) was used for free enzyme reactions. 
4.5.5.  Characterisation 
Powder X-ray Diffraction. Powder X-ray diffraction (PXRD) data were collected on 
a Bruker D8 Advanced X-ray powder diffractometer (parallel X-ray, capillary-loaded) using a 
Cu Kα λ=1.5418 Å radiation source, or Bruker D4-Endeavor diffractometer (flat plate) using 
Co Kα λ=1.78897 Å depending on sample mass. For the D8, samples were mounted in 0.5 mm 
glass capillaries and data collected for between 2θ of 2° to 52.94° with Phi rotation at 20 
rotations per min at 1-second exposure per step at 5001 steps. For the D4, data was collected 
over the range 2θ of 2° to 50° and was expressed as Cu radiation using Pow DLL converter 
(version 2.68.00). The data was processed as per Chapter 3. 
N2 Adsorption Isotherms. N2 (UHP grade, 99.999%) adsorption isotherm 
measurements were performed on a 3Flex physisorption analyser. The temperature was 
maintained at 77 K via a helium cryostat. The 20:400, and 40:640 CALB@ ZIF-8 samples 
were washed with ethanol and dried under vacuum in a desiccator for 1 hour. The dried samples 
were heated under vacuum at 120 °C for 2 hours. The 20:80 and 20:160 CALB@ZIF-8 were 
washed with ethanol and chloroform and dried under vacuum in a desiccator for 1 hour prior 
to activation at 80 °C for 3 hours. 
Scanning Election Microscopy (SEM). SEM images were collected on either the 
Philips XL30 or Quanta 450 Field Emission Scanning Electron Microscopes (FESEM). 
Samples were dry loaded onto carbon tabs on aluminium stages and sputter coated with carbon. 
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Electron Dispersive X-ray Analysis was collected with an Oxford Instruments Ultim Max 170 
EDX attachment on the Quanta 450. 
Zeta Potential Measurements. CALB (or FITC-CALB) (1 mg) was dissolved in water 
or a 160 mM 2-mIM solution. Zeta Potential measurements were recorded on a Malvern 
ZetaSizer Nano using a disposable folded capillary cell (DTS1070). 
Confocal Laser Scanning Microscopy (CLSM). CLSM images were taken on an 
Olympus FV3000 confocal laser scanning microscope. The FITC-CALB samples were excited 
at 488 nm, and the fluorescence signal was collected between 495-545 nm. 
UV-Visible Absorbance Measurements. Absorbance spectra were recorded at 30°C 
on an Agilent Cary 60 or an Agilent Cary 5000 UV/Vis spectrophotometer.  
Gas Chromatography Analysis. Aliquots were diluted/extracted into ethyl acetate, 
dried with magnesium sulfate and analysed via Gas Chromatography (Shimadzu, Nexis GC-
2030) equipped with a DB-wax column (30.0 m, 0.25 mm, 0.25 mm) and a Flame Ionisation 
Detector (FID). The column was held at 60°C for 3 minutes and increased at 6°C per minute 
to 160°C. At the end of each run, the column was heated to 220°C for a burn off. Retention 
times (hexanol; 7.9 minutes, hexyl acetate; 6.1 minutes, see Figure S4.21). 
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4.9.  Supporting Information 
4.9.1. CALB@ZIF-8 Synthesis 
 
Figure S4.1: Time scale photos to visually inspect the formation of ZIF-8 using each ratio (L-
R: 20:80, 20:160, 20:400 and 40:640) after the addition of the Zn2+ solution to the 2-mIM 
solution (t=0). Without the addition of protein, minimal ZIF-8 precipitate formed over the 24-
hour timeframe for the low ratio samples whereas noticeable ZIF formation occurs for the 
20:400 and 40:640 samples at 60 and 2 minutes, respectively. The addition of CALB 
accelerates the initial ZIF-8 nucleation, however this appeared to be a slower process for 40:640 
compared to 20:80. 
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4.9.2. CALB Characterisation 
  
 
Figure S4.2: Hydrolytic activity of free CALB after exposure to 2-mIM (640 mM). CALB (2 
mg) was dissolved in a solution of 2-mIM (1.28 M) and was left at room temperature for 5 
minutes to mimic the maximum exposure time to the pH 11 solution. The protein was diluted 
in tris buffer (50 mM, 7.4) before being exchanged into water using a 10 KDa membrane and 
centrifugation (3600 rpm, 4°, 4 cycles. The assay was performed in tris (pH 7.4, 50 mM)+ 
TritonX-100 (0.1%) using 0.6 µM CALB (calculated from CALB molar extinction coefficient, 
40,690 M-1 cm-1 at 280 nm and CALB molecular weight, 33 KDa).1 p-nitrophenyl butyrate, p-
NPB (0.25 mM) measuring the absorbance of p-nitrophenol at 405 nm (18,500 M-1.cm-1). 
Controls of BSA alone and BSA@ZIF-8 (see Figure S4.9) show minimal hydrolytic activity, 
confirming activity is solely from CALB. 
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Figure S4.3: (a) Absorbance spectrum of FITC- tagged CALB after tagging for 2 hours (Batch 
1) and 16 hours (Batch 2). The peak at 280 nm can be attributed to the protein and the peak(s) 
at 450-500 nm are from the FITC tag. The shift in absorbance of batch 2 from 495 to 477 nm 
and increase in the shoulder 456 nm can be attributed to multi tagged enzyme.2 Prior to use, 
the FITC-CALB was buffer exchanged using a 10 kDa centrifuge membrane until no 
significant absorbance was observed in the flow through, ensuring no unbound FITC remained 
in the protein solution (dashed line). (b) Zeta potential measurements of FITC-CALB showed 
a slight negative shift compared to the untagged enzyme in both water and 2-mIM (160 mM) 
solution however it is important to note that the shift may result in changes to the ZIF-8 bio-
mineralisation process and enzyme spatial distribution. However, due to the highly negative 
zeta potential of the unmodified CALB in 2-mIM and the small change in zeta potential upon 
tagging, minimal changes in biomimetic mineralisation would be expected. (c) FITC tagging 
was shown to not alter the activity of the enzyme. 
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4.9.3. CALB@ZIF-8 Encapsulation Efficiency 
 
 
Figure S4.4: (a) Absorbance spectrum of the UV region of the supernatants of non-tagged 
CALB biocomposites after washing to remove excess 2-mIM (10 kDa membrane with 
centrifugation). SDS-PAGE (Inset) of the concentrated supernatants suggesting that any 
protein that may have been present in the supernatants would be lower than the detection limit 
of the dye (200 ng). L1, L2,L3 and L4 refers to the 20:80, 20:160, 20:400 and 40:640 samples 
respectively. The ladder lane consists of protein standards of known molecular weight, with 
the red box encompassing the 30 kDa standard. (b) Absorbance spectrum of the visible region 
of the supernatants of FITC-CALB biocomposites (before washing) showing a slight shoulder 
at 500 nm indicating the presence of low quantities of FITC for the 20:400 and 40:640 samples. 
Each biocomposite was then washed with water and the washings were collected and 
concentrated as above. (c) CALB and (d) FITC-CALB water washes showed no detectable 
protein in via absorption spectroscopy nor SDS-PAGE analysis.  
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4.9.4. CALB@ZIF-8 Activity (Hydrolysis) 
 
 
Figure S4.5: Hydrolysis activity of the CALB@ZIF-8 biocomposites using p-NPB after (a) 
two water washes and (b) two additional ethanol washes. All assays were undertaken in tris (50 
mM, pH 7.4) + Triton X-100 (0.1%) using 0.6 µM enzyme. Standard error for each time point 




Figure S4.6: Control assays BSA@ZIF-8 biocomposites using p-NPB. The 20:80 (a) and 
40:640 (b) BSA@ZIF-8 samples were tested to account for particle size effects. Assays were 
performed after 30 minutes exposure to tris or phosphate buffer, with only low levels of activity 
being observed. 
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4.9.5. Surface Area and Pore Size 
 
Figure S4.7: (a) N2 sorption/desorption curves at 77 K giving BET surface areas of 1026 ± 4, 
248 ± 2, 1570 ± 11, 1956 ± 20 m².g-1 for 20:80, 20:160, 20:400, and 40:640 CALB@ZIF-8 
respectively. 20:160 CALB@ZIF-8 was not stable to the two activation conditions tested as 
characterised by PXRD (Figure S4.8). (b) Pore Size distribution of each CALB@ZIF-8 
preparation. The samples formed from the high 2-mIM:Zn2+ ratio (20:400, 40:640) displayed 
similar pore size distributions, whereas the lowest ratio sample (20:80) possessed a larger pore 
(~17 Å). 
 
Figure S4.8: PXRD patterns of each CALB@ZIF-8 biocomposite after activation and N2 
sorption/desorption studies. Activation conditions: 20:80 and 20:160 were washed with ethanol 
and chloroform and dried under vacuum in a desiccator for 1 hour prior to activation at 80 °C 
for 3 hours. 20:400 and 40:640 were washed with ethanol, dried in a desiccator and activated 
at 120 °C for 2 hours. 
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4.9.6. CALB Surface Adsorption 
ZIF-8, 1 µm crystals (5 mg, 10mg, 20 mg) were adsorbed with 0.2 mg of CALB 
(calculated from CALB extinction coefficient/equals 2 mg CALB powder). The total external 
surface area of each ZIF-8 sample, and an estimated CALB surface coverage was calculated 
and reported in Table S4.1.  
Table S4.1: Total surface area of 1 um ZIF-8 crystals, showing the maximum potential CALB 
surface coverage and the actual CALB surface coverage calculated from unbound enzyme 
absorbance measurements. 







CALB Surface Coverage 
Calculated (%)+ 
5 990 60 20 
10 1980 30 20 
20 3960 15 11 
 
*External surface areas were calculated per methods provided by Linder-Patton et. al.3  
# Percentage coverage was calculated assuming 100% immobilisation efficiency. The 
dimensions of CALB are 30x40x50 Å,1 was used to calculate the average surface area (SA) of 
a single side of the enzyme that could adsorb to ZIF-8. This was converted to the average side 
SA of 0.2 mg of CALB and presented as a percentage of the total ZIF-8 surface area.  
+ After the surface adsorption process, the ZIF-8 samples were centrifuged, and the 
supernatants were analysed for remaining CALB (Figure S4.10b). Here it was determined that 
a greater proportion of CALB was adsorbed when using a larger mass of ZIF-8 material. 
According to the A280 absorbance, the supernatants of the 5 mg, 10 mg and 20 mg ZIF-8 
samples contained 0.13 mg (A280 :0.14), 0.06 mg (A280 :0.06), and 0.05 mg (A280 :0.05) 
respectively which was then used to calculate the surface coverage percentage.  
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Figure S4.9: CLSM images of FITC-CALB surface bound to pre-synthesised (protein 
free) 40:640 crystals. 
 
 
Figure S4.10: a) Hydrolysis assay data of CALB (0.2 mg) surface bound onto 40:640 ZIF-8 
(5 mg, 10 mg and 20 mg). Rates are similar to BSA@ZIF-8 controls. b) Absorbance spectrum 
of the supernatants obtained of each surface bound sample used to calculate surface coverage 
values in Table S4.1. Analysis of the supernatant of the surface only samples, indicated that 
near 100% adsorption of CALB (and FITC-CALB) was possible, but reduced when the mass 
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4.9.7. Buffer Comparison (Hydrolysis) 
 
 
Figure S4.11: Hydrolytic activity of the CALB@ZIF-8 biocomposites in phosphate buffer (50 
mM, pH 7.4) + Triton X-100 (0.1%) (a) two water washes and (b) two additional ethanol 
washes. All assays were undertaken as per the tris assay. 
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Figure S4.12: Average rates of p-NPB production using ethanol washed samples after 
exposure to tris or phosphate buffer. Both the standard assay conditions, and the filtered 
biocomposites have been reported. 
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4.9.8. CALB@ZIF-8 Stability Testing 
 
Figure S4.13: SEM images of each CALB@ZIF-8 composite after 30 minutes exposure to tris 
buffer. Surface charging was more significant on the smaller crystals (a) and (b) due to the 
greater surface area of the bulk material.  
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Figure S4.14: SEM images of after 15- and 30-minute exposure to 50 mM phosphate buffer. 
Size dependant destruction was observed with the 20:80 (a) and 20:160 (b) samples losing all 
crystallinity, and the larger samples 20:400 (c) and 40:640 (d) retained some structural integrity 
in conjunction with smaller particle formation. Additional images obtained after 15 minutes, 
showed that the complete degradation of some crystals had occurred during the shorter 
exposure time. 
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Figure S4.15: PXRD of each CALB@ZIF-8 after 30 minutes exposure to tris or phosphate 
buffer (50 mM, pH 7.4). All samples retained bulk crystallinity after exposure to tris buffer. 
Smaller crystals of the(a)  20:80 and (b) 20:160 lost all peak intensity after 30 minutes exposure 
to phosphate, whereas the larger crystals of the (c) 20:400 and (d) 40:640 retained some 
crystallinity, further highlighting the size dependant degradation. 
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Figure S4.16: SEM-EDX of each ZIF-8 biocomposites further highlighting the size 
dependence of phosphate buffer degradation. (a) and (b) show complete degradation, 
highlighted by the full coverage of phosphorous across the entire sample. (c) and (d) show 
degradation to a lesser extent, observable by SEM and the isolated regions of phosphorous that 
is concentrated around the surface of the crystals. All samples were washed three times to 
remove soluble sodium-phosphate salts, so phosphorous content can be mainly attributed to 
the formation of insoluble zinc-phosphate salts. 
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Figure S4.17: SEM-EDX of >100 µm protein free crystals. The sample was washed three times 
to remove soluble sodium-phosphate salts. 
 
 
Figure S4.18: PXRD of >100 µm protein free crystals as-synthesised (methanol washed) and 
post tris and phosphate buffer exposure.  
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4.9.9. CALB@ZIF-8 Activity (Transesterification) 
 
 
Figure S4.19: Transesterification of vinyl acetate: hexanol (5:1) in 50:50 water: hexane using 
the free CALB (black). The aqueous layer contained only low levels of hexyl acetate showing 
that most of the product was being extracted into the organic layer throughout the duration of 
the reaction. (grey) Increasing the initial vinyl acetate concentration (10:1), did not change the 
initial production rate or the overall activity trend (pink). In the remaining time points, the 
concentration of hexyl acetate decreased, correlating with an increase in hexanol production, 
suggesting that the ester concentration had reached a threshold where hydrolysis of the product 
was favoured. After 24 hours, the hexyl acetate concentration had decreased to 15%. When in 
the presence of only hexyl acetate, CALB was shown to hydrolyse 90% of the ester after 5 
hours. Reports of 80% ester production have been measured for similar biphasic systems, so it 
is therefore possible for the percentage conversion to have been higher during the first hour of 
the reaction.4 Concentrations refer to the hexane layer of the biphasic system. GC-FID retention 
times are displayed in Figure S4.21. 
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Figure S4.20: SEM images of each CALB@ZIF-8 composite after an 8-hour 
transesterification reaction with hexanol and vinyl acetate in hexane.  
 
 
Figure S4.21: a) Hexanol and hexyl acetate GC-FID control traces, with retention times 7.9- 
and 6.1 minutes respectively. b) Example GC-FID trace of the 4:1 CALB@ZIF-8 biocomposite 
in the 50:50 (water/hexanol) biphasic system.  
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4.9.10. Removal of Surface Bound Enzyme 
 
 
Figure S4.22: Each composite was soaked in a solution of 10% SDS in tris buffered 
saline (TBS, pH 7.5) for 30 minutes, however after centrifugation, a large proportion of 
the particles remained dispersed in solution. Liang et. al. reported using an ethanol wash 
to remove excess surfactant,5 however, as described previously, an ethanol wash lead to 
a reduction in activity for the 20:80 sample. As no spatial distribution could be obtained 
from the CLSM images, it would be challenging to distinguish between the removal of 
surface enzyme via SDS wash and a general loss of activity due to ethanol. 
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Figure S4.23: A secondary method utilised a proteolytic enzyme (protease from 
Bacillus lichenformis) which has a broad substrate range, capable of cleaving most 
peptide bonds. This method should lead to denaturation of only surface bound CALB as 
the pore aperture of ZIF-8 would prevent interaction of the proteolytic enzyme with sub-
surface lipase. When tested with the free enzyme and CALB@ZIF-8 it was found that 
the proteolytic enzyme in tris interfered with the reaction, leading to an increase in the 
key absorbance at 405 nm, at a rate much faster than expected from the lipase (Black). 
Similarly, when tested with the BSA@ZIF-8 biocomposites false positive readings were 
obtained if the protease was not effectively removed (Red) Surface adsorbing of 
enzymes onto ZIF-8 has also been established in previous literature, so it is not 
unreasonable to assume that the protease would adhere to the surface and this would 
need additional steps to remove. Multiple water washes (3x) of the BSA@ZIF-8 sample 
led to a reduction in activity (Green), suggesting that the protease was being removed 
however partial loss of the biocomposite occurred after each centrifugation cycle, likely 
due to the dispersion caused by tris buffer.  
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Figure S4.24: The protease was tested for its influence on the transesterification in the 
biphasic system. First, the protease was shown to not cleave hexyl acetate, so all activity 
variations arise from the change in CALB. a) The free enzyme, measured at the 
maximum conversion (1 hour) timepoint, saw a reduction in activity (~85%) when 
treated with protease in tris buffer, but not in water. b) CALB@ZIF-8 assay, measured 
at the maximum conversion (8 hour) timepoint. Enhanced activity was observed for the 
CALB@ZIF-8 sample treated with protease in both tris and water however, minimal 
interference was noted for the BSA@ZIF-8 (protease treated) control. These findings 
suggest that activity of CALB@ZIF-8 is due to an increased exposure of the lipase to 
the substrates, rather than the degradation and release of Zn2+ and 2-mIM. As such, this 
method was not deemed suitable for removing surface bound enzyme for this assay. 
Attempts using trypsin as the proteolytic enzyme yielded the same result.  
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Chapter 5. Enantioselective Transesterification with Lipase Immobilised within a Metal-
Organic Framework (ZIF-90) and a Hydrogen-bonded Organic Framework (BioHOF-1)  
5.1.  Abstract 
 The immobilisation of enzymes within porous supports has been demonstrated to 
stabilise the biomacromolecules to non-biological media, extending their activity to reaction 
conditions that would otherwise cause protein denaturation. The chemistry and porosity of the 
framework can however alter enzyme activity and careful selection of the immobilisation 
support is required to maximise activity whilst maintaining biocomposite stability, handling 
ease, and reusability. We have immobilised Candida antarctica lipase B (CALB) into zeolitic 
imidazolate framework-90 (ZIF-90) and a porous Hydrogen-bonded Organic Framework 
(BioHOF-1), and have demonstrated that the properties of these frameworks (crystal size, 
hydrophobicity and pore size) provide enhanced enzyme activity and reusability compared to 
the hydrophobic framework, zeolitic imidazolate framework-8 (ZIF-8). The reactions catalysed 
by these new biocomposites maintains the high enantioselectivity (ee. 99%) of the enzyme and 
stability over an extended reaction period. 
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5.2.  Introduction 
The syntheses of enantiopure compounds are an important component of medicinal and 
organic chemistry. The biological function of many pharmaceuticals is often affected by the 
stereochemistry of the drug and hence the separation of enantiomers from a racemate is 
necessary.1-4 Kinetic resolution of enantiomers utilising a chiral catalyst or reagent and relies 
on different reactivity to generate an enantiopure product that can be easily separated from the 
unreacted starting material.5 Enzymes are chiral catalysts that provide control over substrate 
accessibility and orientation within an active site, and thus can mediate these reactions with 
high chemo-, regio- and stereo-selectivity.6 They function under mild reaction conditions, 
making them a ‘greener’ alternate to standard chemical techniques, however their activity can 
be hindered by high temperature, extreme pH and organic solvents. 7-9 Enzymatic reactions are 
further complicated during purification, where intricate and expensive processes are required 
to separate the product from the enzyme catalyst, often denaturing the enzyme and limiting the 
potential turnover number.10-11 Enzyme immobilisation techniques can be implemented to 
generate a heterogeneous enzyme catalyst that can be more easily separated from the reaction 
mixture prior to product purification.12 This enables efficient enzyme recycling, thus 
maximising the overall catalytic output of the enzyme. Enzymes can be immobilised via several 
methods, including enzyme-enzyme cross-linking, attachment to a solid support, or 
encapsulation/entrapment within a porous material, all of which will generate biocomposites 
of varied stability and activity resulting from different enzyme-support interactions.13-15 
Candida antarctica lipase B (CALB) is an enzyme commonly employed for kinetic 
resolution experiments with enantiomeric excess (ee) of 99% reported for certain 
transesterification and hydrolysis reactions.16-18 Care must be taken, however when selecting 
an immobilisation support, as a drastic reduction in catalytic rate and change in selectively are 
possible.19-22 For example, commercially available Novozym 435 (CALB immobilised onto 
Lewatit VP OC 1600) hydrolyses 2-O-butyryl-2-phenylacetic acid (1) with preference for the 
S ester (ee 99%) but prefers hydrolysis of the R ester (99%) of 3-phenylglutaricdimethyl diester 
(2) (Figure S5.1).21 Changing the immobilisation support to Octadecyl-Sepabeads, resulted in 
an inversion in the preference of 1 (90% R ester) but maintained the R preference, with lowered 
selectivity, for 2 (61%, Figure S5.1).21 CALB has also been reported to catalyse reactions with 
little or no selectivity, however, alterations to reaction solvent, pH and temperature can 
instigate enzyme conformation changes which improve reactivity and/or selectivity.23-24 
Activity and selectivity can therefore be controlled through judicious selection of the 
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immobilisation method and conditions; however, predicting this process is challenging for 
different substrates.20-21  
Chapter 4 describes the activity of CALB within a metal-organic framework, ZIF-8 
(zeolitic imidazolate framework-8) which reported the relationship between enzyme activity 
and the synthetic conditions used to generate the CALB@ZIF-8 biocomposite. Metal-organic 
frameworks (MOFs) are network solids composed of metal nodes connected via organic links 
and are noteworthy for their high degree of crystallinity and porosity.25-26 ZIF-8 is a class of 
MOF composed of tetrahedral Zn2+ nodes and 2-methyl imidazole (2-mIM) links that form a 
porous sodalite topology.27 CALB@ZIF-8 was previously examined for a transesterification 
reaction between vinyl acetate and hexanol where size dependant activity was observed for the 
biocomposite i.e. small (500 nm) CALB@ZIF-8 biocomposites exhibited higher activity than 
the larger particles (1 µm). This was attributed to the different formation mechanisms that gave 
rise to a hierarchical pore structure in the smaller biocomposites. However, other factors such 
as framework hydrophobicity and average pore size need to be considered as it is well known 
that these properties can influence enzyme activity retention and substrate diffusion.28-30 
Therefore we sought to examine the immobilisation of CALB on two frameworks, zeolitic 
imidazolate framework 90 (ZIF-90) and a Hydrogen-bonded Organic Framework (HOF) that 
have different hydrophilicities and, in the case of the HOF, significantly different pore sizes.  
ZIF-90 is a zinc-based, sodalite framework, that replaces the 2-mIM linker of ZIF-8 
with 2-imidazole carboxaldehyde (ICA).31(Figure S5.2). This simple change to the organic 
linker creates a protein@ZIF biocomposite that forms via a co-precipitation method rather than 
the biomimetic mineralisation process of ZIF-8.29, 32-33. Whilst the protein plays an integral role 
in seeding and accelerating the growth of ZIF-8, the initial formation (first 500 seconds) of 
ZIF-90 is not strongly influenced by the addition of a protein. The ZIF-90 biocomposite is 
significantly more hydrophilic than ZIF-8, which results in different enzyme-enzyme and 
enzyme-support interactions. This, in addition to the distinct formation processes, will likely 
create CALB@ZIF-90 biocomposites that exhibit different enzyme conformations, spatial 
distribution and activity.20 Indeed, recent reports have shown that catalytic activity of catalase 
is impeded when immobilised onto the hydrophobic ZIF-8 framework but is maintained when 
immobilised on the more hydrophilic framework of ZIF-90.29 Similarly, CALB 
transesterification activity was lost when encapsulated within 1 μm ZIF-8 and only partially 
retained when surface adsorbed on the framework.  
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HOFs are porous, metal-free frameworks that form via intermolecular hydrogen 
bonding of discrete organic ligands.34-38 Much like the assembly of MOFs, this class of porous 
material can be assembled in a modular fashion, and with careful ligand selection and tailoring 
of the synthetic conditions, a vast library of HOF materials of different properties (pore size, 
shape, stability, permanent porosity) can be constructed.39 More recently, HOFs have become 
a target material for biological applications as they can be synthesised in biocompatible 
conditions of aqueous media, low temperature and minimal acid/base inclusion.39-40 In 
particular, the biocompatible assembly of a novel HOF (hereafter termed BioHOF-1), 
comprising of tetra-amidinium and tetra-carboxylate ligands (Figure S5.2), has been 
developed to encapsulate and stabilise enzymes such as catalase and alcohol oxidase.30 
BioHOF-1 has a pore size of 6.4 Å, which exceeds that of the ZIFs (~3.4 Å), and thus may 
allow for larger substrates to be accessible to the enzyme. In a recent study, the solution 
accessible porosity of BioHOF-1 was measured, where it was shown that the fluorescent 
molecule, fluorescein (size 7 Å) could diffuse homogenously throughout the framework.30 
Additionally, BioHOF-1 is stable to buffers, chelating agents, and mild acidic conditions that 
would ordinarily lead to complete degradation of ZIFs, and thus increase the potential reaction 
conditions.30  
In this study we, synthesised encapsulated CALB biocomposites (CALB@ZIF-90 and 
CALB@BioHOF-1) and tested them for the transesterification of hexanol and vinyl acetate. 
We were therefore motivated to understand the effect of the more hydrophilic framework (ZIF-
90) and the novel metal free framework (BioHOF-1) on the activity and selectivity of 
equivalently sized CALB@ZIF-8 particles. 
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5.3.  Results and Discussion 
5.3.1. CALB@ZIF-90 Synthesis 
 The encapsulated CALB biocomposites and their respective protein free samples were 
synthesised according to procedures reported in the literature for catalase.29-30 During the 
screening process for CALB@ZIF-90, a correlation between formation time and particle size 
was observed. Mixing the precursors (Zn2+, ICA, and CALB) led to instant precipitation, 
generating ~1 μm particles after 10 minutes (Figure 5.1a), but when left for 24 hours the 
particle size increased to ~2 μm (Figure 5.1b). Interestingly, the 10-minute sample contained 
a mixture of crystal sizes, including crystals of approximately 5 μm in diameter (similar to the 
protein free control), however these larger crystals were not observed in the 24-hour sample. 
PXRD of these samples revealed that phase pure crystals were formed after 10 minutes (Figure 
5.2a), however longer formation times often led to crystallisation of a second phase (Figure 
5.2b), later determined to be crystallised ligand (Figure S5.3). 
 
Figure 5.1: Scanning Electron Microscopy (SEM) images of CALB@ZIF-90 biocomposites 
after 10 minutes of formation versus 24 hours. The predominant particle size of the CALB 
sample was ~1 μm with some larger crystals (approximate size of protein free ZIF-90, 5μm) 
also being formed suggesting that the lipase is altering the growth. After 24 hours, the 
CALB@ZIF-90 were larger in size (2 μm) and showed the presence of ligand like crystals 
(Figure S5.3). 
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Figure 5.2: PXRD of ZIF-90 biocomposites. a) Phase pure sodalite CALB@ZIF-90 was 
formed in the initial 10 minutes. b) When left for 24 hours the CALB@ZIF-90, transitioned 
into multiple phases with peaks in addition to the sodalite pattern appearing at 2θ values (*). 
Due to variability in the CALB@ZIF-90 samples (repeated twice), BSA, and Catalase, were 
tested and left to form for 24 hours for comparison. Each additional biocomposite retained 
sodalite features in addition to the alternative phase observed with CALB. 
 In the absence of protein, much larger crystals were obtained for ZIF-90 indicating that 
CALB (and other proteins) were influencing crystal growth. (Figure 5.3). Over the course of 
24 hours, the protein free ZIF-90 samples transitioned from large (5-10 µm), rhombic 
dodecahedral crystals of sodalite topology (10 minutes) to a less well-defined structure, 
consisting of a more densely packed crystal phase (24-hour). With the inclusion of an enzyme 
such as CALB, ZIF-90 forms smaller crystals after 10 minutes (1 µm) which are resilient to 
morphological and topological changes, which can be attributed to the influence of CALB on 
the formation rate of the framework relative to the protein free control. The rapid ZIF-90 
formation in the absence of protein may result in significant defects within the crystals, which 
may have caused the phase transition, from sodalite to a more densely packed phase, over the 
24-hour period (Figure 5.4).41 Additionally, during the imaging process, it was noted that the 
larger rhombic dodecahedral crystals of the control (Figure 5.3a-c) were susceptible to 
degradation and loss of edge definition by the electron source of the SEM (10 keV). In the 
presence of CALB, ZIF-90 forms more slowly, potentially allowing for more self-correction 
during framework self-assembly, thereby forming a more stable sodalite composite. The slower 
formation did however lead to competitive crystallisation of the ligand which could not be 
removed using standard water wash procedures. 
Chapter 5   





Figure 5.3: SEM images of time dependent formation of protein free ZIF-90 crystals. After 
the initial mixing of precursors, the protein free ZIF-90 sample was left for (a) 10  minutes, (b) 
1, (c) 2 and (d) 24 hours. 
 
Figure 5.4: PXRD of the protein free ZIF-90 formation at different time points. Monitoring 
via PXRD highlighted a change in powder pattern that lead to a complete change in topology 
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after 24 hours. Peaks began appearing after 10 minutes at 13.2, 13.8 15.6 and 17.2, which 
further increased in intensity relative to the 7.4 peak at the subsequent time points. 
5.3.2. Considerations for ZIF-90 Biocomposite Analysis  
 To enable direct comparison of CALB biocomposites, it is essential to have phase pure 
ZIF-90 samples with consistent crystal morphology to minimise the variability in the enzyme 
- support interaction. For both CALB@ZIF-90 and protein free ZIF-90, sample uniformity was 
greatest for the 10-minute synthetic conditions. Due to the inconsistencies of the 24-hour 
samples (morphology, topology, and ligand crystallisation), there is greater variability in the 
support surfaces and thus possible interactions with the enzyme. As such, initial studies 
focussed on comparing the CALB@ZIF-90 (10-minute) to CALB adsorbed on the surface of 
the protein free ZIF-90 (10-minute). 
5.3.3. Spatial Distribution Analysis with ZIF-90 Biocomposites 
 Prior to activity testing, the spatial distribution and immobilisation efficiency of the 10-
minute samples was determined using Fluorescein isothiocyanate (FITC) tagged CALB. A 
direct comparison was made between CALB@ZIF-90 (10-minute) with a sample of ZIF-90 
(10-minute) to which FITC-CALB had been adsorbed to the surface (CALB on ZIF-90). 
Fluorescence of FITC-CALB was observed across the whole CALB@ZIF-90 crystal showing 
that the FITC tagged enzyme is colocalising with the ZIF-90 (Figure 5.5a). There is an increase 
in fluorescence intensity around the edges of the crystals suggesting that there is a mixture of 
surface bound, and sub-surface (or encapsulated enzyme). Whereas for the surface adsorbed 
sample, CALB on ZIF-90, fluorescence intensity was observed at only the exterior of the 
crystals (Figure 5.5b). No absorbance peak of FITC (495 nm) was observed in the supernatants 
of each biocomposite, which is indicative of complete loading of the FITC-CALB onto the 
support for both the co-precipitation and surface adsorbed samples (Figure S5.4).  
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Figure 5.5: Confocal Laser Scanning Microscopy (CLSM) images of CALB@ZIF-90 and 
CALB on ZIF-90. Fluorescein isothiocyanate (FITC) tagged enzyme (2 mg CALB) was used 
for both encapsulation and surface adsorption. The FITC-CALB sample was washed 
thoroughly using a 10 KDa membrane with centrifugation until no absorbance from the tag 
remained in the flow through, ensuring that the only FITC in the biocomposites was from 
tagged CALB. 
5.3.4. CALB@ZIF-90 Activity (Hydrolysis) 
The activity of CALB@ZIF-90 was measured via the hydrolysis of p-nitrophenyl 
butyrate (p-NPB), and transesterification between hexanol and vinyl acetate (Figure 5.6). The 
reaction conditions, including substrate and CALB concentrations (based on FITC-CALB data, 
Figure S5.4) were consistent with those reported for ZIF-8 biocomposites (Chapter 4) to allow 
for a direct comparison of framework properties.  
 
Figure 5.6: Hydrolysis Reaction Scheme. p-nitrophenyl butyrate (p-NPB) I is hydrolysed, 
generating p-nitrophenol (p-NP) II and a butyric acid III. Assays were measured in tris buffer 
(50 mM, pH 7.4) as ZIF-90 have been proven to be stable to these conditions.29 
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For ZIF-8, the size of the crystals was shown to significantly impact the catalytic output 
of the biocomposite (Chapter 4). Hence, for direct comparison of ZIF-8 and ZIF-90 it is 
important to minimise particle size variation between biocomposite samples. As such, the 
CALB@ZIF-90 (10-minute sample) was tested as the mean particle size was ~1 µm and most 
closely resembled the inactive, 1 µm ZIF-8 (Zn2+:2-mIM; 40:640 mM) biocomposite. In 
contrast to the ZIF-8 biocomposites, the CALB@ZIF-90 (10-minute) was active, with 
respective rates of p-NPB hydrolysis of 0.3 ± 0.1 µM.min-1 (Chapter 4) and 1.0 ± 0.0 µM.min-1 
(Figure 5.7a). The enhanced rate highlights that the more hydrophilic framework immobilises 
CALB in an active conformation with a spatial distribution within the framework that is 
substrate accessible. 
 
Figure 5.7: Hydrolytic activity of ZIF-90 biocomposites in tris buffer (50 mM, pH 7.4)+Triton 
X-100 (0.1%). (a) CALB@ZIF-90 (10-minute) was more active than the equivalently sized 
CALB@ZIF-8 (0.2 ± 0.1 µM.min-1). It is, however, slower than the smaller, 4:1 CALB@ZIF-
8 biocomposite (3.7 ± 0.1 µM.min-1). Adsorbing CALB onto the surface of the 10-minute ZIF-
90 increased the activity (~2x), whereas activity for CALB on ZIF-8 remained low. For (b) 
CALB@ZIF-90 (24-hour), activity was depleted to background hydrolysis rates (Figure S5.5). 
All samples were tested after three water washes to remove excess precursors and unbound and 
loosely bound enzyme. 
 To assess the effect of diffusion constraints and potential defects within the crystal, 
CALB was immobilised onto the surface of ZIF-90 (10-minute). A significant enhancement of 
activity of CALB on ZIF-90 (2.2 ± 0.0 µM.min-1) relative to the CALB@ZIF-90 biocomposite 
was observed (Figure 5.7a). CLSM images, and the absorbance spectrum of the supernatants 
of both CALB on ZIF-90 and CALB@ZIF90 confirm that CALB is being immobilised on both 
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supports with ~100% efficiency (Figure 5.5, Figure S5.4). As the enzyme loading is equal, 
this suggests that the activity of the CALB@ZIF-90 sample is being hindered by the 
encapsulation process, or by substrate diffusion restraints to the embedded enzyme. However, 
both the encapsulated and surface adsorbed samples were significantly more active than the 
CALB@ZIF-8 and CALB on ZIF-8 composite of equivalent size, indicating that the 
interactions on ZIF-90 is more favourable than on the more hydrophobic, ZIF-8 framework.  
Next, the effect of formation time and particle size was determined for CALB@ZIF-90 
by comparing the rate of hydrolysis of the 10-minute (1 µm) and 24-hour (2 µm) samples 
(Figure 5.7b). The rate of hydrolysis with CALB@ZIF-90 (10-minute) sample was 
approximately 10 times faster than the CALB@ZIF-90 sample (24-hour). The CALB@ZIF-90 
24-hour sample had an activity similar to the background hydrolysis of BSA@ZIF-90 (10-
minute) (Figure S5.5). Whilst, the presence of crystalline ligand (Figure S5.3), complicated 
the assessment of the CALB@ZIF-90 24-hour sample, the loss of activity suggests that longer 
formation times are not favourable for the immobilisation of CALB.  
5.3.5. CALB@ZIF-90 Pore Size Analysis 
Activity, in the 24-hour sample may be being inhibited by increased encapsulation 
(larger crystal sizes) or pore blockage caused by ligand crystallisation. Additionally, FITC 
diffusion experiments suggested that, based off of size alone, substrate (p-NPB) diffusion 
would be unfavourable in perfect ZIF-90 crystals,30 so the activity that was measured for 
CALB@ZIF-90 (10-minutes) may indicate the presence of crystal defects or a higher 
proportion of surface bound enzyme. Analysis of the BET surface areas, by performing 77 K 
N2 adsorption isotherms, revealed that the smaller, faster forming CALB@ZIF-90 (10-minute) 
exhibited a larger surface area (1051 ± 0 m².g-1) than the CALB@ZIF-90 (24-hour) sample 
(623 ± 0 m².g-1). This observation was likely due to ligand crystallisation in the 24-hour sample 
contributing to sample mass, and thus lower N2 adsorption (Figure S5.6a). Additionally, 
similar pore size distribution between the two different sample preparations (calculated via 
DFT N2 model) (Figure S5.6b), suggests that the activity was not due to the differences in 
porosity of the two samples.  
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5.3.6. CALB@ZIF-90 Activity (Transesterification) 
Next, we investigated the range of CALB@ZIF-90 reactions by testing the activity and 
stability of the biocomposite to the  transesterification conditions (Figure 5.8). 
Transesterification yields can be greatly enhanced in organic solvents by lowering the water 
content of the reaction, thus minimising the product hydrolysis that would arise in aqueous 
media.  
 
Figure 5.8:The transesterification of vinyl acetate IV with hexanol V to generate hexyl acetate 
VI and vinyl alcohol VII. Vinyl alcohol tautomerises to acetaldehyde VIII, inhibiting the 
reverse reaction. Hexyl acetate VI can hydrolyse to form acetic acid and hexanol V in the 
presence of water. 
In Chapter 4, it was shown that the 1 µm CALB@ZIF-8 (and CALB on ZIF-8) samples 
are not active for the transesterification reaction between hexanol and vinyl acetate, and thus 
we were motivated to determine whether the hydrophilic support of ZIF-90 would result in 
activity. CALB@ZIF-90 (10 min) was active at a similar initial rate to CALB on ZIF-90, 
leading to a maximum measured conversion after 8 hours of 80- and 90 % respectively (Figure 
5.9).  
 
Figure 5.9: Transesterification of hexanol and vinyl acetate by CALB@ZIF-90 and CALB on 
ZIF-90 (both 10-minute). 
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The similarities between encapsulated and surface bound samples suggest that enzyme 
activity is not limited by substrate diffusion and could result from CALB that is substrate 
accessible (surface bound or sub-surface). CLSM suggested that some surface bound enzyme 
was present on the CALB@ZIF-90 (10-minute) sample (Figure 5.5) which may be responsible 
for the observed transesterification activity. Alternatively, the substrate shape and size 
(hexanol; 5.37 Å) and reaction time (hours) may well allow for better substrate transfer 
compared to the hydrolysis reaction (minutes, p-NPB; 6.57Å). The levels of background 
hydrolysis of p-NPB by the MOF control, however, prevented extending the reaction time to 
further test this theory. In either case, CALB@ZIF-90 was active whereas CALB@ZIF-8 
(equivalent size) was not, despite similar enzyme loadings, further highlighting the advantage 
of the ZIF-90 framework. SEM and PXRD after transesterification showed no noticeable 
change to the crystal structure after the reaction (Figure 5.10, Figure S5.7). 
 
Figure 5.10: SEM of the (a) CALB CALB@ZIF-90 and (b) CALB on ZIF-90 (10-minute) 
after a 24-hour transesterification reaction in 100% hexane. 
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5.3.7. CALB@BioHOF-1 Synthesis 
After establishing the impact of the framework (ZIF-90 versus ZIF-8), we proceeded to 
immobilise CALB using the chemically and structurally different BioHOF-1 framework. The 
metal-free, hydrogen-bonded framework retained the activity of enzymes that were not active 
within ZIF-8 (catalase, alcohol oxidase) so we were motivated to apply the BioHOF-1 
immobilisation method to CALB. Unlike ZIF-8, BioHOF-1 is stable to both tris and phosphate 
buffers and thus will allow for activity screening in buffered media without the risk of support 
degradation.  
The synthesis of the protein free BioHOF-1 was confirmed by PXRD and SEM (Figure 
5.11a, 5.12) and upon the addition of a control protein (BSA), no significant changes to the 
crystallinity or morphology where observed (Figure 5.11b, 5.12). Interestingly when 
synthesised using CALB, the HOF showed a significant reduction in crystallinity evidenced by 
a broadening of the peaks in the powder pattern (Figure 5.12). This coincided with a change 
in morphology via SEM where the CALB@HOF crystals became shorter and more rounded at 
the edges (Figure 11c). Additional small crystallites (or aggregates) less than 1 µm in size, 
were also present in the CALB sample that may be responsible for the peak broadening in the 
PXRD pattern. This observation was consistent across multiple batches indicating that either 
the CALB enzyme, or additives within the lyophilised powder were changing how the HOF 
was being formed. Different enzyme types (i.e. surface chemistry) and preparations 
(lyophilisation and purification), as well as the concentration used may be responsible for the 
observed changes, however this phenomenon is not well understood. Catalase and alcohol 
oxidase, both generate rod shaped crystals, however their thickness and length varied between 
samples.30 
 
Figure 5.11: SEM of as-synthesised BioHOF-1 made without protein, with BSA (2 mg), and 
with CALB (2 mg). The choice of protein appears to alter the crystal size and morphology with 
respect to the as-synthesised protein free sample.  
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Figure 5.12: As-synthesised PXRD pattern of BioHOF-1 made in the presence of CALB, BSA, 
or no protein. The additional peaks in the simulated pattern will appear in the synthesised 
samples upon manual grinding, as the effects of preferred orientation are overcome.30 Peak 
broadening and reduced intensity of CALB@BioHOF-1 was an element of all 
CALB@BioHOF-1 synthetic attempts and can be attributed to the formation of small 
crystalline aggregates (Figure 5.11). The simulated powder pattern was generated form single 
crystal X-ray diffraction data of the protein free BioHOF-1.39 
 To investigate the morphological change, a lower concentration of FITC-CALB (1 mg 
per sample) that had been washed to remove excess salts was used for fluorescent mapping of 
the crystals (Confocal Laser Scanning Microscopy, CLSM). Despite the change in enzyme 
concentration and the buffer exchange, CLSM images showed that the rounded crystals 
remained the dominant morphology (Figure 5.13a). Fluorescence was observed across all of 
the crystals, with its central location indicating encapsulation; however according to reports in 
the literature, low levels of surface bound enzyme are also expected.30 Again, no FITC 
absorbance was observed in the supernatant of the framework, indicating full CALB 
immobilisation (Figure S5.8). FITC-CALB combined with the pre-synthesised HOF sample 
confirmed that adsorption of CALB on the HOF external surface was also possible (Figure 
5.13b). 
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Figure 5.13: Confocal Laser Scanning Microscopy (CLSM) images of CALB@BioHOF-1 (a) 
and CALB on BioHOF-1. (b) Fluorescein isothiocyanate (FITC) tagged enzyme (1 mg CALB) 
was used for both encapsulation and surface adsorption. The CALB@BioHOF-1 sample (1 mg 
enzyme) retained the same morphology and crystallinity as the standard CALB@BioHOF-1 
preparation (2 mg enzyme).  
  
Chapter 5   
- 164 - 
 
5.3.8. CALB@BioHOF-1 Activity (Hydrolysis) 
The reported pore aperture of BioHOF-1 is 6.4 Å which may restrict the diffusion of 
large substrates such as the p-nitrophenyl esters (p-NPB, 6.5 Å) used in the lipase hydrolysis 
assay. Whilst the flexibility of the BioHOF-1 framework allows for diffusion of molecules 
(fluorescein) much larger than p-NPB, the short time scale of the hydrolysis reaction (10 
minutes, due to the background hydrolysis in the buffer) may not allow sufficient transfer of 
the substrate through the pores. This was confirmed during the testing process, when the 
CALB@BioHOF-1 composite only catalysed background level p-NPB hydrolysis in tris and 
phosphate buffer (Figure 5.14a, S5.9). The activity however was increased ~7-fold when 
CALB was surface adsorbed only (Figure 5.14b) implying that the process of immobilisation 
on the surface of BioHOF-1 was not causing enzyme deactivation, and therefore the 
CALB@BioHOF-1 samples are likely to consist primarily encapsulated rather than surface 
bound enzyme.  
 
Figure 5.14: Hydrolytic activity of the BioHOF-1 composites in tris buffer and phosphate 
buffer (50 mM, pH 7.4) + Triton X-100. (a) CALB@BioHOF-1 was only slightly more active 
than the BSA@BioHOF-1 control (0.0 ± 0.0 µM. min-1, Figure S5.9). However, when 
adsorbed onto the surface of the crystals (b) CALB on BioHOF-1 was capable of p-NPB 
hydrolysis. In both cases, activity was slightly higher in the phosphate Buffer which is expected 
based on free enzyme activity being faster in phosphate buffer. There was no evidence in this 
study, nor those reported previously, for buffer mediated BioHOF-1 degradation. All samples 
were tested after three water washes to remove excess precursors and unbound and loosely 
bound enzyme. 
  
Chapter 5   
- 165 - 
 
5.3.9. CALB@BioHOF-1 Activity (Transesterification) 
Next, CALB@BioHOF-1 (and CALB on BioHOF-1) was tested for the 
transesterification of hexanol and vinyl acetate. The initial rate of CALB@BioHOF-1 was 
slower than CALB@ZIF-90 (10-minute) however a greater maximum conversion of 97%, 
compared to 80%, was reached after 12 hours (Figure 5.15). The surface adsorbed CALB on 
BioHOF-1 reached 100% conversion in the hexane solvent at a rate faster than the encapsulated 
enzyme equivalent, suggesting that there were diffusion constraints in the encapsulated sample. 
The framework topology and crystal size/morphology of the as-synthesised CALB@BioHOF-
1 and CALB on BioHOF-1 samples, post-transesterification (100% hexane) were consistent 
with the pre-assay samples, as determine by PXRD and SEM analysis (Figure 5.16, S5.10). 
Due to the high activity of CALB@BioHOF-1 in hexane, and the promising substrate 
accessibility of BioHOF-1 relative to the ZIF materials, this sample was examined for its 
reusability. Here, CALB@BioHOF-1 could be reused to maximum conversion (~97%) for 5 
cycles without loss in activity (Figure 5.17).  
 
 
Figure 5.15: Transesterification of hexanol and vinyl acetate by CALB@BIOHOF-1 (red) and 
CALB on BioHOF-1 (black). 
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Figure 5.16: SEM images of (a, b) CALB@BioHOF-1 and (c, d) CALB on BioHOF-1 as-
synthesised and post transesterification. 
 
 
Figure 5.17: Activity of the CALB@BioHOF-1 after multiple cycles (normalised to the first 
cycle). After each cycle, the hexane was removed, and the sample was washed three times with 
fresh hexane to remove reactant/ product from the previous reaction. Activity was maintained 
after each 16-hour cycle, with the first cycle equalling 96% conversion.  
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5.3.10. Enantioselective Transesterification 
The enantioselectivity of the CALB@ZIF-90 (10-minute) and CALB@BioHOF-1 
samples were then determined for the transesterification of (R/S)-1-phenylethanol (1-PE) using 
the same concentrations and solvents as the hexanol/vinyl acetate assay (Figure 5.18-19). 
Novozym435, tested as a control, selectively converts (R)-1-PE into (R)-1-phenylethyl acetate 
(1-PEA) reaching 60% (R) production after 24 hours (Figure S5.11-12, Table S5.1). In the 
subsequent time-points, however, Novozym435 began hydrolysing the ester (XI) in hexane, 
reducing the product to 19% after 5 days. 
 
Figure 5.18: Enantioselective transesterification reaction scheme. In the presence of 
(R/S)-1-phenylethanol X, CALB enantioselectivity esterifies the R isomer to yield (R)-
1-phenylethyl acetate XI and (S)-1-phenylethanol XII. 
 
Figure 5.19: Gas chromatogram of chiral column separation of substrate and product 
standards. The retention times of (R)-1-phenylethanol, and (S)-1-phenylethanol were 11.7-and 
11.9 minutes respectively. The retention times of (R/S)-1-phenylethyl acetate was 11.3 and 
12.1 minutes.  
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Immobilising CALB within ZIF-90 an BioHOF-1 led to a reduction in rate, however the 
enantioselectivity was maintained, with no (S)-PEA appearing for any samples during the 5-
day reaction (Figure 5.20-21, Table S5.1).  
 
Figure 5.20: Concentration of (R)-1-phenylethyl acetate generated by CALB@ZIF-90 (10-
minute) and CALB@BioHOF-1, and their surface adsorbed counterparts, over a 5-day 
reaction. Percent conversions are tabulated in Table S5.1. 
1-Phenylethanol (6.86 Å) is of a similar size to p-NPB (6.5 Å), and therefore substrate 
diffusion through the framework is expected to be slow. However, as the enantioselective 
transesterification reaction was monitored for 5 days, there was sufficient time for the substrate 
to diffuse and reach the enzyme. Using the ZIF-90 framework, the encapsulated enzyme was 
more active than the surface bound variant, indicating encapsulation process was better for 
long term stability and that there is likely to be sub-surface enzyme that is protected but still 
accessible to the substrate. For the BioHOF-1 framework, the surface bound CALB was more 
active, highlighting potential diffusion restrictions of the encapsulated sample, and that the 
BioHOF-1 is a better candidate for stabilising enzymes in long term reactions. 
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Figure 5.21: Gas chromatogram of chiral column separation of (R/S)-1-phenylethanol 
transesterification. No (S)-1-phenylethyl acetate was produced (retention time; 11.2 minutes). 
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5.4.  Conclusion 
CALB was immobilised for the first time into ZIF-90 and BioHOF-1 via one-pot 
synthesis in each case. The activity of CALB@ZIF-90 was determined to be dependent on the 
formation time of the composite. A 10-minute synthesis time generated 1 µm crystals that were 
active to hydrolysis and transesterification reactions, whereas the 24-hour synthesis formed 2 
µm crystals and saw a significant reduction in catalytic output. This can be attributed to the 
degree of encapsulation of the different sample preparations, with the smaller CALB@ZIF-90 
crystals containing a higher proportion of surface bound or sub surface crystals compared to 
the larger crystals that consistently encapsulate enzyme in the literature.29 Additionally, longer 
formation times lead to ligand crystallisation which is not removed by water washes, which 
may contribute to pore blockage that reduced activity of the larger samples. CALB@BioHOF-
1 was not active for the hydrolysis reaction due to the larger substrate size and the short reaction 
time that was not complementary to diffusion. CALB@ZIF-90 (10-minute) demonstrated 
enhanced activity over CALB@ZIF-8 (similar sized) biocomposites for the transesterification 
of hexanol and vinyl acetate in hexane. CALB encapsulated within or surface bound to ZIF-8 
were not active indicating that the activity of the ZIF-90 framework must be affording more 
favourable interactions with CALB. CALB@BioHOF-1 was also stable and active to 
transesterification in hexane and could be reused for 5 cycles with minimal loss in activity. 
Additionally, the enantioselectivity of the CALB biocomposites studied were unaltered, 
relative to Novozym435, maintaining selectivity (R, ee: 99%) over a 5-day reaction.  
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5.5.  Experimental 
5.5.1. Materials 
 Lipase B from Candida antarctica (CALB) recombinant from Aspergillus oryzae 
(Product Code 62288, 9 U.mg-1) was purchased from Merck as a lyophilised powder and used 
without purification. Novozym435 (Product Code 1002850352, 5000 U.g-1) as lipase 
immobilised on macroporous acrylic resin was purchased from Merck and used as is. The 
BioHOF-1 tetrahedral amidinium and carboxylate ligand precursors were supplied by Dr. 
Nicholas White of Australian National University.40 All other chemicals were purchased from 
commercial sources and used as received. Ultra-pure Milli-Q (MQ) with resistivity of >18 MΩ 
cm-1 (Merck Millipore purification system) was used for all syntheses, wash protocols and 
buffer preparations. 
5.5.2. Fluorescein Tagged CALB 
 CALB was tagged using fluorescein isothiocyanate (FITC) as per previously reported 
protocols. Detailed protocols can be found in the experimental for Chapter 4. 
5.5.3. Biocomposite Syntheses 
BioHOF-1 Protein Free Synthesis. HOF synthesis was adapted from literature 
reported for enzymes, catalase and alcohol oxidase. Structures are shown in Figure S5.2. 
Ligand 3 (amidinium) (4 mg) was dissolved in water (1 mL). Ligand 4 (carboxylate) (3 mg) 
was added to water (0.95 mL) and dissolved with the addition of a 1% ammonia solution (~50 
μL). Under gentle stirring, the carboxylate solution was added dropwise to the amidinium 
solution over the course of 15 minutes. The resulting suspension was left to stir for an additional 
hour to ensure complete HOF formation, after which the product was collected by 
centrifugation and washed three times with MQ water. 
Protein@ZIF-90 Synthesis. A similar method was used for protein encapsulation, 
where a protein solution (2 mg, 0.25 mL) combined Ligand A solution (4 mg, 0.75 mL). 
Protein Free Synthesis. 62 mg ICA dissolved in 3.8 mL MQ water at elevated 
temperature (approximately 80 degrees) with rapid stirring. The solution was cooled to 30°C 
prior to use as cooling the ligand below 30°C leads to precipitation of the ligand that cannot be 
fully separated from the ZIF-90 crystals. Zinc nitrate hexahydrate (47 mg) dissolved in 200 μL 
MQ water was added and quickly mixed into the ICA solution. The resulting suspension was 
left undisturbed for 10 minutes before collection via centrifugation (6000 rpm, 5 minutes). 
Leaving the product to form for a longer timeframe initially leads to a loss of crystal definition 
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followed by a complete collapse in crystal structure. The product was washed three times with 
water to remove excess precursors.  
Protein@ZIF-90 Synthesis. A similar method was used for protein encapsulation, 
where the protein (powder or solution was added to the ICA solution (upon reaching 30 
degrees). After the addition of Zn2+, the resulting precipitate was collected after 10 minutes or 
24 hours. 
Surface Adsorbed Biocomposites. CALB or FITC-CALB (2 mg) in water 0.5 mL was 
gently shaken for 4 hours with the protein free BioHOF-1 or ZIF-90. The sample was washed 
twice with water to remove loosely bound CALB prior to use. 
5.5.4. Activity Determination 
Hydrolysis: The hydrolysis of p-nitrophenyl butyrate (p-NPB) assay was adapted from 
literature procedures and is outlined in Chapter 4.42-43 
Transesterification: Hexanol or (R/S)-1-phenylethanol (2 mM) and vinyl acetate (10 
mM) in hexane (2 mL) was combined with an air-dried biocomposite in hexane (2 mL) in a 5 
mL glass vial. The reaction mix was shaken at 30°C, and aliquots were taken from the hexane 
at 1-hour intervals. 
5.5.5. Characterisation 
Powder X-ray Diffraction (PXRD), Scanning Electron Microscopy (SEM) and 
UV-Visible Absorbance Measurements. All instrument descriptions and characterisation 
protocols are described in Chapter 4 and were used without modification. 
N2 Adsorption Isotherms. N2 (UHP grade, 99.999%) adsorption isotherm 
measurements were performed on a 3Flex physisorption analyser. The temperature was 
maintained at 77 K via a helium cryostat. The samples were washed with ethanol and dried 
under vacuum in a desiccator for 1-hour. The dried samples were heated under vacuum at 120 
°C for 2 hours.  
Gas Chromatography Analysis. Aliquots were diluted/extracted into ethyl acetate, 
dried with magnesium sulphate and analysed via Gas Chromatography (Shimadzu, Nexis GC-
2030) equipped with a DB-wax column (30.0 m, 0.25 mm, 0.25 mm) and a Flame Ionisation 
detector (FID). The column was held at 60 °C for 3 minutes and increased at 6 °C per minute 
to 160 °C. At the end of each run, the column was heated to 220 °C for a burn off. For separation 
of enantiomers the samples were analysed by Gas chromatography (Shimadzu GC-2010) 
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equipped with a chiral Restek-BDEXse column (30.0 m, 0.32 mm, 0.25 μm) and a Barrier 
Ionisation Discharge (BID) detector. The column was held at 80 °C for 3 minutes and increased 
at 5 °C per minute to 140 °C. At the end of each run, the column was heated to 220 °C for a 
burn off. Retention times are as follows. Hexanol; 7.9 min and hexyl acetate; 6.1 min, see 
Chapter 4, Figure S4.21. (R)-1-phenylethanol; 11.7 min, (S)-1-phenylethanol; 11.9 min, (R)-
1-phenylethyl acetate 12.1 min, see Figure 5.18. 
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5.8.  Supporting Information 
5.8.1. CALB background information  
 
 
Figure S5.1: Enantioselective hydrolysis reactions of a) 2-O-butyryl-2-phenylacetic acid and 
b) 3-phenylglutaricdimethyl diester. Changing the support from Lewatit VP OC 1600 to 
Octadecyl Separose results in an inversion of enantioselectivity of 1 (S to R) but reduces the R 
preference of 2 (99-to 61%).1 
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5.8.2. Biocomposite building units 
 
 
Figure S5.2: The structure of the ligands used in the synthesis of the ZIF materials (a) and 
BioHOF-1 (b). ZIF-8 is formed from zinc acetate dihydrate, Zn(CH3COO-)2·H2O and 2-methyl 
imidazole, 2-mIM (1). ZIF-90 is formed from zinc nitrate hexahydrate, Zn(NO3)2·6H2O and 
imidazole-2-carboxaldehyde, ICA (2). BioHOF-1 is synthesised from poly- amidinium (3) and 
poly-carboxylate (4) tectons. Two CALB@ZIF-8 preparations are referred to in this work. 
Large (1 µm) crystals formed using a Zn2+:2-mIM ratio of 40:640 mM was used for direct 
activity comparison to equally sized ZIF-90 samples. Smaller (500 nm) crystals formed using 
a ratio of 20:80 mM were used for enantioselectivity testing (Figure S5.13). 
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5.8.3. ZIF-90 Characterisation 
 
 
Figure S5.3: a) SEM and b) PXRD pattern of the ICA ligand. Repeating the 24-hour ZIF-90 
protocol with ICA but no zinc source led to crystallisation of the ligand, generating a PXRD 
pattern with a major peak at 2θ value of 12°. This peak appeared in all 24-hour protein@ZIF-
90 samples (Figure 5.2b), and a similarly shaped crystal was observed in the CALB@ZIF-90 
SEM images (Figure 5.1b). Due to the low solubility of the ICA ligand in water at room 
temperature standard washing protocols (water) are not sufficient for removing excess ligand 
from the ZIF-90 crystals. 
 
Figure S5.4: Absorbance spectrum of the supernatants of FITC-CALB@ZIF-90 (10-minute) 
before washing. No absorbance peak was observed at 495 nm (corresponding to FITC) 
indicating no FITC or FITC-CALB was left in solution. The absorbance of the FITC-CALB is 
shown as a dotted reference line. Traces are offset on the y axis for clarity.  
Chapter 5   
- 181 - 
 
5.8.4. ZIF-90 hydrolysis controls 
 
 
Figure S5.5: Control assays BSA@ZIF-90 (10-minute) in tris and phosphate buffer. Assays 
were performed after 0- and 30-minutes exposure to each buffer and are reported as the mean 
and standard error. Low levels of background hydrolysis was reported for each buffer with the 
small standard error range indicating that incubation time was not impacting the rate. 
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5.8.5. CALB@ZIF-90 N2 sorption analysis 
 
 
Figure S5.6: N2 sorption/desorption curves at 77 K giving BET surface areas of 1051 ± 1 and 
623 ± 0 m².g-1 respectively for the 10-minute and 24-hour CALB@ZIF-90. (b) Pore size 
distribution of each CALB@ZIF-8 preparation indicate a similar pore size for both samples. 
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5.8.6. CALB@ZIF-90 stability characterisation 
 
Figure: S5.7: PXRD patterns of the CALB@ZIF-90 and CALB on ZIF-90 (10-minute) after 
24 hours transesterification in 100% hexane. 
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5.8.7. BIOHOF-1 characterisation 
 
 
Figure S5.8: Absorbance spectrum of the supernatants of FITC-CALB@BioHOF-1 before 
washing. No absorbance peak was observed at 495 nm (corresponding to FITC) indicating no 
FITC or FITC-CALB was left in solution. The absorbance of the FITC-CALB is shown as a 
dotted reference line. Traces are offset on the y axis for clarity. 
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5.8.8. BioHOF-1 hydrolysis controls 
 
 
Figure S5.9: Control assays BSA@BioHOF-1 in tris and phosphate buffer. Assays were 
performed after 0- and 30-minutes exposure to each buffer and are reported as the mean and 
standard error. Low background hydrolysis was reported for each buffer with the small 
standard error range indicating that incubation time was not impacting the rate. 
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5.8.9. BioHOF-1 stability testing  
 
 
Figure S5.10: PXRD of CALB@BioHOF-1 (a) and CALB on BioHOF-1 (b) as-synthesised 
and post transesterification. 
  
Chapter 5   
- 187 - 
 
5.8.10. Enantioselective transesterification 
 
 
Figure S5.11: Concentration of (R)-1-phenylethyl acetate generated by Novozym435 and 
CALB@ZIF-8 (20:80 mM) over a 7-day reaction. Novozym435 was the most active 
biocomposite, yielding 60% of the R-ester after 24 hours. In the remaining timepoints, the ester 
concentration was reduced due to ester hydrolysis to 19 %. Vinyl acetate addition after day 5 
pushed the reaction towards hexyl acetate production again, however a maximum production 
of 62% was possible, with further addition on day 6 not increasing it further. CALB@ZIF-8 
yielded approximately 25% (R)-1-phenylethyl acetate and did not increase further upon vinyl 
acetate addition, suggesting that the biocomposite was being deactivated. 
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Figure S5.12: Gas chromatogram of chiral column separation of 1-phenylethanol 
transesterification.Novozym435 saw an initial increase in peak area at 12.1 minutes and 
reduction at 11.7 minutes, due to the production of (R)-1-phenylethyl acetate and consumption 
of (R)-1-phenylethanol (day 1, black trace). In the following days the ester peak reduced, and 
the R alcohol increased due to product hydrolysis (day 5, red). CALB@ZIF-8 (20:80 mM) 
generated a small R- ester peak on day 1 which did not increase significantly at day 5. The R 
and S alcohol peaks did reduce slightly, potentially due to adherence of the alcohols to the ZIF 
surface. There is no peak at 11.3 minutes indicating that no (S)-1-phenylethyl acetate was being 
produced. 
Table S5.1: Comparison of CALB percentage yields of hexyl acetate and (R)-1-phenylethyl 
acetate of CALB@BioHOF-1, CALB@ZIF-90 (10-minute) and their surface bound 
equivalents. CALB@ZIF-8 (20:80 mM) and Novozym435 are included for comparison. 
 (R/S)-1-Phenylethanol 
Support % Conversion ee 
 Day 1 Day 5  
CALB@BioHOF-1 16 28 >99 
CALB on BioHOF-1 26 53 >99 
CALB@ZIF-90 (10-minute) 3 40 >99 
CALB on ZIF-90 (10-minute) 4 28 >99 
CALB@ZIF-8 (20:80 mM) 17 26 >99 
Novozym435 58 19 >99 
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Chapter 6. Enhanced Stability and Activity of a Haloalkane Dehalogenase Immobilised 
in a Hydrogen-bonded Organic Framework (Compared to Metal-Organic Frameworks) 
6.1.  Abstract 
The encapsulation of enzymes within porous materials is a rapidly developing area of 
research that is focussed on the immobilisation of biomacromolecules to enhance their activity, 
stability, and reusability. Recombinant protein expression enables the creation of extensive 
libraries of enzymes to fully capitalise on this by creating novel biocomposites with a broad 
range of applications. Here we describe the expression and purification of a haloalkane 
dehalogenase enzyme, LinB and demonstrate, for the first time, its immobilisation within 
zeolitic imidazolate frameworks, ZIF-8 and ZIF-90, and a porous hydrogen bonded organic 
framework, BioHOF-1. The activity of LinB immobilised within BioHOF-1 (LinB@BioHOF-
1) was comparable to the free enzyme, reaching 75- and 98% single step dehalogenation of 
alkyl halides, 1,2-dibromoethane and 1,3-dibromopropane respectively. The LinB@BioHOF-
1 composite displayed enhanced reusability and thermal stability relative to the free enzyme, 
whereas ZIF immobilisation afforded biocomposites that were either inactive or unstable to the 
reaction conditions. These findings highlight a general strategy for enzyme immobilisation in 
porous materials, demonstrating that BioHOF-1 can accommodate enzymes which are not 
active or stabilised in ZIF materials. 
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6.2.  Introduction 
Haloalkane dehalogenases, HLDs (EC 3.8.1.5) are a family of microbial enzymes that 
share structural similarities with α/β hydrolase enzymes (esterases, lipases etc).1 HLDs function 
via a hydrolytic mechanism, and target the cleavage of carbon-halogen bonds, to yield the 
corresponding alcohol and free halide. The reaction is catalysed by a triad of amino acids 
(Aspartate; Asp, Histidine; His, and Aspartate or Glutamate; Glu), initiated via nucleophilic 
attack of an Asp residue onto the substrate, followed by hydrolysis of the enzyme bound 
intermediate (Figure 6.1).2-4 
 
Figure 6.1: (a) General reaction mechanism of haloalkane dehalogenases (HLDs). (b-c) 
Simplified HLD active site mechanism of the dehalogenation reaction.2-4 The catalytic triad 
(Asp-His-Asp/Glu) are depicted in blue. The first step (b) involves the formation of an alkyl-
enzyme intermediate via an SN2 attack of the substrate by the acidic Asp residue. This is 
followed the cleavage of the alkyl-enzyme intermediate (c) by an active site water molecule. 
The His residue activates the water molecule and is itself stabilised the third catalytic residue 
(Asp/Glu). Additional residues (Asn, Trp) are shown in black and position and stabilise the 
halide. 
The reaction proceeds with water as the only external cofactor,1, 5 making HLDs a 
relatively simple enzyme to employ for biotechnological purposes.1, 6 HLDs are useful for 
biosynthesis, being favoured for their enantioselectivity and kinetic resolution of alcohols.7-9 
Additionally, their ability to break down toxic halogen containing compounds make HLDs an 
attractive system for the bio-remediation of environmental contaminants.8, 10-12 
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One such HLD is LinB from the bacterial species Sphingobium japonicium (formerly 
Sphingomonas paucimobilis) UT26.13 Within this bacterial strain, LinB is one of 15 proteins 
involved in the metabolism of insecticide, γ-hexachlorocyclohexane (lindane) to benzene-1-4-
diol, and is responsible for the second and third dehalogenation steps of this compound (Figure 
S6.1).13-15 LinB has a large active site relative to other HLDs and as such accepts a broad range 
of substrates including bromo-, chloro- and iodo-alkanes.4, 16-17 LinB maintains activity over a 
broad pH range (7.5-10.5), and mildly elevated temperatures (30-50°C), however in order to 
apply LinB for the aforementioned purposes, there is a need to increase its stability, reusability 
and longevity, to a wider variety of environmental conditions and substrates.7, 18  
HLD immobilisation is of interest as this affords a heterogeneous biocatalyst that can 
be utilised at elevated temperatures enabling catalysis of volatile substrates at a solid to gas 
interface.19 The process of immobilisation involves the attachment of the enzyme to a solid 
support, which enhances structural stability and reusability. This has allowed the application 
of various HLD enzymes for the sensing and bioremediation of airborne pollutants.20 
Nevertheless, while, many immobilisation strategies (cross-linking, covalent attachment, and 
entrapment within mesoporous materials) have been tested in a research setting,21-22 there has 
been limited reports of the commercial application of immobilised LinB.7 As such, there is a 
need to develop new methods of immobilisation for LinB. Post synthetic entrapment within 
mesoporous materials, provides control over substrate diffusion and the enzyme’s 
microenvironment, however there is a high potential for enzyme leaching as the pore size must 
be larger than the size of the enzyme.23 An alternative to entrapment, is encapsulation within a 
microporous material, which can be synthesised around the enzyme in processes termed 
‘biomimetic mineralisation’24 or ‘co-precipitation’.25 In these cases the of pore apertures of the 
microporous network are smaller than the enzyme thus leaching is hindered but diffusion of 
small substrates is sustained.26-28  
Metal-Organic Frameworks (MOFs) and Hydrogen-bonded Organic Frameworks 
(HOFs) are two classes of porous materials that can be utilised for enzyme immobilisation. 
They are synthesised via a modular approach, that allows for control of the frameworks 
hydrophobicity, pore size, topology, particle size and morphology.29-30 Zeolitic-imidazolate 
frameworks (ZIFs) are porous materials constructed from tetrahedral Zn2+ nodes linked via 
imidazolate organic units. ZIF-8 is synthesised from Zn2+ and 2-methyl imidazole (2-mIM) and 
is known to form a number of crystalline topologies. With respect to the formation of 
enzyme@ZIF-8 biocomposites the topology (and also particle size) can be controlled through 
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judicious selection of precursor concentrations.31 This is noteworthy, as topology and particle 
size lead to enzyme biocomposites of distinct activity and stability. Employing imidazole-2-
carboxaldehdye (ICA) as the organic link, generates ZIF-90, a topologically identical material 
to ZIF-8.32 However, the aldehyde group renders the ZIF-90 framework more hydrophilic than 
ZIF-8. Indeed, this proved advantageous for enzymes that exhibit unfavourable conformational 
changes upon immobilisation on hydrophobic supports.33 Similar trends were observed for 
CALB (Candida antarctica Lipase B) in Chapter 5, thus highlighting the potential influences 
of framework chemistry on enzyme activity. 
More recently, the Hydrogen-bonded Organic Framework (BioHOF-1), has been 
demonstrated to encapsulate enzymes in a metal-free framework.34 BioHOF-1 is synthesised 
from tetra-amidinium and tetra-carboxylate components, to yield an extended network that has 
a larger pore aperture (6.4 Å) than both the ZIF materials studied ( ̴ 3.4 Å), potentially allowing 
for a larger range of substrates to be utilised.35-37 BioHOF-1 was selected as a complementary 
candidate for LinB immobilisation as it retains water within its framework, making it more 
compatible for enzymes such as LinB that require water as cofactor.34, 38 Each of the 
aforementioned frameworks, ZIF-8, ZIF-90 and BioHOF-1, form in aqueous, room 
temperature conditions, via protocols that that can initiate immobilisation without the need for 
additional precipitants or enzyme modification steps. As LinB has yet to be immobilised within 
these porous materials, we were motivated to synthesise biocomposites of each, hereafter 
known as LinB@ZIF-8, LinB@ZIF-90 and LinB@BioHOF-1, to ascertain if they can preserve 
the activity of LinB for the dehalogenation of 1,2-dibromoethane and 1,3-dibromopropane. 
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6.3.  Results and Discussion 
The proteins studied for ZIF and BioHOF-1 immobilisation are often obtained from 
commercial sources as lyophilised powders and have the potential to contain undisclosed buffer 
salts and stabilising agents from the lyophilisation process. Alternatively, proteins can be 
expressed recombinantly prior to immobilisation, which allows greater control over handling 
and purification.39 Additional benefits to this process include the ability to modify the sequence 
from which the protein is translated, enabling the incorporation of tag sequences for 
purification, as well as mutations to expand substrate recognition. In this study, a histidine 
tagged-LinB protein was expressed in Escherichia coli and purified using nickel column 
chromatography to yield a highly active and pure enzyme (Figure 6.2, S6.2-S6.3).  
 
Figure 6.2: SDS-PAGE (Poly Acrylamide Gel Electrophoresis) analysis of purified LinB 
(MW: 34 KDa). L1: Protein MW Standard, L2: Purified LinB. The purified LinB fraction was 
concentrated via ultra-filtration and analysed via SDS PAGE (12% acrylamide) to determine 
the enzymes purity. A single intense band between the 26-34 KDa marker indicates successful 
expression and purification of LinB.  
The activity of LinB (free enzyme) was determined using 1,2-dibromoethane (1,2-
DBE) and 1,3-dibromopropane (1,3-DBP), as these alkyl halides are known to be rapidly 
dehalogenated by LinB to yield products of 2-bromoethanol and 3-bromopropan-1-ol 
respectively (Figure 6.3).13 The bromo-alcohol product can be dehalogenated further to 
produce the diol products (ethane-1,2-diol, and propane-1,3-diol) however this process is less 
favourable and often requires significant depletion of the first product.40-41 As the 
dehalogenation reaction only requires water as a cofactor, activity can be monitored directly 
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via gas chromatography, enabling simultaneous measurement of both the substrate and the first 
dehalogenation product.  
 
Figure 6.3: (a) The dehalogenation of 1,2-dibromoethane to 2-bromoethanol, which can be 
dehalogenated further to form ethan-1,2-diol. (b) The dehalogenation of 1,3-dibromopropane 
to 3-bromopropan-1-ol, followed by propane-1,3-diol. 
It was established that for free LinB, that maximum substrate conversion to the bromo-
alcohol products occurred within the first 16 hours for both substrates, but between 16- to 24- 
hours there was a noticeable decrease in the product concentration, suggesting conversion to 
the diol product was occurring (Figure 6.4, Table 6.1). However, due to the increased 
hydrophilicity of the diol products, they were not extracted out of the buffer solution and thus 
could not be directly accounted for in this reaction.  
 
Figure 6.4: Free LinB enzyme conversion of the 1,2-DBE to 2-bromoethanol and 1,3-DBP to 
3-bromopropan-1-ol reactions. The substrate and first product (the haloalcohol) concentrations 
were calculated from separate calibration curves at times, t = 8-, 16- and 24-hours and are 
reported as a mole fraction of the reaction. Red, black stripes and white segments account for 
substrate, product, and remaining mole fraction, respectively. 
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Table 6.1: Quantitative analysis for the mole fraction data showing the percent production of 
2-bromoethanol and 3-bromo-1-propanol. 
Time 2-bromoethanol (%) 3-bromopropan-1-ol (%) 
8 hr 86 86 
16 hr 89 91 
24 hr 67 48 
 
To investigate the observed reduction in concentration during the free enzyme testing, 
substrate and product volatility studies were undertaken. The substrate and product controls (1 
mM) in tris (50 mM pH 8) were shaken at room temperature for 8-,16- and 24- hours and the 
concentrations were quantified via GC-FID analysis (Figure S6.4-S6.5, Table S6.1). 1,2-DBE 
and 1,3-DBP were both susceptible to significant evaporation due to their volatility, however 
the bromo-alcohol controls remained unchanged, confirming that product depletion was not 
due to evaporation. These experiments provided convincing evidence that the observed 
decrease between 16- and 24- hours is likely due to conversion to the secondary diol products 
by the enzyme. Furthermore, in a control reaction, the free LinB could convert 2-bromoethanol 
to the diol product, as shown by a reduction in the concentration of 2-bromoethanol (0.79 mM) 
relative to a control (1.1 mM, in the absence of the enzyme) (Figure S6.6). As such, we opted 
to analyse 8-hour reactions to minimise product loss that was prevalent at later timepoints due 
to the conversion to the diol product that could not be easily quantified. 
We then proceeded to investigate the impact of the immobilisation strategy on enzyme 
activity using the different encapsulation protocols reported for ZIF-8, ZIF-90 and BioHOF-1. 
The study in Chapter 4 using CALB@ZIF-8 (CALB: Candida antarctica Lipase B) 
demonstrated that changing the synthetic conditions yields biocomposites of vastly different 
particle size, pore structure and activity and we were interested in seeing if this trend extended 
to the LinB system. As such, two preparations of LinB@ZIF-8 were synthesised by changing 
the Zn2+:2-mIM ratios from 20:80 to 40:640 mM and analysed by SEM (Figure 6.5a-b). After 
16 hours, these conditions generated particle sizes of 500 nm and 1 µm respectively, consistent 
with samples synthesised with proteins of low surface charge. Histidine tagged LinB has an 
isoelectric point of 5.5 and induced ZIF-8 formation via biomimetic mineralisation at low 
precursor ratios. The crystallinity of all biocomposites was confirmed to match their respective 
simulated powder diffraction patterns (Figure S6.7). 
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Figure 6.5: SEM of LinB ZIF biocomposites, (a) 500 nm ZIF-8, (b) 1 µm and (c) ZIF-90. The 
ZIF-8 control does not form under the same conditions used for the 500 nm sample, whilst the 
conditions for the 1 µm composite generates crystals of the same morphology and size when 
synthesised without the protein. The inclusion of LinB into the ZIF-90 crystals yield crystals 
ranging from 500 nm to 1 µm, compared to 2-5 µm in the protein free samples. No 5 µm 
crystals were observed (compared to the CALB@ZIF-90, Chapter 5, Figure 5.1) indicating 
that the CALB and LinB are influencing the formation in different ways. Further investigation 
is therefore required. 
LinB@ZIF-90 was synthesised to compare the effect on enzyme activity of a more 
hydrophilic framework, as well as the impact of synthetic conditions (ligand, pH) and a 
different microenvironment relative to ZIF-8. In the synthesis of ZIF based biocomposites, the 
enzyme is usually dissolved with the ligand rather than the Zn2+ solution to favour enzyme 
dissolution. It is important to account for the enzyme exposure to the different ligands as the 
ICA solution for ZIF-90 has an approximate pH range of 6-7 whereas the 2-mIM for ZIF-8 can 
easily exceed pH 11. These distinct synthesis conditions would likely impact the conformation 
of LinB during immobilisation. The LinB@ZIF-90 material was collected after 10 minutes 
(formation time) to prevent the crystallisation of ligand which has been observed for CALB in 
Chapter 5. As previously observed, the LinB@ZIF-90 biocomposite comprised of two 
approximate particle sizes in the one (500 nm and 1 µm, Figure 6.5c), which would afford 
different enzyme to crystal loading and could impact activity. In contrast, the LinB@BioHOF-
1 biocomposites were uniformly sized with well-defined crystal edges with topology and 
morphology matching the enzyme free BioHOF-1 control (Figure 6.6, S6.8) This framework 
has demonstrated promise for enzyme encapsulation due to its pore size, and broader pH 
stability (see also Chapter 5) making it an ideal candidate for testing the substrate range of 
LinB. Additionally, the pH of the tetra amidinium solution in which the enzyme is dissolved is 
approximately 6, thus avoiding the extreme basic conditions that occur during ZIF-8 formation.  
Chapter 6   
- 200 - 
 
 
Figure 6.6: SEM of as-synthesised BioHOF-1 made (a) without protein or (b) with LinB (2 
mg). Crystal size and shape were unaltered upon the addition of LinB. 
After establishing appropriate reaction conditions, we proceeded to investigate the 
relationship between immobilisation and enzyme activity. Each LinB biocomposite was 
examined for the dehalogenation of 1,2-DBE and 1,3-DBP and were directly compared to the 
free enzyme activity after 8 hours (Figure 6.7). LinB@BioHOF-1 was the most active 
biocomposite for both 1,2-DBE and 1,3-DBP, reaching conversions of 75% and 98%, 
respectively, compared to the 86% conversions reported for free enzyme. This result implies 
that LinB@BioHOF-1 was retaining the enzyme’s active conformation upon immobilisation 
and was not being restricted by substrate diffusion. In comparison, when tested for the 
dehalogenation of 1,2-DBE the ZIF-8 samples (500 nm and 1 μm) demonstrated no conversion 
(<1% and not detected) whilst ZIF-90 was only slightly active with a yield of 11%. The slow 
production of the ZIF-90 material, and the lack of activity in the ZIF-8 samples suggest that 
the ligand pH and framework hydrophobicity do not solely contribute to the loss of activity 
observed and another factor such as substrate diffusion, or the combined effect of these three 
parameters was causing activity loss. Interestingly, changing the substrate to 1,3-DBP resulted 
in a significant increase in activity for LinB@ZIF-8 (500 nm) and ZIF-90 biocomposites with 
conversion to 3-bromopropan-1-ol reaching 54% and 97%. LinB@ZIF-8 (1 μm) remained 
practically inactive, with only 2% product being detected after 8 hours. These results indicate 
that activity is substrate dependent and influenced by the method of ZIF-8 formation. 
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Figure 6.7: Percentage yield of (a) 2-bromoethanol and (b) 3-bromo-1-propanol in the first 
dehalogenation step of 1,2-DBE or 1,3-DBP. Values were calculated from a GC calibration 
curve of 2-bromoethanol and 3-bromo-1-propanol and are relative to the maximum production 
of 1 mM. The ZIF-8 samples displayed were made using Zn2+:2-mIM ratios of 20:80 mM (500 
nm) and 40:640 mM (1 μm). Additional ZIF-8 samples gave similar results for 1,2-DBE with 
20:160 mM ( ~700 nm) yielding < 1%, and 20:400 mM (~1 μm) showing no detectable (n.d) 
product after 8- and 16- hours (Table S6.2-S3). A second ZIF-90 sample yielded 5% after 8 
hours. For 1,3-DBP, the additional ZIF-8 (700 nm and 1 μm ) samples produced 36% and < 
1% respectively whilst ZIF-90 reached 85% conversion. 
To further understand the activity of the LinB materials for different substrates, the 
biocomposites were analysed post reaction via SEM and PXRD to visualise the structural 
stability of each sample. The crystallinity and morphology of LinB@BioHOF-1 remained 
unchanged for both substrates demonstrating the high compatibility of the BioHOF-1 materials 
for enzyme catalysis (Figure 6.8a, S6.9). After exposure to 1,3-DBP, the surface of the small 
ZIF-8 crystals was noticeably damaged, however the bulk crystallinity was retained (Figure 
6.8b, S6.10). This would expose the immobilised enzyme to the substrate or cause the enzyme 
to leach into solution. The larger LinB@ZIF-8 appeared to be less susceptible to degradation, 
with the bulk material remaining visually unchanged in the SEM images (Figure 6.8c, S6.11). 
Adsorption of tris onto the ZIFs may have masked etching of the crystals and surface 
degradation, however there is a clear distinction between the ZIF-8 (500 nm) samples after 
exposure to each alkyl-halide highlighting potential particle size or morphological dependent 
substrate effects. We have previously reported size dependant, ZIF-8 surface instability 
towards hydrophobic substrates containing polar functional groups, which was more prominent 
on smaller ZIF samples.42 It is therefore likely that degradation was influenced by the size of 
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the ZIF-8 particles and the hydrophobicity of the substrates suggesting that ZIF-8 
biocomposites would not be suitable for applications with even larger compounds. LinB@ZIF-
90, which consisted of both large (1 µm) and small (500 nm) particles was also susceptible to 
degradation by 1,3-DBP, with the smaller particles degrading completely after 8 hours (Figure 
6.8d, S6.12). This supports the size dependent degradation of ZIF-8 and suggests that the 
smaller particles contained the majority of the LinB enzyme as product formation reached a 
conversion similar to the free enzyme. Forming ZIF-90 without a protein yields 1-2 µm crystals 
which are also observed in the LinB samples potentially indicating two separate mechanisms 
of ZIF-90 formation (protein free vs protein containing crystals).  
For the 1,2-DBE assay, where biocomposite degradation was not significant, the 
variation in activity between the BioHOF-1 and ZIF materials may be explained by their 
porosity and ability to accommodate each substrate. The crystallographic pore aperture of the 
BioHOF-1 (6.4 Å) is also significantly larger than the ZIFs (~3.4 Å) and would best favour 
diffusion of the target alkyl halide substrates. Indeed, in a diffusion study by Liang et. al. the 
porosity of BioHOF-1 enabled the solution phase uptake of fluorescein (7 Å), implying 
structural flexibility of the framework that allows diffusion of compounds that are the larger 
that the solid-state aperture.34 BioHOF-1 could therefore allow the diffusion of both di-
brominated alkyl halides (1,2-DBE, 4.89 Å and 1,3-DBP, 5.58 Å) whereas activity was only 
regenerated upon crystal degradation of the ZIF materials. Diffusion of these substrates may 
be possible for the ZIFs (aperture ~3.4 Å), as framework flexibility allows for diffusion of 
substrates up to ~5 Å,43 however the diffusion of these compounds is restricted and quite slow. 
Analysing the activity results for 1,2-DBE suggest that diffusion was either slow or not 
occurring.  
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Figure 6.8: SEM images of each biocomposite after reaction with 1,2-DBE, and 1,3-DBP. a) 
LinB@BioHOF-1 remained unchanged after both reactions. b) LinB@ZIF-8 (500 nm) 
appeared to be relatively unchanged (mild degradation was possible) after reaction with 1,2-
DBE, however, was substantially degraded after reaction with 1,3-DBP. c) Minimal sample 
variation was observed for LinB@ZIF-8 (1 µm). d) The as-synthesised LinB@ZIF-90 
possessed large and small crystals, which were unchanged after reaction with 1,2-DBE. 
Exposure to 1,3-DBP caused complete loss/degradation of the small crystals. 
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When analysing the composition of reaction mixtures at 8 hours there was a noticeable 
discrepancy between the actual and expected concentrations of the substrate and bromo-alcohol 
products (Figure S6.13). When using porous materials, substrate/product adsorption to the 
support surface or within the pores is possible so care must be taken when analysing the 
reaction progress, as the support chemistry may influence the concentrations of substrates/ 
products in solution43. To account for this, biocomposite controls made with BSA were shaken 
with 1 mM 1,2-DBE or 1,3-DBP for 8 hours and the reaction composition was analysed 
(Figure S6.14a-b). No product was detected in each control reaction however the substrate 
concentration was affected by the different support materials. In particular, the large ZIF-8 
crystals saw a reduction in 1,2-DBE by 70% and 1,3-DBP by 90%, whereas the small ZIF-8 
particles, ZIF-90 and BioHOF-1 support had a considerably reduced affinity for adsorption of 
either alkyl halide (Figure S6.14a-b). The differences between the large and small ZIF-8 
samples implies that there are structural or surface chemistry differences that arise from the 
different formation mechanisms, which need to be explored further. ZIF-90 demonstrated 
minimal substrate adsorption, but low activity, whereas BioHOF-1 was favourable for both 
attributes. Each bromo-alcohol product was also tested, and no adsorption was observed for 
any of the biocomposites meaning that the reported conversion percentages (calculated from 
product calibrations) were not been impacted by adsorption effects (Figure S6.14c-d). These 
results highlight how porous materials may affect the substrate and product composition in 
solution, and the care that is required when analysing and interpreting different reaction types.  
The above data confirmed that BioHOF-1 was the best immobilisation support for LinB 
maintaining similar activity to the free enzyme whilst being stable to both substrates. As such, 
LinB@BioHOF-1 was examined further to demonstrate the reusability and protective capacity 
of the support. Under the same conditions for 1,2-DBP, LinB@BioHOF-1 could be reused for 
5 cycles, maintaining activity (98% conversion) after each 8-hour reaction (Figure 6.9). 
Heating the free LinB at 60 °C for 30 minutes in solution, led to aggregation and precipitation 
of the enzyme, (Figure 6.10) and a corresponding loss of activity. LinB@BioHOF-1, however, 
retained activity post heat treatment, demonstrating the capacity of the framework to stabilise 
the enzyme in an active conformation to elevated temperatures (Figure 6.11a). Additionally, 
LinB@BioHOF-1 dried at ambient temperature and pressure, maintained full activity relative 
to the fully solvated composite and could be heated without any activity depletion (Figure 
6.11b). These findings demonstrate that the process of LinB immobilisation in BioHOF-1 can 
stabilise the enzyme to thermal conditions that would otherwise inactivate the enzyme. As such 
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BioHOF-1 is a suitable support porous material to investigate LinB catalysis under non-
physiological conditions. 
 
Figure S6.9: Recycling study using LinB@BioHOF-1 and 1,2-DBP. Percent conversion has 
been normalised relative to the first cycle. Minimal variation in activity was observed in each 
successive reaction cycle. 
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Figure 6.10: GC trace of the free enzyme after an 8-hour reaction with 1,2-DBE to yield 2-
bromoethanol (retention time:17.35 min) and the corresponding GC trace after the thermal 
treatment of LinB. The GC traces were normalised relative the internal standard (1-
bromodecane, retention time 15.4 min). Inset: The free LinB sample in water after heating at 
60 °C for 30 minutes. 
 
Figure 6.11: GC traces of the 1,2-DBE assay using LinB@BioHOF-1 before and after heat 
treatment at 60 °C for 30 minutes, whilst in (a) solution or (b) dried under ambient temperature 
and pressure. GC traces were normalised as per Figure 6.10. 
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6.4.  Conclusions 
LinB was recombinantly expressed and purified with the aid of a genetically 
incorporated histidine tag and subsequently immobilised in ZIF-8, ZIF-90 and BioHOF-1. 
BioHOF-1 was the most compatible framework for LinB, maintaining high levels of activity 
and stability for dehalogenation of 1,2-dibromoethane and 1,3-dibromopropane whereas 
activity was significantly or completely reduced upon immobilisation in ZIF-90 and ZIF-8 
particles. The clear distinction between the BioHOF-1 and the ZIF-8/90 frameworks, suggests 
that the pore size of BioHOF-1 is large enough to allow free substrate diffusion, whilst the 
smaller pores of the ZIFs is too restrictive. The encapsulation process may also lead to varied 
enzyme activity due to changes in microenvironment of the enzyme, with formation of 
LinB@BioHOF-1 yielding uniform crystals that retained activity and stability to both reaction 
conditions. In contrast, the ZIF materials comprised of greater particle size variability, that 
complicated characterisation and interpretation of activity. The crystallinity, morphology and 
surface texture of LinB@BioHOF-1 crystals was fully maintained during each alkyl halide 
reaction and could be reused for multiple cycles and heated without activity reduction whereas 
each ZIF material was partially degraded under the same reaction conditions. LinB@BioHOF-
1 could be synthesised according to procedures reported for different enzymes, forming 
structurally identical biocomposites without enzyme surface modification steps or optimisation 
of synthetic protocols. The general approach to immobilisation, in combination with its large 
pore size relative to the ZIF materials, make BioHOF-1 an excellent candidate to create novel 
biocomposites with interesting applications. 
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6.5.  Experimental 
6.4.1. Expression and Purification 
General DNA and microbiological experiments were carried out according to standard 
protocols, outlined in the Supporting Information. 
6.4.2. Biocomposite Synthesis 
LinB@ZIF-8, LinB@ZIF-90, LinB@BioHOF-1 and their surface adsorbed equivalents 
were synthesised according to previously reported protocols,33-34 and are outlined further in 
Chapter 5. The LinB enzyme was stored in glycerol at -20 °C prior to use and was exchanged 
into ultra-pure water using a 10 KDa membrane and centrifugation (3400 rpm 4 x 15 minutes, 
4°C). Each biocomposite was washed and made up to 1 mL in MQ water (LinB concentration: 
2 mg.ml-1) 
6.4.3. Dehalogenation Reaction 
The LinB protein was washed via ultrafiltration to remove glycerol and exchanged into 
water prior to assay testing. For each reaction, the LinB concentration was set at 0.4 mg.ml-1 
in tris (50 mM, pH 8) with an initial substrate concentration of 1 mM. 1,3- dibromopropane, or 
1,2-dibromoethane (10 µL, 100 mM) was added to tris buffer (790 µL, 50 mM, pH 8) 
containing the LinB biocomposite (200 µL). Aliquots were taken at 8-, 16- and 24-hours and 
extracted into cold ethyl acetate containing internal standard (bromodecane). 
6.4.4. Characterisation 
PXRD and SEM. Characterisation is outlined in Chapters 2 and 3. 
Gas Chromatography Analysis. Aliquots were extracted into ethyl acetate, dried with 
magnesium sulfate and analysed via Gas Chromatography (Shimadzu, Nexis GC-2030) 
equipped with a DB-wax column (30.0 m, 0.25 mm, 0.25 mm) and a Flame Ionisation detector 
(FID). The column was held at 40°C for 5 minutes and increased at 8°C per minute to 120°C. 
At the end of each run, the column was heated to 220°C for a burn off for 3-minutes. 
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6.8.  Supporting Information 
6.8.1. LinB biological function 
 
 
Figure S6.1: Metabolism of γ-hexachlorocyclohexane (lindane) to benzene-1-4-diol. The 
upstream pathway is a multistep dehalogenation catalysed by LinA. LinB acts on 1,3,4,6-
tetrachloro-1,4-cyclohexadiene (1,4- TCDN) converting it into 2,5-dichloro-2,5-
cyclohexadiene-1,4-diol (2,5-DDOL) in a 2-step process. The downstream reactions are multi 
enzyme processes can either produce benzene-1,4-diol or smaller metabolites (e.g. succinyl-
CoA; R=COOH, or acetyl-coA; R=CH3 that can enter the citric acid cycle for energy 
production. This figure has been adapted from Nagata et. al.1 
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6.8.2. LinB gene and pET28a(+) 
The linB gene was purchased from Genscript within the pET-28a(+) vector (Merck-
Millipore). WT LinB (Uniprot: Q6VQX3, Genbank: AY331259). 
Genscript linB (A141C mutant) synthetic gene to be cloned into pET28a(+). An 
additional 6x histidine (6x His) tag sequence at the C-terminal to aid in purification steps. A 
sequence mutation at codon 141 (GCG to TGC) was introduced to replace an alanine with a 
cysteine residue. Cysteine residues are often targeted for site selective immobilisation so was 
included for potential extension to different immobilisation methods.2 The position of the 
incorporated cysteine residue was based on a study by Badieyan et. al. in 2017 which showed 
the high retention of activity upon immobilisation via this site.3 The gene sequence was codon 
optimised, which replaces uncommon codons of the gene with a redundant codon that is more 
frequently occurring in the expression system (Escherichia coli). This process does not alter 
the amino acid sequence but is designed to improve translation efficiency into the protein. 
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Start and stop codons are in bold, restriction sites NdeI at the 5’ end and KpnI and 




















pET28a(+) Vector: pET-28a(+) is a 5.4 kilobase standard expression (Merck 
Millipore) vector containing a kanamycin resistance gene (for selection purposes), a lac operon 
and the 5’ NdeI and 3’ HindIII restriction site (for cloning purposes).  
DNA replication: The pET-28a(+)(linB) vector was transformed into competent E.coli 
strain DH5-α via standard methods to increase the concentration of DNA. Successfully 
transformed cells were cultured in Luria Broth (LB) containing kanamycin (30 μg.mL-1) for 6 
hours (37°C, 100 rpm) and the pET-28a(+)(linB) DNA was extracted and purified using a 
Promega Magic miniprep kit. The presence of the LinB gene was confirmed via gel 
electrophoresis after digestion with HindIII and NdeI restriction site enzymes (Figure S6.1). 
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Figure S6.2: (a) The linB gene cloned into the pET28a(+) plasmid flanked by a 5’ NdeI and 
3’ HindIII restriction sites. (b) Electrophoresis gel of the linB-pET28a(+) replication product 
after restriction digest with NdeI and HindIII showing the correct linB fragment size (906 bp) 
and pET-28a(+) backbone (5.4 kbp). L1: DNA size marker lane, L2: Digested linB-pET28a(+). 
 
6.8.3. Protein Expression and Purification 
Final Amino Acid Sequence. The 6 x His tag is in italics and the A141C mutation 
highlighted in yellow. The molecular weight (MW) expected from the sequence is 34,084 Da 
with an isoelectric point of 5.54 and Molar Extinction of 56170 M-1.cm-1 Coefficient(ExPASy 
Bioinformatics Resource Portal).4 For comparison, without the His tag the MW (33,261 Da) 







Expression: The pET-28a(+)(linB) was transformed into competent Escherichia coli 
strain BL21 (DE3) for protein expression. The cells were cultured in LB (2 litres) with 
kanamycin (30 μg.mL-1) for 8 hours to increase the cell density (37°C, 100 rpm). The culture 
was cooled to 20°C and protein expression was induced with the addition of IPTG (0.1 mM). 
The culture was grown for a further 20 hours and the cells were harvested by centrifugation 
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(4000 g, 10 min, 4°C). The cell pellet was resuspended in phosphate buffer (50 mM, pH 7.4), 
placed on ice, and lysed by sonication (25 cycles at 20:40 seconds on:off, 70 %, 19 mm probe, 
Sonics Vibra-Cell). The lysed cells were centrifuged (40,000 g, 10 min, 4°C) to separate the 
protein from cell debris.  
Purification: The protein solution was loaded onto a HisTrap Crude FF column (GE 
Life Science, 5 mL) pre-equilibrated with binding buffer (50 mM tris, pH 7.4, 300 mM NaCl, 
20 mM imidazole, 1 mM dithiothreitol). The column was washed with 5 column volumes of 
Binding Buffer to remove non-His tagged proteins, and the LinB protein was eluted with 2 
column volumes of elution buffer (50 mM tris, pH 7.4, 300 mM NaCl, 300 mM imidazole, 1 
mM dithiothreitol). The protein was concentrated and exchanged into phosphate buffer (50 
mM, pH 7.4) via ultra-filtration (4x, 10 KDa, 4000 rpm) and combined with an equal volume 
of 80% glycerol. The protein was filtered through a 0.22 µm syringe filter and stored at -20°C. 
LinB protein concentration and purity was determined by Bradford Assay (Figure S6.3) and 
SDS-PAGE (Figure 6.2) respectively. Prior to use, the protein was exchanged into water and 
concentrated by ultra-filtration (4x, 10 KDa, 4000 rpm).  
Bradford Assay: A Bradford Assay was performed to calculate the LinB concentration 
as per the Sigma Aldrich Protocol.5 All BSA protein standards and the LinB sample were made 
up in sodium phosphate buffer (50 mM, pH 7.4) and the absorbance of the protein-coomassie 
(dye) complex was measure at 595 nm. The concentration of BSA (MW: 66,400 g.mol-1) was 
calculated using the extinction coefficient of 43,824 M-1.cm-1 at 280 nm. According to the 
Bradford calibration curve (Figure S6.3) a 2 L broth expression yielded approximately 73 ± 5 
mg of purified LinB. The theoretical extinction coefficient of LinB (56,170 M-1.cm-1 @ 280 
nm) was used to cross check concentrations prior to usage. 
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Figure S6.3: Bradford assay calibration curve using Bovine Serum Albumin (BSA). Duplicate 
calibrations were made with absorbance values measured after 15 minutes with the standard 
error for each BSA concentration shown in red. 
  
Chapter 6   
- 219 - 
 
6.8.4. Substrate/product controls. 
 
 
Figure S6.4: GC calibration of 1,2-DBE (left) and 1,3-DBP (adjusted for internal standard 
variability) from which the time dependant reduction in concentration was calculated from. 
 
 
Figure S6.5: GC calibration of 2-bromoethanol and 3-bromo-1-propanol (adjusted for internal 
standard variability). No significant reduction in concentration was observed over the 24-hour 
period. 
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Table S6.1: The concentration of the 1 mM 1,2-DBE, 1,3-DBP, BrEtOH, and BrPrOH controls 
as calculated from a time=0 substrate and product calibration curve. 
  Concentration (mM)  
Time (hours) 1,2-DBE BrEtOH 1,3-DBP BrPrOH 
0 1 1 1 1 
8 0.99 1 0.98 1 
16 0.70 0.89 0.71 0.98 
24 0.53 0.88 0.52 0.82 
 
 
Figure S6.6: GC traces of 2-bromoethanol after 8 hours without LinB (black) and with free 
enzyme showing consumption of the first bromo-alcohol product. 
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6.8.5. Biocomposite formation. 
 
 
Figure S6.7: As-synthesised PXRD pattern of ZIF-8 (500 nm), ZIF-90 (1 µm) and ZIF-90 
made in the presence LinB.  
 
Figure S6.8: As-synthesised PXRD pattern of BioHOF-1 made in the presence LinB or no 
protein. Additional peaks will appear upon grinding the sample, as the effects of preferred 
orientation are overcome.6 The simulated powder pattern was generated form single crystal X-
ray diffraction data of the protein free Bio-HOF-1.7  
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6.8.6. Biocomposite activity testing. 
 
Table S6.2: Percentage conversion of the 1,2-DBE to 2-bromoethanol by free LinB, 
LinB@BioHOF-1, LinB@ZIF-8 (500 nm), LinB@ZIF-8 (1 µm) and LinB@ZIF-90 When 
allowed to react for 16 hours, both the free LinB and LinB@BioHOF-1 reached 93% 
conversion, whilst all ZIFs were susceptible to substrate loss without further product formation. 
Time Free BioHOF-1 ZIF-8 (500 nm) ZIF-8 (1 µm) ZIF-90 
8 hr 86 75 <1 n.d 11 
16 hr 93 94 1 n.d 14 
24 hr 67 76 3 n.d 10 
 
Table S6.3: Percentage conversion of the 1,3-DBP to 3-bromopropan-1-ol by free LinB, 
LinB@BioHOF-1, LinB@ZIF-8 (500 nm), LinB@ZIF-8 (1 µm) and LinB@ZIF-90. 
Time Free BioHOF-1 ZIF-8 (500 nm) ZIF-8 (1 µm) ZIF-90 
8 hr 86 97 54 2 97 
16 hr 90 85 67 1 100 
24 hr 48 58 80 2 92 
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6.8.7. Post assay characterisation. 
 
 
Figure S6.9: PXRD of the LinB@BioHOF-1 composite post assay with 1,2-DBE, and 1,3-
DBP. No changes to crystallinity were observed post catalysis. 
 
Figure S6.10: PXRD of the LinB@ZIF-8 (500 nm) composite post assay with 1,2-DBE, and 
1,3-DBP. Despite the degradation, no changes to bulk crystallinity were observed post 
catalysis. 
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Figure S6.11: PXRD of the LinB@ZIF-8 (1 µm) composite post assay with 1,2-DBE, and 1,3-
DBP. No changes to bulk crystallinity were observed post catalysis. 
 
 
Figure S6.12: PXRD of the LinB@ZIF-90 composite post assay with 1,2-DBE, and 1,3-DBP. 
Despite the degradation, no changes to bulk crystallinity were observed post catalysis. 
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Figure S6.13: Mole fraction of the reaction mixture using free LinB and each biocomposite 
after an 8-hour reaction with (a) 1,2-DBE and (b) 1,3-DBP. The substrate (stripes) and first 
products (solid red) concentrations were calculated from calibration curves whilst the white 
dashed segment represents substrate and/or product that was unaccounted for.  
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Figure S6.14: Substrate and product adsorption controls for 1,2-DBE (left) and 1,3-DBP 
(right) after 8 hours. The amount of BSA biocomposite was set to be equivalent to the LinB 
counterpart. As such, a larger mass of ZIF-8 (1 µm) compared to ZIF-8 (500 nm) would be 
present in solution and would contribute to the larger percentage of substrate loss. Only minor 
product adsorption was observed for each biocomposite. 
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Chapter 7. Conclusions and Future Directions 
7.1.  Outlook 
This thesis describes the investigation of a selection of porous materials that have been 
developed as enzyme immobilisation supports. The work in this thesis has developed general 
protocols for protein immobilisation using porous supports, and in doing so has improved our 
understanding of how these processes can influence enzymatic activity. The chemistry of 
porous frameworks and enzymatic catalysis are both well established, independent fields. 
However, at the interface of the two, lies a burgeoning area of research, known as enzyme 
immobilisation using porous frameworks (MOFs/HOFs). This thesis investigated the 
immobilisation process, through systematic screening of conditions. Enzymatic activity assays 
were used to probe the compatibility of the framework for immobilisation. As a result, 
improved protocols were developed for the immobilisation of enzymes whilst maintaining their 
activity. In summary, this study has contributed to an increased understanding of the interplay 
between the framework and the enzyme chemistry. 
In Chapters 2 and 3, we established consistent and predictable protocols for 
encapsulating proteins using ZIF-8 as the support material. In the initial screening, we observed 
that the biomimetic mineralisation methodology used for BSA@ZIF-8 could not be universally 
applied to all proteins. Through the screening of a diverse range of proteins, we now understand 
the impact that protein surface chemistry plays in seeding the biomimetic mineralisation of 
ZIF-8 in aqueous solutions. With this knowledge, we developed synthetic conditions to 
enhance the immobilisation process, through modulation of precursor concentrations and 
surface functionalisation of the protein.1-2 An important outcome of this study was that the zeta-
potential of the protein in a 2-mIM solution (both experimental and computational) can be used 
to determine the efficacy of ZIF-8 nucleation using proteins. Here, it was established that the 
isoelectric point (pI) of the protein could also be used as a predictive tool, i.e. proteins with a 
pI value of <6 afforded successful nucleation. This could be used to select suitable proteins for 
future studies or to determine how the protocol of immobilisation could be modified.2 This 
work enabled us to encapsulate a range of structurally and chemically diverse proteins. 
However, the influence of protein surface chemistry on spatial distribution within ZIF-8, upon 
immobilisation, is still relatively unknown. Within our group, work has been previously 
undertaken to understand this process, however the focus of that study was limited to one 
encapsulation method.1 Variation in the spatial distribution of the protein within the crystals 
(central, subsurface or surface bound) was seemingly dictated by the surface chemistry of the 
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fluorescently tagged proteins (fluorescein or rhodamine). However, the impact of both the 
protein surface chemistry, and the synthetic conditions on the growth phase and properties of 
protein@ZIF-8 biocomposites is still largely unknown, which necessitates further 
investigation. However, the work described in Chapters 2 and 3, enabled the development of 
consistent methods of forming different sized enzyme@ZIF-8 biocomposites to be examined 
for enzymatic activity. 
In the literature, there have been many studies of enzyme@ZIF-8 biocomposites. 
However, there are inconsistencies in the reporting of the synthesis conditions, material 
handling and storage of materials which have resulted in conflicting activity data.3-5 The work 
described in Chapter 4 investigated the relationship between the synthetic conditions (for 
biocomposite formation) and enzymatic activity. Biocomposites of lipase (CALB) of different 
particle sizes and network topologies were obtained, through modulation of the precursor 
concentrations and washing protocols, and their enzymatic activity was measured using 
different reactions catalysed by lipase. The method of CALB@ZIF-8 formation was shown to 
impact the catalysis of both a transesterification and hydrolysis reaction. For the 
transesterification reaction, that was conducted in hexane, the CALB@ZIF-8 biocomposites 
synthesised using low ligand concentrations, outperformed the free enzyme, that was unable to 
catalyse the reaction in 100% hexane. Additionally, the smaller (low ratio) CALB@ZIF-8 
biocomposites demonstrated the best activity for both reactions, with the larger (high ratio) 
samples being essentially inactive.  
In order to account for the variation in synthetic protocols, careful reporting of the 
reaction conditions and sample treatment was necessary. Indeed, by investigating the use of 
reaction media, such as phosphate buffer, which cause framework degradation and enzyme 
leaching, we have begun to understand source of the variations that have been reported in the 
literature.3, 6-7 The data presented in Chapter 4 has expanded our knowledge of CALB@ZIF-
8 catalysis, however, to fully comprehend the variations reported, additional studies with 
alternate enzymes are needed. With further investigation, we aim to understand how the protein 
surface chemistry, and the formation kinetics ZIF-8, dictate biocomposite activity and stability.  
In order to understand why the larger (high ratio) CALB@ZIF-8 samples were inactive, 
Chapter 5 investigated two structurally and chemically different frameworks as 
immobilisation supports for CALB; ZIF-90 and BioHOF-1.3, 8 Similar to previous studies with 
catalase, CALB was shown to retain activity upon immobilisation with both ZIF-90 and 
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BioHOF-1 and thus highlights the potential advantages of these frameworks, over ZIF-8 as 
enzyme immobilisation supports. An important finding of this study was that CALB 
maintained its stereoselectivity for the transesterification of phenyl ethanol with vinyl acetate 
(ee 99%), suggesting that the immobilisation process was not significantly impacting the 
enzyme structure. However, studies which directly probe protein conformation are required to 
fully understand the relationship between the framework and the protein. There are inherent 
difficulties in analysing these interactions for the solid phase biocomposites, as the majority of 
methods which probe protein/peptide folding/unfolding are solution based and so new solid 
phase techniques must be developed to do so. The preliminary investigations with 
CALB@ZIF-90 and CALB@BioHOF-1, suggested that the enzyme was impacting the 
formation of both materials. However, there remains little understanding of the mechanism of 
framework formation was affected in each case. The systematic screening of different proteins 
may aid our understanding of this process to establish the rules and generality of biocomposite 
formation, in a similar manner outlined in Chapters 2 and 3. 
Chapter 6 built upon our knowledge from the previous studies to extend our protocols 
to a new dehalogenase enzyme (LinB). Importantly this enzyme had yet to be immobilised in 
any of the frameworks tested here (ZIF-8, ZIF-90, or BioHOF-1). Additionally, there have been 
few examples of the immobilisation of recombinantly expressed enzymes using ZIF-8, ZIF-90 
and none for BioHOF-1, as such this was described for the first time in Chapter 6. LinB could 
be immobilised in each material, however this study highlighted some of the challenges of 
using ZIFs for enzymatic catalysis. More specifically, for the two dehalogenation reactions 
tested, LinB@BioHOF-1 exhibited greater activity and stability, compared to both ZIF 
materials which were either inactive or degraded under the reaction conditions. The BioHOF-
1 framework has only recently been applied as a support material for enzyme immobilisation, 
and as such has substantial scope for investigation.8 Despite the infancy of using BioHOF-1, 
this method has already shown promise for the stabilisation of multiple enzymes to a range of 
non-biological conditions. In the investigation described in Chapter 6, LinB@BioHOF-1 was 
stable to thermal treatment at 60 °C, and could be reused for five cycles with minimal loss in 
activity. These findings have prompted further exploration of LinB@BioHOF-1, to examine 
the potential of the biocomposite, extending the substrate range and reaction conditions to more 
industrially relevant applications. This may include chiral resolution of small molecules. 
Additionally, the volatile substrates of LinB, make this enzyme an ideal candidate for gas phase 
catalysis testing. 
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 This work could be extended to focus on understanding the variations highlighted above 
and broadening the application of these porous supports to new enzymes, and reaction 
conditions. We limited our investigation to specific enzyme/reaction systems, and thus have 
only begun to uncover the potential of porous frameworks (in particular BioHOF-1) for enzyme 
immobilisation. There is a diverse library natural, recombinant, and genetically engineered 
proteins that are available which can direct our focus towards the development of novel 
protein/enzyme biocomposites. However, due to the challenges associate with ZIF materials, 
and the complexity of the biocomposite formation, little attention has been given to multi-
enzyme reactions, and systems requiring external cofactors. With the recent development of 
BioHOF-1, an exciting extension of this work is to examine the immobilisation of complex, 
multi-enzyme systems that have yet to be investigated. As such, targeting more complex, 
industrially relevant reactions is now possible. 
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